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ABBREVIATIONS 
A Age 
ACC Accelerations 
ADA American Diabetes Association 
ANOVA Analysis of variance 
AP Anterior posterior 
BA Baseline 
BMI Body Mass Index 
CAD Cadence 
CNS Central nervous system 
CG Control group 
COM Centre of mass 
COP Centre of pressure 
COPnet COP computed with two force-plates 
CV Coefficient of variation 
CVGCT Coefficient of variation of gait cycle time 
D Diabetes without neuropathy 
DEG Degree 
DFR Dorsiflexion range of motion 
DG Diabetic group 
DIFF Difference 
DM Diabetic patients without peripheral neuropathy 
DPN Diabetic patients with peripheral neuropathy 
DPU Diabetic patients with a previous ulcer 
E.G. Exempli gratia (For example) 
EMG Electromyogram 
ENMG Electro-neuro-myogramm 
EO Eyes open 
EC Eyes closed 
ES Effect sizes 
FES-I Falls Efficacy Scale- International version 
FLD Feedback loop delay 
FP Force platform / Force plate 
FU Follow-up 
G Grass 
GC Gait cycle 
GCT Gait cycle time 
GE Gender 
GRFs Ground reaction forces 
H Healthy 
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NCT National clinical trial 
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NRV Non-reported values 
PFTP Plantar flexor peak torque 
PI Post-intervention 
PN Peripheral neuropathy 
POMA Performance-Oriented Mobility Assessment 
POMA-B Performance-Oriented Mobility Assessment-Balance 
PRoFaNE Prevention of Falls Network Europe 
PSSD Pressure specified sensory device 
PVD Peripheral vascular disease 
R Right 
RMS Root mean square 
RSG Rosiglitazone 
S Cobblestones 
SD Standard deviation 
SDC Smallest detectable change 
SEM Standard error of measurement 
SI Sway index 
T Tarred surface/tarred terrain/tarred pathway 
TO Toe-off 
U Unselected 
V Vertical 
VIF Variance inflation factor 
VPT Vibration perception threshold 
W Weight 
WHO World Health Organisation 
 
Comment: When a unit of measurement is associated with another, the following 
internationally recognised format is applied: i.e. for “metres per second” read: “ms-1”; 
“kilograms per metre”: “kgm-1”. 
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BACKGROUND 
My interest in the gait patterns, balance and fall prevention springs from my background in 
Physiotherapy and introduced me to the world of gait analysis and human movement 
sciences. This, combined with a realisation of the high prevalence of diabetes [1] and of its 
costly consequences for health care management, made it worthwhile to investigate 
further the impact of the disease on patients’ gait and physical function. 
The American Diabetes Association (ADA) estimates that diabetes affects more than 20 
million Americans and costs employers more than $132 billion annually in direct and 
indirect costs [2]. Approximately 58% of patients with type 2 diabetes have one or more 
complications from the disease resulting in an increased demand for medical services [2]. 
The most symptomatic complication of this disease is peripheral neuropathy (PN) which 
affects approximately 50% of all patients diagnosed with diabetes, older than 60 years of 
age [3]. 
Gait characteristics differ in individuals with diabetes compared with those without 
diabetes [4]. Furthermore, diabetes mellitus is recognised as an independent risk factor for 
falls among elderly persons [5]. In a prospective study of 139 elderly patients in a long-term 
care facility, Maurer et al. [5] examined the association between falls and multiple 
domains, which included clinical diagnoses, medication, orthostatic blood pressure change, 
gait, balance, mental status, well being, activities of daily living, affect/behaviour, range of 
motion and communication. The results identified diabetes, gait and balance as significant 
and independent predictors for a heightened risk of falling. Wallace et al. [6] reported an 
overall incidence of falls of 1.25 falls per person-year in cohorts of diabetic individuals. 
Forty-one percent reported 2 or more falls, which could be associated with higher fracture 
risk. 
Two main care paradigms are suggested for diabetic patients. The first paradigm is lifestyle 
management (including behavioural advice on diet and physical activity) [7, 8] and the 
second is medication (oral hypoglycaemias and insulin), proposed when lifestyle changes 
fail to be effective [9]. In order to avoid the complications of diabetes, patients are 
recommended to be physically active for at least 30 min a day, 6 days a week [10]. 
However, this advice leads to a dilemma: how can individuals at increased risk of falling 
carry out a regular physical activity? Patients with inadequate gait stability or who 
experience a fall related injury, may consequently not be able to meet these 
recommendations, thereby finding themselves in a vicious circle of reduced physical activity 
levels, leading to an increased risk of diabetic complications and decreased musculoskeletal 
function. This decline in musculoskeletal function may have a further negative impact on 
physical activity, thus perpetuating the cycle. Within this context, one may further wonder 
whether fear of falling could be an additional factor influencing this whole model (Figure 
1.1). 
Another complex issue, which is described in the literature, is the importance of patients’ 
compliance with the regimen and adherence to self-management behaviours to achieve 
long-term diabetes control. However, diabetic patients are known to show only moderate 
motivation as well as sparse compliance and treatment achievement [11, 12], which can 
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have a further negative influence on patient’s physical activity level and consequently on 
their gait. 
Figure 1.1.  Vicious circle between risk of falling and regular physical activity. This block diagram was adapted from 
the diagram published by Hausdorff et al. [13]. It shows some of the physiological and
neuropsychological factors that may be associated with gait instability. It further illustrates the
locomotor system’s and certain age-associated changes (shaded boxes) in physiological capacity that 
may mediate gait instability. An unstable gait with its consequences of falls and fear of falling may
further negatively influence physical activity levels, a fact, which itself leads to a de-conditioning of 
skeletal and cardiac muscle and thus perpetuates this cycle. 
With this in mind, our research group was interested in what is already known about gait 
characteristics of diabetic patients, the causes of gait alterations and possible treatment 
strategies. 
Evidence that diabetic neuropathy is strongly associated with gait alterations, postural 
instability and with an increased risk of falls has been identified [5, 6, 14-16]. However, the 
variety of studies, providing a wealth of experimental data, made it difficult to gain a 
thorough insight into possible causes of gait alterations and fall risk in diabetic patients or 
to get a clear view of which gait parameters could be clinically relevant to fall risk 
prevention [15]. Furthermore, discussion about the causes and clinical factors related to 
gait abnormalities [4, 15] hampered the definition of what kind of population should be 
targeted for prevention or intervention. Most surprisingly, only very few studies 
investigating how to improve the gait of patients with type 2 diabetes were identified, a 
fact which provided the incentive to investigate whether the gait and balance of a diabetic 
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patient, as well as other clinical factors related to gait (e.g. muscle strength, joint mobility), 
may be improved with a physiotherapy treatment. 
To achieve the aforementioned goals, several steps were necessary. Firstly, an adequate 
method and tool to measure gait abnormalities in patients with type 2 diabetes had to be 
identified. Secondly, knowledge gaps in the current literature had to be addressed in order 
to gain an in-depth understanding of the gait characteristics of diabetic patients, with and 
without neuropathy. As several functions, such as plantar cutaneous sensation and 
proprioception, which are compromised in the presence of diabetic neuropathy [17, 18] 
affect both gait and balance, and as balance impairments are likely to contribute to diabetic 
patients’ gait alterations, we were further interested in the postural control of diabetic 
patients with and without neuropathy. Finally, clinical parameters associated with gait 
abnormalities of patients with type 2 diabetes had to be identified in order to adequately 
develop and test a treatment approach. 
Before specifying the objectives and outline of this thesis, information about Diabetes 
Mellitus will be provided and the fundamental characteristics of gait analysis along with 
some reference values for normal gait will be presented. At the end of this introduction the 
general practical and methodological choices made in order to address the study’s aims will 
be explained. 
DIABETES 
Diabetes is a condition primarily defined by the level of hyperglycaemia giving rise to risk of 
microvascular damage (retinopathy, nephropathy and neuropathy). It is associated with 
reduced life expectancy and significant morbidity due to specific diabetes related 
microvascular complications, increased risk of macrovascular complications (ischemic heart 
disease, stroke and peripheral vascular disease) and diminished quality of life [19]. 
Although all forms of diabetes are characterised by hyperglycaemia, the pathogenic 
mechanisms by which hyperglycaemia arises differ widely [20]. Some forms of Diabetes 
Mellitus are characterised by absolute insulin deficiency or a genetic defect leading to 
defective insulin secretion, whereas other forms share insulin resistance as their underlying 
aetiology [20, 21]. The pancreatic β-cell and its secretory product insulin are central in the 
pathophysiology of diabetes. Type 1 or insulin-dependent diabetes mellitus results from an 
absolute deficiency of insulin due to auto-immunological destruction of the insulin-
producing pancreatic β-cell. Type 2 diabetes, which is the focus of this thesis, is a 
heterogeneous group of disorders usually characterised by variable degrees of insulin 
resistance, β-cell dysfunction with impaired insulin secretion [22] and increased glucose 
production [20, 21]. At each end of this spectrum are single-gene disorders that affect the 
ability of the pancreatic β-cell to secrete insulin or the ability of muscle, fat and liver cells to 
respond to insulin’s actions. Muscle and fat cells are ‘resistant’ to the actions of insulin and 
compensatory mechanisms that are activated in the β-cell to secrete more insulin are 
insufficient to maintain blood glucose levels within a normal physiological range [20, 22]. 
This chronic hyperglycaemia of diabetes is associated with long-term damage, dysfunction 
and failure of various organs, especially the eyes, kidneys, nerves, heart and blood vessels 
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[20-22]. Although the major genes that predispose to this disorder have yet to be 
identified, it is clear that the disease is polygenic and multifactorial [21]. Various genetic 
loci contribute to susceptibility [21, 23]. Additionally environmental factors (such as 
nutrition and physical activity) further modulate phenotypic expression of the disease [21]. 
Diagnosis 
Consensus panels of experts from the National Diabetes Data Group and the World Health 
Organisation (WHO) have issued criteria for diagnosis of Diabetes Mellitus. These criteria 
are a fasting plasma glucose ≥ 7.0 mmoll-1 (126 mgdl-1) or 2 hour plasma glucose ≥ 11.1 
mmol-1 (200 mgdl-1) [19]. 
Prevalence of diabetes 
The WHO has described type 2 diabetes as an international epidemic. Recent estimates 
indicated 171 million people in the world with diabetes in the year 2000. The number is 
projected to increase to 366 million by the year 2030 [1]. In Europe there are 2 data 
sources on the prevalence of diabetes. The WHO European Health for All database 
compiles data from national diabetes registers, where available, or from routine reporting 
systems [24]. These data show that the prevalence of diagnosed diabetes is increasing in 
nearly all countries of Europe with the highest prevalence in 2004 in Malta (7.6%) and the 
Czech Republic (7.0%) [24]. The WHO data however, greatly underestimates the true 
prevalence of diabetes in the population as around 50% of diabetes is undiagnosed [25-27]. 
The Atlas of the International Diabetes Federation [27] collates population-based 
prevalence studies across Europe and reports data on diagnosed and non-diagnosed 
diabetes combined. This study estimates an overall European prevalence of 7.8% with over 
48 million adults aged 20 to 79 years in Europe living with diabetes in 2003. 
Risk factors 
Non-modifiable risk factors for type 2 diabetes include age (diabetes incidence and 
prevalence increases with age), race or ethnicity [28, 29] (e.g. African Americans are more 
likely to develop diabetes), family history [30] (genetic predisposition), history of 
gestational diabetes [21] and low birth weight [21]. Modifiable or lifestyle risk factors 
include, among others [28, 29, 35], increased Body Mass Index (BMI) [29, 31], physical 
inactivity [29, 32], overly rich nutrition [29], hypertension [21], smoking [21, 33] and 
excessive alcohol consumption [21, 34]. 
Complications 
The risk of chronic complications increases as a function of the duration of hyperglycaemia 
[21]. Since type 2 diabetes may have an asymptomatic period many individuals have 
complications at the time of diagnosis [21, 35]. The chronic complications of diabetes can 
be subdivided into vascular and nonvascular complications [21]. The vascular complications 
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are further subdivided into microvascular (retinopathy, neuropathy, nephropathy) and 
macrovascular complications (coronary artery disease, peripheral vascular disease, 
cerebrovascular disease) [36]. Nonvascular complications include problems such as 
gastroparesis [37], sexual dysfunction [38] and skin changes [39]. In addition to these 
chronic complications Diabetes Mellitus is a major cause of non-traumatic lower extremity 
amputation [21, 40] due to foot ulcers and infections (Figure 1.2). 
Foot ulcers and infections are known to be major sources of morbidity in individuals with 
diabetes [41, 42]. The reasons for this lower extremity complication are complex and 
involve the interaction of several pathogenic factors: neuropathy, abnormal foot 
biomechanics, peripheral vascular disease and poor wound healing [21, 43]. Peripheral 
sensory neuropathy interferes with normal protective mechanisms and allows the patient 
to sustain major or repetitive minor trauma to the foot, often without knowledge of the 
injury [21]. Disordered proprioception causes abnormal weight bearing [21, 44]. Motor and 
sensory neuropathy in the foot leads to abnormal foot muscle mechanism and to structural 
changes [21, 44, 45]. 
 
After having described the basis of the disease Diabetes, the following paragraph will 
address the fundamentals of gait analysis, in view of facilitating the appraisal of the studies 
included in this thesis. 
GAIT 
Walking is the body’s natural means of moving from one location to another. Functional 
versatility allows the lower limbs to readily accommodate stairs, doorways, changing 
THESIS_L_Allet_v15.pdf
Figure 1.2.  Prevalence of most common diabetes-related complications among people with diabetes. National 
Health and Nutrition survey 1999-2004 [46]. 
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surfaces and obstacles in the path of progression. Efficiency in these endeavours depends 
on free joint mobility and muscle activity that is selective in timing and intensity [47]. 
Walking is also known as a pattern of motion under control, a repetitious sequence of limb 
motion while simultaneously maintaining stance stability and forward motion. 
Interestingly, every individual has a unique gait pattern [47]. By evaluating the gait pattern 
of an individual, a therapist can determine specific weaknesses and adjust rehabilitation 
programs to address these issues [48]. The term “gait cycle” is used to depict the complex 
activity of walking, or our gait pattern. It describes the motions from initial placement of 
the supporting heel on the ground to when the same heel contacts the ground for a second 
time. Each gait cycle (also known as stride) is divided into 2 periods, stance (entire period 
during which the foot is on the ground) and swing (foot is in the air for limb advancement). 
Stance is subdivided into 3 intervals according to the sequence of floor contact (initial 
double stance, single limb support and terminal double support). The gross normal 
distribution of the floor contact is 60% for stance (10% for each double stance and 40% for 
single limb support) and 40% for swing (Figure 1.3). The gait cycle provides a framework for 
gait analysis. The gait characteristics (spatiotemporal gait parameters, kinematic, kinetic 
and muscular activity values) can be extracted from each gait cycle and used to interpret 
the walking pattern of an individual or of a group of patients [50]. 
 
This thesis will focus on spatiotemporal gait parameters (gait speed, cadence, stride length 
and gait cycle time, single support time, double support time and the stride to stride 
variability) because of their clinical relevance for patients’ quality of life and daily activities 
[51, 52] and because of their association with heightened fall risk [53-55]. Before 
continuing with some reference values, interested readers can refer to Appendix I for a 
precise description and illustration of the divisions of gait cycles, and to Appendix II for a 
definition of spatiotemporal gait parameters. 
Gait speed is one of the most widely reported spatiotemporal gait parameters. Gait speed 
depends on several factors such as height, lower limb length and age [56]. It can be further 
influenced by the conditions under which it is measured [57]. Gait speed is greater in a 
large and spacious place than in a narrow short corridor [58]. For these reasons it is most 
appropriate to compare the measured parameters of a target group with values from an 
age and height-matched healthy control group using the same measurement method. As 
shown in Table 1.1, different authors propose a considerable range of values for the speed 
categories slow, comfortable and rapid gait. The range of slow gait speed has been 
described as between 0.5 ms-1 and 1 ms-1 (1.8 to 3.8 kmh-1), comfortable walking speed 
from 1.3 ms-1 to 1.6 ms-1 (4.7 to 5.8 kmh-1) and a range of 1.9 ms-1 to 2.45 ms-1 (6.8 to 8.8 
kmh-1) is considered a rapid walking speed. Summarising these findings, Viel [56] suggests 
values for adult gait speed that may be a useful reference point for data interpretation 
(Table 1.2). 
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60% 40%
Right Stride / Cycle
L.swing
R.stance
L.stance L.swing
R.stanceR.swing
Left Stride / Cycle
L. Toe off L. Heel contact L. Toe off L. Heel contact
R. Toe off R. Heel contact R. Toe off R. Heel contact
 
Figure 1.3.  Schematic diagram of the temporal sequence of the gait cycle showing complete right (shaded bars)
and left strides (white bars). HC = heel/initial contact; L = left; R = right. 
The areas of overlap between HC and TO represent periods of double limb support, which 
coincidences with the period of pre-swing on the trailing limb and loading response on the leading 
limb. The figure above was inserted with reference to the original diagram published by Barr and 
Backus [49]. 
Table 1.1. Tables with reference values of gait speed in ms-1 [56] 
Author Slow Comfortable Fast 
Lamoreux [59] 0.97 1.45 1.72 
Winter [60] 1.04 1.26 1.54 
Herman [61] 0.92 1.28 1.98 
Larsson [62] 1.24 1.54 2.40 
Riley [63]  - 1.25 to 1.56  - 
Growney [64]  - 1.19  - 
Stolze [65]  - 1.51 to 1.54  - 
 
Table 1.2. Estimated gait speed for adults [56] 
Speed ms-1 mmin-1 kmh-1 
Very slow 0.4  24 1.44 
0.5  30 1.80 Slow 
0.7  42 2.52 
Moderate 1.0  60 3.60 
1.3  79 4.68 Ascertained 
1.6  96 5.76 
Fast 1.9 114 6.84 
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Associations of gait parameters with an increased fall risk 
Several changes in gait characteristics such as slower self-selected gait speed [66-69], 
shorter stride length [66-69], increased double support time [68, 69] and increased gait 
variability [66, 69, 70] have been related to an increased risk of falls. These parameters 
have been frequently studied in elderly persons. The next table (Table 1.3) provides a 
comparison of different studies evaluating spatiotemporal gait parameters of older adults 
considered as active, independent, frail or as fearful fallers [53, 69, 71, 72]. 
Table 1.3.  Spatiotemporal parameters of older adults considered as active, independent, frail or as fearful fallers 
 
 
Population 
Active life style, 
No gait-related  
pathologies 
Independent,  
Randomly selected  
from community 
 
Transitioning to 
frailty 
 
Fearful 
fallers 
 Winter [72] Lord [71] Kressig [53] Maki [69] 
N  15  80  50  26 
Age (years)  68.90 (4.0)  71.10 (5.2)  79.60 (5.8)  82.00 (6.0) 
Gait speed ( ms-1)   1.29 ( - )   1.11 (0.19)   0.97 (0.23)   0.66 (0.19) 
Stride length (m)   1.38 (0.12)   1.15 (0.13)   1.11 (0.18)   0.83 (0.16) 
Cadence (stepsmin-1) 111.80 (8.7) 115.40 (11.2) 105.70 (12.7)    - 
Stance (%)  65.50 (1.7)  64.20 (1.8)  66.00 (3.1)    - 
Double Support (%)  31.00    -  32.10 (5.8)  19.80 (5.5) 
 
In a recent article [73], it was shown that slower gait speed was associated with higher risk 
of falls. Moreover, a higher variability for swing time and stride length variability were 
identified as fall risk predictors. This confirms quantitative gait markers as independent 
predictors of falls in older adults. 
Among these gait markers, gait variability is increasingly used as a fall risk predictor [54, 55, 
74]. For example an evaluation in a one year prospective study of gait variability and fall 
risk in community-living older adults [70] showed that measures of gait variability were 
predictive of future falls. Survival analysis indicated that subjects with increased gait 
variability were likely to fall sooner than those subjects who had less variability in gait 
during their clinical assessment (the 2 groups did not differ significantly with respect to age, 
gender, height, weight, BMI, health status, mental health, level of education, physical 
activity levels or ability to perform daily activities). 
Like most physiological parameters, measures of gait are not constant but rather fluctuate 
with time and change from one stride to the next, even when environmental and external 
conditions are fixed [54]. In healthy adults, these stride-to-stride fluctuations are relatively 
small and the coefficient of variation (CV) of many gait parameters (e.g. gait speed, gait 
cycle time) is of the order of just a few percent. When the systems regulating gait are 
disturbed (e.g., as a result of certain diseases), movement control may be impaired leading 
to increased stride-to-stride fluctuations [54] (Figure 1.4). 
However, only few articles describe a cut-off point above which patients were declared at 
high fall risk. In spite of this, a binary threshold was determined post hoc using a sensitivity 
analysis (CV gait cycle time > 4%) in a study conducted by Kressig et al. [74]. This cut off point 
supports the results of another clinical study in which a CV of 2.1% was reported for elderly 
non-fallers compared to a CV of 4.1% for elderly fallers during a 6 min walking test [55]. 
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Figure 1.4. Example of the stride-to-stride fluctuations in the gait cycle time as measured in older adults by 
Hausdorff [54]. An older adult non-faller and an idiopathic faller; SD = standard deviation; CV = 
coefficient of variation. 
Before providing the outline of this thesis some general practical and methodological 
choices are now described. 
GENERAL PRACTICAL AND METHODOLOGICAL CHOICES 
Population 
In this research only patients with diagnosed type 2 diabetes were studied. The previously 
described diagnostic criterion from the WHO (fasting plasma glucose ≥ 7.0 mmoll-1) was 
applied by the medical staff working in the recruitment units. All patients were recruited 
either from the Service of Therapeutic Education for Chronic Diseases or from the Service 
of Endocrinology at the University Hospital in Geneva. 
Choice of environment and equipment for gait analysis 
Gait is normally analysed in specialised laboratories which are equipped with specific 
measurement tools. The choice of equipment depends mainly on the target parameters 
which are to be measured. Spatiotemporal gait parameters can be measured with pressure 
mats [75, 76], optoelectronic systems [77], accelerometers [78, 79] and/or gyroscopes [80, 
81] or footswitches [79]. To measure kinematics, goniometers [82], an optoelectronic 
system [83] or accelerometers and gyroscopes [84] are needed. Kinetic parameters are 
measured with either load cells [85] or force platforms [83]. However, the traditionally 
performed indoor gait analysis does not reflect real life conditions. The predefined, clean 
and flat specific pathways enable standardisation and control of the environment and 
permit precise recordings, but are not representative of a patient’s typical daily 
environment. Activities of daily life require us to move in challenging environments and to 
walk on varied surfaces. Irregular terrain has been shown to influence gait parameters such 
as speed, especially in a population at risk of falls [57]. Its influence on gait parameters and 
the fact that falls most commonly occur in a complex environment [86] emphasise the need 
for clinicians to dispose of objective gait data recorded in a real life context. For the 
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aforementioned reasons and based on the results of our systematic review, all gait analyses 
in this project were performed outdoors, in a challenging environment. 
Gait can be studied in different environments with recently developed body-fixed sensors. 
In comparison with other motion measurement devices, body-fixed sensors have the 
advantage of being lightweight and portable, which enables subjects to move relatively 
freely [87]. They permit data collection in a challenging environment, they are easy to use 
and capture data from many gait cycles. At the moment a large choice of sensors exists. 
Body-fixed sensors have not only been used to monitor gait [88-90] but also to examine sit-
to-stand transfers [91], postural sway and fall risk [92] as well as physical activity levels 
[93]. Although an overview of all these different systems is beyond the scope of this thesis, 
it is important to remember that the choice of body-fixed sensors and their location must 
be consistent with the objective of the assessment [94]. If the main interest is to detect 
spatiotemporal gait parameters, it has been shown that one accelerometer on the trunk 
[90] or one gyroscope at each shin [80] is sufficient [90]. For clinical decision making 
however, the evaluation of spatiotemporal gait parameters is often insufficient. In this 
case, further information is provided by kinematic data measured by accelerometers and 
gyroscopes on hips, knees and ankles. Thus, a system computed with sensors (combination 
of accelerometers and gyroscopes) on the trunk and limbs may enable better interpretation 
of gait parameters. Having consulted the literature we decided that the Physilog® system 
(BioAGM, CH) [80] best met our requirements for the study. This system is presented in 
detail in Appendix III. The gyroscopes on both thighs and shins were used for the analysis of 
spatiotemporal gait parameters. The data provided from the trunk sensor as well as the 
data from the shin were used to assess patients’ postural stability, which may influence 
patients’ gait and fall risk. 
Standing balance and measurements 
As several structures which are compromised in the presence of diabetic neuropathy, such 
as plantar cutaneous and proprioception sensation [17, 18], affect both gait and balance, 
and as balance impairments are likely to contribute to diabetic patients’ gait alterations, 
postural control could not be ignored. Thus, a balance study to investigate and quantify 
more precisely the balance alterations in diabetic patients has been conducted. 
Nevertheless, as most falls occur during physical activities rather than in a static position 
[86] we opted to focus on gait parameters as main indicators in this thesis. The analysis of 
the relationship between quantified gait and balance parameters will be addressed in 
further studies and thus not included in this thesis. Regarding to standing balance, it is 
relevant that most studies evaluated postural stability with force plates, using 
measurements of the centre of pressure (COP) displacement [95]. Ankle and hip postural 
strategies using inverse dynamic calculations, sway area, as well as the scalar distance 
between the COP and the centre of mass (COM) are also reported [16]. In recent years, 
however, the use of miniature sensors such as accelerometers has become increasingly 
well accepted [96]. Although accelerometry data cannot be directly compared to COP 
parameters, it can discriminate between different conditions challenging the balance 
system [97]. Using an accelerometer fixed near the COM, trunk accelerometry data shows 
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good discriminative validity during standing [97]. In addition, the root mean square (RMS) 
value of the accelerometric signal was previously used [97] as the main parameter to 
discriminate young from elderly subjects during different standing conditions (i.e. quiet 
standing with eyes open, quiet standing with eyes closed and quiet standing on a compliant 
mat). 
Based on this knowledge, the range and RMS of trunk and shin acceleration during quiet 
standing was compared between healthy persons and diabetic patients with neuropathy 
and with diabetic patients without neuropathy. All data were recorded during the POMA-B 
test, a performance-oriented assessment of balance [98] and measured with the Physilog® 
system. 
Development of treatment 
Since elderly people often show symptoms similar to those in diabetic patients (de-
conditioning, muscle weakness, decreased joint mobility and decreased foot sensation), we 
surmise that programs developed for the elderly could also be effective to improve gait 
patterns and balance in diabetics and consequently decrease their fall risk. Thus, we 
reviewed the different fall prevention protocols available for the elderly in order to develop 
a specific treatment approach to improve diabetic patients’ gait characteristics and 
balance. The most effective exercises described in the literature to reduce the fall risk in a 
geriatric population are balance exercises, Tai Chi and strengthening [99]. Davies et al. 
[100] further showed that an agility training component is an equally promising type of 
exercise. Furthermore, Barnett et al. [101] found that participation in a weekly group 
exercise program with ancillary home exercises can improve balance and reduce the rate of 
falling in at-risk community dwelling older people. 
Faber et al. [102] provide a clear description of 2 exercise programs, both derived from 
programs with evidence for effectiveness in preventing falls in the elderly. Key components 
in both programs were balance and functional strength. Treatments were carried out in 
groups to increase motivation for participation. The exercises were tailored to the 
functional needs of the participants, maintaining a moderate intensity that focused on 
long-term sustainability and enjoyment. The first program, referred to as functional 
walking, was derived from the tailored exercise program developed by Robertson et al. 
[103] in New Zealand. Functional walking consisted of 10 clearly described exercises 
forming the core program, which focused on balance, mobility and transfer training. The 
exercises consisted of standing up from a chair, reaching and stepping forward and 
sideways, heel and toe stands, walking and turning, stepping on and over an obstacle, 
staircase walking, tandem foot standing and single-limb standing. The second program, 
referred to as “in Balance”, was derived from principles of Tai Chi. Functional walking and 
“in Balance” exercise programs were effective for reducing fall risk and improving the 
balance and physical performance scores in the subgroup of pre-frail elderly. Positive 
effects became apparent after 11 weeks of exercise and the authors concluded that 
supervised in-patient exercise rehabilitation is a safe and effective intervention. Finally, 
Rubenstein et al. [104] investigated effects of a group exercise program on strength, 
mobility and falls among fall-prone elderly men. They conducted a 12 week group exercise 
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program. Exercise sessions (90 min, 3 times per week) focused on increasing strength and 
endurance and improving mobility and balance. Results showed an improvement in 
strength, physical activity, general health, muscle endurance and gait. 
On the basis of the aforementioned literature about fall prevention in the elderly and of 
our knowledge about gait characteristics and postural stability in diabetic patients we 
developed a specific treatment approach. The training program we designed took place 
twice a week for 60 min over 12 weeks. Each session was directed by a physiotherapist and 
an assistant. Four different physiotherapists and 4 assistants were trained to direct the 
sessions in order to guarantee continuity. A session consisted of a warm up (5 min) 
followed by a circuit training (40 min) including gait and balance exercises. The circuit 
training was composed of a set of 10 tasks. Static and dynamic balance tasks were altered 
with functional strength exercises. Each task was performed twice during 1 min and the 
complexity of each task could be increased progressively. Each session was completed with 
interactive games to train agility (10 min) and a short feedback with suggestions for 
individual home exercises (5 min). The treatment exercises are summarised in the 
corresponding study and a detailed description is provided in Appendix IV. 
 
Now that the general practical and methodological choices of this thesis have been made 
explicit, its detailed aims and outline are presented. 
AIM OF THIS THESIS 
This thesis encompasses 3 objectives. Firstly, we wanted to identify gait characteristics of 
patients with type 2 diabetes. The second objective was to identify clinical factors 
associated with gait difficulties of patients with type 2 diabetes. These 2 aims were 
prerequisites for our third and final purpose, which was to develop and test the efficacy of 
a physiotherapy program that aimed to improve the gait, balance and related clinical 
factors of patients with diabetes. 
In order to achieve these aims several steps were necessary. The following section presents 
these steps and describes which chapter addresses the different aims. 
OUTLINE OF THE THESIS 
The project started with a systematic literature review about gait characteristics of diabetic 
patients (Chapter 2: Gait characteristics of diabetic patients: a systematic review), which 
partially addressed the first aim. With respect to this systematic review’s conclusions and 
considering the advantages of ambulatory gait measurements, we proposed to further 
study the gait characteristics of diabetic patients, with and without neuropathy, outdoors 
under real life conditions. This would allow us to gain an in-depth knowledge of gait 
difficulties in patients with type 2 diabetes. In view of this objective, an ambulatory gait 
measurement system was needed. The Physilog® is a valid ambulatory gait measurement 
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system [80], which fulfils all necessary criteria for carrying out our study. However, its 
reliability was never measured among diabetic patients walking outside on challenging 
surfaces. Thus, a reliability study was conducted prior to studying the gait of diabetic 
patients under real life conditions (Chapter 3: Reliability of diabetic patients’ gait 
parameters in a challenging environment). In the next step, we completed our first 
objective and studied the gait characteristics of diabetic patients, with and without 
neuropathy, outdoors. (Chapter 4: Gait alterations of diabetic patients while walking on 
different surfaces). Conscious that falling is a complex phenomenon and that poor balance 
is one of the major risk factors for falls [105], we were interested to investigate the balance 
performance of patients with diabetes. Thus, balance performance of diabetic patients with 
and without neuropathy was compared to that of healthy control group using the 
Performance-Oriented Mobility Assessment scale for balance (POMA-B) [98], which is a 
widely used tool for assessing mobility and fall risk in older people. Simultaneously postural 
stability was evaluated by means of trunk and shin sensors including accelerometers and 
gyroscopes. (Chapter 5: Investigation of standing balance in diabetic patients with and 
without peripheral neuropathy using accelerometers). However, as most falls occur during 
physical activities rather than in a static position [86], we opted to follow-up on gait 
parameters as indicators of dynamic balance abilities instead of postural stability 
parameters derived from static testing conditions. The next chapter identified clinical 
parameters associated with gait alterations of patients with diabetes and thus addressed 
our second objective (Chapter 6: Clinical factors associated with gait alterations in 
diabetic patients). Finally, based on this information a physiotherapeutic approach was 
developed, which was subsequently tested by means of a randomised controlled trial 
(Chapter 7: Diabetic patients’ gait and balance can be improved with a specific training 
program. A randomised controlled trial). The paper about this randomised controlled trial 
(submitted for publication) presents the most clinically relevant parameters: influence of 
the treatment on gait speed and coefficient of variation while walking on a tarred surface 
together with the results concerning balance, strength, mobility and fear of falls. However, 
several other gait parameters (speed and coefficient of variation on cobblestones, cadence, 
stride length, stance phase and swing phase while walking on a tarred surface and on 
cobblestones) were explored and will also be submitted for publication. For the sake of 
completeness these results will be summarised at the end of the said publication, which 
figures in Chapter 7. Chapters 2 to 7 have been originally written as separate articles for 
publication in international peer-reviewed scientific journals, which is why some overlap 
between chapters could not be avoided. The last chapter (Chapter 8: General discussion) 
provides an overall discussion and conclusion about this PhD thesis project (Figure 1.5). 
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Figure 1.5. Flow chart of the outline of the thesis. 
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SUMMARY 
Background 
Patients with diabetes are at higher risk of experiencing fall-related injuries when walking 
than healthy controls. The underlying mechanism responsible for this is not yet clear. Thus, 
we intend to summarise diabetic patients’ gait characteristics and emphasise those which 
could be the possible underlying mechanisms for increased fall risk. 
Aims 
This systematic review aims, in particular, to: a) evaluate the quality of existing studies 
which investigate the gait characteristics of diabetic patients, b) highlight areas of 
agreement and contradiction in study results, c) discuss and emphasise parameters 
associated with fall risk and d) propose new orientations and further areas for research 
needed for fall risk prevention in diabetic patients. 
Methods 
We conducted an electronic search of Pedro, PubMed, Ovid and Cochrane. Two authors 
independently assessed all abstracts. Quality of the selected articles was scored and the 
study results summarised and discussed. 
Results 
We considered 236 abstracts of which 28 entered our full text review. Agreement on data 
quality between 2 reviewers was high (kappa: 0.90). Authors investigating gait parameters 
in a diabetic population evaluated in particular parameters either associated with fall risk 
(speed, step length or step-time variability) or with ulcers (pressure). There is agreement 
that diabetic patients walk slower, with greater step variability, and present higher plantar 
pressures than healthy controls. 
Discussion and conclusion 
Diabetic patients present gait abnormalities, some of which can lead to heightened fall risk. 
To understand its underlying mechanisms, and to promote efficient prevention, further 
studies should analyse gait under real life conditions. 
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INTRODUCTION 
The World Health Organisation has described type 2 diabetes as an international epidemic. 
Current estimates suggest that the number of persons with diabetes will reach 250 million 
by 2010 and 300 million by 2025 [1]. Fifty percent of patients who have suffered from 
diabetes for more than 20 years develop peripheral neuropathy (PN), which affects nerve 
function from the periphery to more proximal regions [2, 3]. 
Diabetes is associated with an increase in injurious falls [4-7]. Fall frequency in diabetic 
patients has been highlighted and as a consequence increased attention to fall prevention 
by diabetes care providers is recommended [8]. Wallace et al. [6] reported an overall 
incidence of falls of 1.25 falls per person-year in cohorts of diabetic individuals. Forty-one 
percent reported 2 or more falls, which could be associated with a higher fracture risk. The 
authors further showed that diabetes, gait and balance were significantly and 
independently associated with heightened risk of falling. A closer examination of the 
literature dealing with gait characteristics in diabetic patients revealed that gait 
abnormalities are common in the aforementioned population [2, 9-20]. Studies have shown 
a decrease in quality of spatiotemporal gait parameters such as speed, stride length, gait 
cycle time, or single support time in diabetic patients with or without PN, when compared 
to healthy controls. In similar groups, authors found increased gait variability [2], higher 
reaction times [21], less ankle mobility, ankle moment and ankle power [16] or changes in 
ground reaction forces (GRFs) during walking [17]. Parameters, such as gait variability 
(stride-to-stride temporal variations) [22, 23] or reduced speed [24-26] demonstrated clear 
association with falling, albeit in an elderly population. The impact of abnormal gait 
parameters on diabetic patients’ falling is thus well demonstrated. Studying diabetic 
individuals’ gait parameters could therefore be useful to predict falling and could also 
facilitate the understanding of the causes and underlying mechanisms of heightened fall 
risk in the said population. However, questions remain about the main causes of gait 
abnormalities in diabetic patients. Various authors [7, 12, 13, 19, 27] found an association 
between neuropathy and gait abnormalities and/or falls. Ducic et al. [28] examined the 
intuitive relationship between increasing loss of foot sensibility and increasing loss of 
balance in diabetic patients. They stated that PN rather than ocular changes are responsible 
for gait problems. These authors concluded that neuropathy, leading to loss of sensation 
and to the neuromuscular control system’s inability to respond to a challenging 
environment, could be the mechanism responsible for gait abnormalities and increased risk 
of falls. Cavanagh et al. [7] also demonstrated that PN has an effect on gait and posture. 
The latter authors described 15 times more falling in the diabetic neuropathy group than in 
the diabetic control group. However, Petrofsky et al. [15] found gait impairments in 
diabetic patients with no sensory loss and concluded that whatever the mechanism, 
patients with diabetes present deficits in gait long before objective loss of sensation in the 
feet. This apparent contradiction between authors underscores the fact that the causes for 
gait abnormalities and falls are yet under debate. 
There is sufficient evidence that diabetic patients show gait abnormalities and that some of 
these parameters lead to heightened risk of falling. However, the variety of studies, 
providing a wealth of experimental data, makes it difficult to get a clear view of what gait 
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parameters could be clinically relevant to fall risk prevention. Furthermore, discussion 
about the influence of neuropathy on gait abnormalities hampers the definition of what 
population should be targeted for prevention. 
We thus intend to summarise gait characteristics in diabetic patients and then emphasise 
those which could be possible underlying mechanisms for increased risk of falls. This 
systematic review aims in particular to: a) evaluate the quality of existing studies 
investigating diabetic patients’ gait characteristics, b) highlight areas of agreement and 
contradiction in study result, c) discuss and emphasise parameters associated with fall risk 
and d) propose new orientations and further domains for research needed for fall risk 
prevention in diabetic patients. 
METHODS 
Search methods for identification of studies 
In May 2006 a professional librarian performed an electronic search of the Pedro, PubMed 
(Medline since 1950), Ovid (Biosis, Cinahl) and Cochrane (Central, Dare/CRD, HTA) 
databases covering the years 1950 to May 2006. The search strategy included the following 
keywords: (gait OR gait disorder OR walking OR kinematic OR gait analysis system OR gait 
analysis device) AND (polyneuropathy OR diabetic neuropathy OR diabetes mellitus) NOT 
amputation. Language was restricted to English, German or French. 
First selection based on abstracts 
Two independent reviewers (L.A., S.A.) assessed the title and abstract of each identified 
study. Abstracts were included in the full text review when they satisfied criteria 
mentioned below about types of studies, patient characteristics and outcome measures. 
Types of studies 
Only clinical trials evaluating gait characteristics of patients with diabetes were included. 
We excluded single case studies and pilot studies. 
Types of participants 
Persons with diabetes (type 1 or 2, with or without PN) without amputation or dependence 
on assistive devices. Studies focusing on foot deformities were excluded. 
Types of outcome measures 
Gait-related characteristics for diabetic patients (e.g. spatiotemporal results, kinematics, 
kinetics and/or electromyography (EMG)) had to be reported. 
In case of disagreement between the 2 reviewers, a third person (E.D.deB.) decided 
whether the article should be included in the systematic review. 
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Method for quality assessment in selected full text articles 
Quality assessment of the included articles was based on the checklist of Downs et al. [29], 
which was developed for the assessment of the methodological quality of both randomised 
and non-randomised studies. The reviewed articles did not focus on treatment approaches 
but rather on the evaluation of gait characteristics of patients with diabetes compared with 
a healthy group. We therefore had to adapt the checklist used, discarding items 14 and 15 
about blinding, item 17 about follow-up, items 21 and 22 about recruitment of intervention 
and control groups and items 23 and 24 about randomisation. All other items remained in 
the quality checklist. Considering the item adverse events we also evaluated events as a 
consequence of a measurement system. Four independent reviewers (D.M., E.D.deB., L.A. 
and S.A.) piloted the adapted quality checklist on 3 articles to ensure the content and to 
certify reliable data extraction. Results were compared and differences were resolved by 
discussion. After the pilot session we standardised item description to ensure good 
interrater reliability. The final quality checklist consisted of 20 items with a theoretical 
maximum score of 25 points. The checklist scored on 5 different domains: quality of 
reporting (10 items, maximum 11 points), external validity (3 items, maximum 3 points), 
internal validity bias (4 items, maximum 4 points), internal validity (2 items, maximum 2 
points) and power (1 item with maximum 5 points). The checklist was converted to an 
electronic extraction sheet and used to collect data and to control for quality of the 
included studies. We chose double extraction by 2 independent reviewers (L.A., S.A.). 
Where necessary we checked the precision of data in previous papers by the same author. 
Analysis 
Kappa statistics and bootstrapped confidence intervals were performed to ensure 
agreement in the quality assessment [30]. 
To describe the quality of the article the total points for each article and the mean value of 
each domain assessed, along with the standard deviation, were calculated. All articles 
fulfilling inclusion criteria after the abstracts had been read were considered in the results. 
A meta-analysis was not possible because results and data were presented in an 
incompatible form. A descriptive summary of the results was therefore carried out. 
RESULTS 
First selection based on abstracts: the literature search identified 236 abstracts for 
consideration. None of the articles had to be excluded on the basis of language. After 
application of the inclusion criteria 28 articles entered our full text review (Figure 2.1). 
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Figure 2.1. Procedure for the study selection with utilised database for the literature search and with defined 
selection criteria. 
Data quality 
The agreement on data quality between the 2 reviewers was high. The estimated Kappa 
value was 0.90 (0.02). The 95% confidence interval ranged from 0.86 to 0.93. The quality 
scores of studies ranged from 13 to 21 points out of a maximum of 25 points. The mean 
quality was 16.74 (1.81). The mean score was 7.85 (1.35) out of 11 for reporting, 1.39 (0.49) 
out of 3 for external validity, 3.46 (0.69) out of 4 for internal validity bias, 1.57 (0.57) out of 
2 for internal validity and 2.40 (1.50) out of 5 for power. For several items we had to report 
“unable to evaluate” due to lack of relevant information. For example, few authors 
discussed adverse events due to equipment, testing conditions or procedures. It is possible 
that authors did not feel it necessary to report the absence of adverse events. Another 
aspect that was not well reported was the number of patients approached for participation 
compared to the number of patients who actually agreed to participate. This raises 
236  
ABSTRACTS 
PEDRO PUBMED OVID BIOSIS OVID CINAHL COCHRANE 
CENTRAL 
COCHRANE 
DARE/CRD 
HTA 
28 ARTICLES 
Fulfilled all 
selection 
criteria
208 articles did not fulfil one or 
several of the following criteria: 
 
• Clinical trials   22 
• DM=Target population 114 
• Gait parameters   174 
• No amputation   21 
• No foot deformity   37 
• No assistive device    22 
Evaluation 
with a quality 
check list
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questions about whether those who took part in the studies were truly representative of 
the population of diabetic patients. In addition, the staff and place of examination were 
often difficult to evaluate. We considered them to be standardised and adapted if 
measurements were performed in a gait laboratory (explicitly mentioned in the article) or if 
they described which person carried out the tests and under which conditions. We scored 
one point if it was always the same person or if the interrater reliability was reported and 
satisfactory (Table 2.1). 
Table 2.1. Results of study scored by the reviewers L.A. and S.A. (score for each study based on the quality 
checklist published by Downs et al. [29]) 
 
 
Author [Ref] 
 
Reporting 
(max 11) 
External 
validtiy 
(max 3) 
Internal 
validity bias
(max 4) 
Internal 
validity 
(max 2) 
 
Powera 
(max 5) 
Total 
score 
(max 25 ) 
 L.A. S.A. 
 
L.A. S.A. L.A. S.A. L.A. S.A. 
 
L.A. S.A. 
 
L.A. S.A. 
Abboud [31]  6  5 2 2 4 4 1 1 3 3 16 15 
D’Ambrogi [32]  7  6 1 1 3 3 1 1 3 3 15 14 
Courtemanche [21]  9  9 2 2 3 3 2 2 0 0 16 16 
Dingwell [18]  8  8 1 1 4 4 2 2 2 2 17 17 
Dingwell [2]  9  9 1 1 4 4 2 2 1 1 17 17 
Dingwell [19]  9  9 1 1 4 4 2 2 1 1 17 17 
Giacomozzi [33]  7  6 1 1 4 4 1 1 3 3 16 15 
Hiltunen [34]  4  4 2 2 4 4 0 0 5 5 15 15 
Hsi [35] 10 10 1 1 3 3 2 2 4 4 20 20 
Hsi [36]  9  8 1 1 3 3 2 2 3 3 18 17 
Menz [20]  9  9 1 2 4 4 1 1 4 4 19 20 
Katoulis[17]  7  7 2 2 4 4 2 2 3 3 18 18 
Kwon [37]   9  9 2 2 3 3 2 2 0 0 16 16 
Meier [38]  9  9 2 2 3 4 1 1 2 2 17 18 
Mueller [16]  9  9 1 2 4 4 1 1 0 0 15 16 
Mueller [39]  8  8 1 1 4 3 2 2 0 0 15 14 
Pataky [40]  7  7 1 1 3 3 2 2 2 2 15 15 
Patil [41]  8  8 1 1 3 3 2 2 4 4 18 18 
Perry [42]  9  8 2 2 3 3 2 2 3 3 19 18 
Petrofsky [15]   6  6 1 1 3 3 2 2 2 2 14 14 
Petrofsky [14]  9  9 1 1 4 4 2 2 3 3 19 19 
Petrofsky [43]  8  7 1 1 3 3 1 2 3 3 16 16 
Richardson [11]  8  9 2 1 4 3 2 2 5 5 21 20 
Richardson [9]  8  9 1 1 4 4 2 2 1 1 16 17 
Sacco [44]  5  6 2 2 4 4 1 2 2 2 14 16 
Sacco [45]  7  7 2 1 4 3 1 2 1 1 15 14 
Uccioli [46]  8  8 1 1 3 3 2 2 3 3 17 17 
Walker [47]  8  7 
 
2 2 1 1 1 2 
 
3 3 
 
15 15 
a Sample size have been calculated to detect a difference of 10%. 
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Measurement conditions 
The 28 articles were written by 20 different authors. All authors conducted at least one of 
their studies on a straight walkway. Two articles evaluated gait while walking on a treadmill 
[18, 44]. One article examined not only forward gait but also turning to one side or the 
other and the reaction time when stopping suddenly [43]. Two authors were interested in 
challenging environments [9, 11, 20]. Patients recruited for the study of Richardson et al. 
[9, 11] had to walk on a poorly lit walkway with different obstacles and the subjects in 
Menz et al.’s [20] study were asked to walk on a 20 x 1.5 m walkway constructed to provide 
a partially yielding, irregular walking surface. Five further studies evaluated the influence of 
assistive devices or the use of medication in improving the gait parameters of diabetic 
people. Perry et al. [42] were interested to evaluate gait pressures in those wearing running 
shoes and Hsi et al. [35, 36] the influence of wearing rocker soles. Richardson et al. [11] 
analysed gait parameters using different assistive devices (a cane, a vertical surface or an 
orthosis). Petrofsky et al. [14] were the only authors who tested the influence of 
medication on gait parameters [14]. 
Population 
Seventeen articles described a diabetic group versus a healthy control group. Three studies 
did not compare patients to a control group [9, 35, 36], but the same group of patients 
under different conditions. Three studies [18, 42, 45] differentiated between diabetes with 
and without neuropathy and 5 further articles [17, 32, 33, 41, 46] distinguished a diabetic 
group with previous ulcers. The severity of the diabetes (with or without neuropathy or 
previous ulcer) was part of all of the studies’ selection criteria. These criteria together with 
other selection criteria are summarised in Table 2.2. 
Seven [20, 21, 31, 34, 41, 45, 47] out of the 25 studies comparing 2 or more groups did not 
report anything about matching factors used to guarantee similarity between groups. Five 
[21, 31, 34, 41, 47] of these 7 articles did not discuss demographic data. However, their 
results suggest similarities between groups except in the study of Abboud et al. [31]. Sacco 
et al. [44] reported a significant difference in age and Menz et al. [20] in weight. All other 
studies comparing groups used at least the factor “Age” to match groups. Nine studies [2, 
17-19, 32, 38, 40, 42, 44] used “Gender” and “Age” together with either “BMI” or “Weight 
and Height”. 
In all but 4 studies [31, 34, 41, 45] the authors clearly described exclusion criteria so as to 
avoid possible confounders for gait abnormalities. One study considered a diabetic 
population with a mean age of less than 30 years [34], 17 studies evaluated a population 
with a mean age between 40 and 60 and 9 studies with a mean age between 60 and 70 
years. Only one study had a population with a mean age higher than 70 years [20]. Two 
studies did not report the mean age of their population [41, 47] and 4 studies that of their 
control group [20, 40, 46, 47]. Four studies showed a significant difference in age between 
the patient and control groups [14, 31, 44, 45]. Weight ranged from 51.3 to 106.6 kg for the 
controls and from 62.5 to 105.4 kg for the diabetic group (Table 2.2). 
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Gait characteristics 
It is worth looking closer at the different gait parameters described in the included studies 
to understand the walking pattern of diabetic patients. 
Spatiotemporal parameters 
Gait  speed  of  controls  and  diabetic  patients was  described  in  10  studies.  The  speed  in 
diabetic  patients  ranged  from  0.7  to  1.24 ms‐1  and was  significantly  lower  than  that  of 
controls, which ranged from 0.9 to 1.47 ms‐1. Petrofsky et al. [43] described a significantly 
higher speed in controls compared to groups with either type 1 or 2 diabetes. Additionally 
they assessed slower reaction times in patients with diabetes and a much slower gait while 
turning than among control subjects. They demonstrated that subjects with type 2 diabetes 
used an average of 2 steps to turn, whereas control subjects on average used one step. The 
subjects with  type 2 diabetes  took 1.66 s  to execute  this  free pivot, whereas  the control 
subjects took on average 0.78 s. 
Step length was described in 6 studies [2, 16, 18‐20, 39]. Values ranged from 1.38 to 1.54 m 
for controls and from 1.08 to 1.38 m  in diabetic patients. Four authors [9, 16, 18, 21, 39] 
described gait cycle time. Gait cycle time ranged from 1.00 to 1.22 s for controls and from 
1.15 to 1.26 s  in diabetic patients [2, 9, 11, 13, 16, 18, 19, 21, 39]. Only 2 authors  [9, 20] 
described step time variation which ranged from 0.04 to 0.07 s  in diabetic patients (Table 
2.3). 
Richardson  et  al.  [9]  showed  that  environmental  factors  have  a  significant  effect  on  all 
spatiotemporal gait parameters in diabetic subjects. In a challenging environment in which 
either walking surface conditions or lighting intensity were manipulated, a decrease in step 
length and speed and an  increase  in step width, step width variability, step width to step 
length  ratio and  step  time  variability were observed.  In general,  controls  showed  similar 
effects,  although  less  markedly.  Furthermore,  the  controls  did  not  decrease  their  step 
length or increase step width in the challenging environment, unlike patients with diabetes. 
Another  finding was  that  under  standard  conditions  (ideal walking  surface  and  optimal 
lighting)  only  one  parameter  (mean  step  width)  correlated  with  neuropathy  severity, 
whereas  4  parameters  (step  width,  step  width  variability,  step  width  range,  step  time 
variability)  correlated  with  neuropathy  severity  when  gait  was  analysed  under  the 
challenging conditions. Comparable results were found by Menz et al. [20]. They reported 
that the walking speed of patients with PN was 19% slower while walking on a level surface 
and 25% slower on an irregular surface than among healthy controls. Patients with diabetic 
neuropathy  reduced  their  step  length  significantly when walking on  the  irregular  surface 
(17.8% vs. 12.9% p = 0.02) and showed a greater variability in step time (p = 0.003). 
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Kinematics 
Three  authors  [2,  14,  15,  20,  43]  investigated  acceleration.  Petrofsky  et  al.  [14,  15,  43] 
compared healthy controls to diabetic patients without sensory  loss  in the feet or muscle 
weakness  in  the  legs.  The  accelerometers measured  side‐to‐side  and  forward‐backward 
directions.  The  coefficient  of  variation was  higher  at  the  head  than  the  shoulders  and 
higher  for  the  hip  than  the  shoulders  for  both  controls  and  diabetics.  However,  the 
coefficient of variation for movement was much larger in diabetic patients. Based on these 
findings  they concluded  that patients with diabetes would apparently be at  risk of  falling 
long before loss of sensation or muscle weakness is noticed. Menz et al. [20] found smaller 
magnitude  accelerations  in  patients  with  diabetes  compared  to  controls  and  recorded 
more erratic acceleration signals  in diabetic patients, particularly at the head. Dingwell et 
al. [2] using a tri‐axial accelerometer on the upper body to measure the standard deviation 
could find no difference between diabetes patients with neuropathy and healthy controls. 
Kinetics 
Four authors [17, 38, 45, 46] described GRFs. All authors  found similar results for healthy 
controls and for diabetic patients with and without neuropathy in comparing peak vertical 
GRFs. Sacco et al.  [45] were  the only group who differentiated 2 peaks,  the  first at heel 
strike  and  another  at  the  moment  of  propulsion.  For  the  first  peak  they  agreed  with 
Katoulis et al.  [17] and Uccioli et al.  [46] who did not  find a difference  in  the mean GRFs 
between controls and patients with or without neuropathy. Concerning  the second peak, 
however,  they  found a  significant difference between  vertical  forces of  controls and  the 
values of the diabetic group. In addition to patients with and without neuropathy, Katoulis 
et  al.  [17]  evaluated  a  group  with  previous  ulcers.  They  described  a  decrease  in  the 
maximum  value  of  the  vertical  component  of  the  GRF  for  these  patients  compared  to 
healthy controls and diabetic patients without neuropathy (p < 0.03). 
Meier et al.  [38] were  interested  in anterior posterior  (AP) and medial  lateral  (ML)  forces 
during stopping  tasks. They  found a slower AP velocity of  the centre of mass  (COM) and 
larger AP and ML centre of pressure (COP) overshoots than in controls. Furthermore, they 
described  decreased  shock  absorption  at  heel  strike  and  increased  impulsion  at  the 
forefoot. Uccioli  et  al.  [46]  described  significantly  reduced  peak  forces  recorded mainly 
during heel  strike and push off  for patients with diabetes  compared  to a healthy group. 
Also  Katoulis  et  al.  [17]  described  larger  AP  forces  for  controls  than  for  diabetics with 
neuropathy  or  previous  ulcer  than  for  controls  or  diabetics  without  neuropathy.  Their 
results,  however,  were  only  significant  when  comparing  patients  with  previous  ulcers 
versus diabetics without neuropathy. Three authors  [17, 37, 39] described  joint moments 
during walking.  Two  of  them  said  authors,  Kwon  et  al.  [37]  and Mueller  et  al.  [39]  had 
similar  findings  and  reported  a  significant  difference,  with  lower  plantar  flexor  peak 
moment, for patients with diabetes. 
Muscle activity 
Four authors used electromyography (EMG) [14, 31, 37, 44] to record muscle activity. Two 
authors [37, 44] described the results of activity onset or cessation in either percentage of 
the gait cycle [37] or  in percentage of the stance phase [44]. Abboud et al. [31] described 
the results as time difference between heel strike and maximum muscle contraction. Sacco 
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et al. [44] evaluated muscle activity to  investigate the dynamic mechanisms developed to 
compensate for sensory and motor deficits. They collected electromyographic data of the 
vastus  lateralis, the tibialis anterior and the  lateral gastrocnemius muscles simultaneously 
with GRFs when  subjects walked on a  treadmill,  reporting a  significant delay  in  the  right 
vastus  lateralis and  in both  tibialis anteriors muscles compared  to controls. These  results 
were  replicated by Abboud et al.  [31] who  recorded muscle activity and measured  shoe 
pressures over 6 steps. Aiming to find a correlation between in‐shoe plantar foot pressure 
and  the  coordinated  activity  of  5  lower  limb  muscles  (tibialis  anterior,  gastrocnemius, 
soleus  and  peroneus  brevis  and  longus)  for  patients with  diabetes,  they  found  that  all 
muscles showed a delay in contraction compared to controls and a faster forefoot contact 
with the ground. The significant delay recorded for the tibialis anterior muscle means that 
its  normal modulating  role  in  lowering  the  foot  to  the  ground  after  heel  strike  through 
eccentric  contraction  is  disturbed.  In  contrast,  Kwon  et  al.  [37]  described  a  significantly 
earlier  activation  for  the  soleus, medial  gastrocnemius  and medial  hamstring muscles  in 
patients  with  diabetes  and  PN.  Cessation  time  for  the  soleus,  tibialis  anterior,  vastus 
medialis and the medial hamstring muscles occurred later in subjects with PN. These results 
contradict those of Abboud et al. [31]. Petrofsky et al. [14] recorded the muscle activity of 
the  gastrocnemii  and  tibialis  anterior  during  initiation  of  gait,  steady  state walking  and 
turns of 0.33 and 0.66  radius. They showed  that controls used on average approximately 
30% of the maximum muscle activity of the tibialis anterior and gastrocnemius to  initiate 
gait. Persons suffering from diabetes used nearly twice the muscular activity compared to 
controls to initiate and maintain gait at a lower walking speed as well as to turn. 
Pressures  
Nine  authors  investigated  pressure  measurements  that  might  have  relevance  for  the 
prevention of ulcers [31‐33, 35, 36, 40‐42, 45, 47]. Four authors used  in‐shoe transducers 
[31, 35, 36, 42, 47], 3 authors used a force platform [32, 33, 45] and Patil et al. [41] used an 
optical pedograph. Higher pressure values were found in diabetic patients with neuropathy 
compared to diabetic patients without neuropathy [42, 45]. Sacco et al. [44, 45] found that 
patients with ulcers had higher values than normal but lower values than diabetic patients. 
Diabetic  patients with  neuropathy  had  the  highest  peak  pressures,  followed  by  diabetic 
patients without  neuropathy whose  pressures were  higher  than  controls.  In  contrast  to 
these  findings, however, Pataky et al.  [40]  found  increased plantar pressure and pressure 
duration under the big toe and fifth metatarsal head in patients with no clinical evidence of 
neuropathy and described an anterior displacement of weight bearing even  in  this early 
stage of diabetes. 
Intervention studies 
Six  studies  investigated  interventions  to  improve diabetic patients’  gait. Perry et  al.  [42] 
investigated the use of running shoes to reduce plantar pressures; Hsi et al. [35] compared 
plantar  pressures  in  patients  wearing  their  own  shoes  compared  to  wearing  diabetic 
footwear. In another study [36], they  investigated the  influence of rocker soles on plantar 
pressure. Perry et al.  [42] showed that modestly priced athletic shoes can reduce plantar 
pressures  in  diabetic  patients.  They  state  that  a  number  of  factors must  be  considered 
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before  the  routine use of  running  shoes  can be  recommended,  the main one being  foot 
deformities. Hsi et al. [35] described a positive effect on pressure measurements in patients 
wearing  rocker  soles  or  diabetic  shoes. A method  of  reducing  ground  contact  time was 
assessed  by Walker  et  al.  [47] who  found  that  diabetic  patients  could modify  their  gait 
pattern to reduce ground contact, using an auditory sensory feedback system. 
Ways to improve the spatiotemporal parameters of gait were evaluated by Petrofsky et al. 
[15] and Richardson et al.  [11]. Petrofsky et al.  [15]  investigated  the effect of medication 
(Rosiglitazone)  on  different  gait  parameters.  They  reported  positive  results  after 
administration of Rosiglitazone in a decreased step width (p < 0.01), a reduction in reaction 
time (p < 0.01) and less acceleration at the joints. Richardson et al. [11] found that the use 
of  a  cane,  ankle  orthoses  or  touching  a wall  all  improved  step width  range,  step  time 
variability and speed while walking under challenging conditions. 
DISCUSSION 
The quality of  articles  investigating  gait  characteristics  in diabetic patients, when  scored 
with  an  adapted  and  reliable  checklist  [29], was moderate  to  high.  Although  some  gait 
characteristics of patients with diabetes were well described, we noted that results varied 
in  different  studies  and  that  authors  sometimes  disagreed  on  general  tendencies. 
Spatiotemporal data and pressure values seem to be well established parameters whereas 
opinions on accelerations, EMG and kinetic parameters, such as GRFs are not yet clear. 
Some gait parameters, namely variation of step time and/or step width [22, 23], or reaction 
time [22, 23, 48], are known to be associated with an increased risk of falls. As in a geriatric 
population  [22,  23,  25],  these  parameters  are  also  associated  with  fall  risk  in  diabetic 
patients, as shown by Menz et al. [20]. 
Other  factors,  such  as  acceleration measurements  [25]  or  specific  alterations  in  sagittal 
plane  joint kinetics [48] are not yet used as characteristic  indicators for fall risk. However, 
both Menz et al.  [25] and Kerrigan et al.  [48] show  that  the  latter  two may be potential, 
identifiable markers with which  to detect  individuals who may be at  risk  for  falls.  In our 
overview of gait characteristics, we seek to highlight those factors which, in particular, may 
explain increased risk of falling in diabetics. 
Gait characteristics 
Spatiotemporal data 
The most frequently cited spatiotemporal parameter for fall risk prediction is the variation 
of  step  parameters  [22,  23,  48],  such  as  step  time  variability.  However,  one  should  be 
aware that this factor is speed dependent [49, 50]. Reduced speed itself has been described 
several times as a predictor [24‐26]. 
Menz  et  al.  [20]  and  Richardson  et  al.  [9‐11]  studied  step  time  variability  in  a  diabetic 
population.  They  could  not  find  significant  differences  between  groups  regarding 
measurements done on a  level surface. However, they found significant differences when 
subjects walked on an irregular surface, which could be related to an increased demand on 
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balance control. Richardson et al. [11] further described a significant cost in terms of speed 
and efficiency when patients with PN walk on irregular surfaces under low light conditions. 
As  irregular  surfaces  and  unfamiliar  circumstances  reflect  patients’  environments,  these 
study  results  have  a  high  clinical  relevance.  Clinical  experiences  indicate  that  diabetic 
subjects have higher walking related fall accidents that happen during performance of daily 
activities. Similar findings were described by Freiberger et al. [51] investigating falls among 
elderly people. From this, it can be inferred that gait analysis in diabetic patients should be 
performed  in  environments  that mimic  real  life  conditions when we want  to be  able  to 
pinpoint problems  related  to walking  in  this population. We  should  take gait analysis  for 
this  population  out  of  laboratory  settings  and  into  environments  in which  people move 
during their daily routine. 
The examination of speed, which  is also known to be associated with fall risk, emphasises 
again  the  importance of  gait  analysis under  real  life  conditions. Authors  generally  agree 
that diabetics walk more  slowly  than healthy  controls.  This  loss of  speed becomes even 
more marked when patients walk  in challenging environments. However, there are major 
differences in the measured walking velocities which remain difficult to explain. Age is said 
to  decrease  walking  speed  in  persons  older  than  70  [52]  but  this  cannot  explain  the 
considerable  speed  range  between  different  studies.  Regarding  the  protocols  that were 
used,  all  authors  asked  patients  to walk with  a  self‐selected,  comfortable  speed,  except 
Petrofsky et al. [14, 15]. This group did not report on this item. Thus, even this parameter 
can  not  explain  the  speed  differences  observed.  Two  possible  parameters  which  may 
explain the speed difference between the various studies could be the group composition 
[9, 17, 37] or in one study [37] the high body weight of the included population. 
Kinematics 
Menz et al.  [25]  found  that acceleration patterns at  the head and pelvis were associated 
with an  increased  fall  risk  in elderly.  In our  review, only 3 authors  reported acceleration 
data  in  5  studies  [2,  14,  15,  20,  43].  Although  they  reported  contradictory  findings 
concerning comparisons of acceleration magnitude between controls and diabetic patients, 
2  authors  [14,  15,  20,  43]  recorded  more  erratic  accelerations  in  diabetic  patients 
compared  to  healthy  controls  and  higher  acceleration  variation  whilst  walking  under 
demanding  circumstances.  These  results  again  reveal  the  importance  of measuring  gait 
characteristics  in  challenging  conditions.  These  authors  further  showed  that  acceleration 
data could be of interest in fall risk evaluation in diabetic patients. 
Kinetics 
Kerrigan  et  al.  [48]  demonstrated  that  sagittal  plane  joint  moments  could  be  useful 
parameters  to  understand  the  gait  mechanics  of  the  elderly  suffering  from  falls.  The 
presence  of  alterations  in  sagittal  plane  joint  kinetics  in  fallers  implies  specific  intrinsic 
pattern differences and may help for the evaluation of fall risk in elderly. 
In our review 3 authors [17, 37, 39] observed  joint moment during diabetics’ walking, but 
only Kwon et al. [37] reported knee extension moments. They found lower knee extension 
moments in subjects with diabetic neuropathy compared to control subjects. Mueller et al. 
[39] and Kwon et al.  [37] observed a decreased plantar  flexor moment during walking  in 
patients with diabetes, which could be  related  to decreased strength  in calf muscles  [20, 
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33, 37, 39]. Questions remain about the utility of these parameters for fall risk evaluation in 
diabetic patients.  In addition,  causes and consequences are not yet clear;  is  it decreased 
muscle  strength  or  sensitivity  that  alters  the  gait  pattern,  or  does  the  altered  pattern 
contribute to a loss of strength? 
Several authors described other kinetic values, such asGRFs, [17, 38, 45, 46] which are not 
yet known  to be associated with  fall  risk. Comparisons between  their  results are difficult 
because  of  diverse  evaluated  variables  and  the  use  of  different material.  The  reported 
results do not permit us  to  take a  firm stand.  It seems, however,  that vertical  forces are 
quite similar in patients with diabetes and in healthy controls. Sacco et al. [45] and Uccioli 
et al. [46] even agreed on measured absolute values, whereas Katoulis et al. [17] reported 
slightly higher  forces  for all assessed groups. The  significant difference between diabetic 
and controls showed by Sacco et al. [45] during the second peak needs more investigation 
to determine whether the second peak  is a discriminating factor, whereas the mean peak 
force is not. Although those vertical forces do not really differ between healthy persons and 
patients with diabetes, the AP forces revealed differences indicating a so‐called flat‐footed 
gait. 
Muscle activity 
EMG  is  not  yet  used  in  the  evaluation  of  fall  risk.  Nevertheless,  it  appears  to  be  an 
interesting parameter. Whereas Abboud et al.  [31] associated muscle dysfunction of  the 
lower extremity with the development of abnormal plantar pressure distribution, Petrofsky 
et  al.  [14]  and  Kwon  et  al.  [37]  hypothesised  that  muscle  co‐contraction  might  reflect 
increased use  of  agonist‐antagonist muscle  pairs, which denotes  search  for  stability  and 
balance during gait. However, authors  found different  results  concerning  the  timing and 
amplitude  of muscle  activity  in  diabetic  patients.  Several  factors  could  have  influenced 
these discrepancies [31, 37, 44]. First,  it  is apparent that data over studies have not been 
normalised  in  the  same  way  concerning  amplitude  and  timing.  Several  studies,  using 
different  methods  for  amplitude  normalisation  [53‐55]  showed  the  influence  of 
normalisation  methods  on  the  interpretation  of  EMG  signals.  Another  difficulty  is  the 
determination of onset and or cessation of muscle activity. Further the difference in weight 
of  the  control  group  could  be  another  parameter  influencing  the  results.  It  is  therefore 
important  to  remember  that  Kwon  et  al.  [37],  who  contradicted  the  study  results  of 
Abboud et al. [31] and Sacco et al. [44], had the population with the highest body weight. 
Another  important demographic  factor  is age, which  is known to  influence walking speed 
and further could have an effect on muscle activity. 
Pressures 
Plantar pressure  is a well‐described parameter  in  the diabetic population. However,  it  is 
usually  studied  in  relation  with  “ulcers”.  It  could  be  used  to  investigate  a  preventive 
approach that would regulate pressure distribution and thus avoid ulcers. Various types of 
shoes  and  auditory  sensory  feedback were  tested  [35,  36,  42,  47].  However,  the most 
effective strategy to reduce plantar pressure remains to be determined. 
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Intervention studies 
Only  a  few  interventions  such  as  auditory  feedback,  different  shoes  or  soles  as well  as 
medication were tested. All showed positive effects on gait parameters. However, we could 
not find any studies concerning preventive approaches for falls among diabetic patients. 
CONCLUSIONS 
This  systematic  review evaluated 28  studies with moderate  to high quality,  investigating 
gait characteristics of 772 diabetic patients. The  large number of articles published about 
diabetic gait reflects the importance of research in this domain. The increasing prevalence 
of diabetes and  the well‐known  risk of  falling  require understanding of  the possible gait 
pattern changes where diabetic patients are confronted with. 
Authors  investigating  gait  parameters  in  a  diabetic  population  evaluated  in  particular 
parameters  either  clearly  associated  with  fall  risk  (speed,  step  length  or  step  time 
variability) or with ulcers (pressure). There is agreement that diabetic patients walk slower 
and with greater step variability, although one should be aware that speed is a confounding 
factor  for  step  variability.  Patients  also  present more  plantar  pressure  and  higher  peak 
pressures under the metatarsal heads than healthy controls. 
Our review also demonstrates that less well studied parameters, such as accelerations and 
changes in muscle activity could be of interest in fall risk evaluation in diabetic patients. 
However, questions  remain about  the exact  causes of gait alterations and about how  to 
prevent falling in diabetic individuals. 
Which of the measured parameters are especially  involved and which could contribute to 
developing protective strategies? To understand  the underlying mechanism  that causes a 
subject  to  fall  and  to  promote  efficient  prevention,  further  studies  are  needed.  Future 
research  should analyse gait under  real  life  conditions  in more challenging environments 
(e.g. walking on different  road  surfaces, on  grass, on  ramps and  stairs),  since  falls occur 
mostly during a patient’s daily routine. Treatment strategies that  influence gait should be 
established  and  reassessed  on  the  basis  of  fall  predictive  gait  parameters,  taking  into 
account possible confounding factors. 
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SUMMARY 
Background 
Activities of daily life require us to move about in challenging environments and to walk on 
varied surfaces. Irregular terrain has been shown to influence gait parameters, especially in 
a population at risk for falling. A precise portable measurement system would permit 
objective gait analysis under such conditions. 
Aims 
The aims of this study are to a) investigate the reliability of gait parameters measured with 
the Physilog® in diabetic patients walking on different surfaces (tarred pathway, grass and 
cobblestones); b) identify the measurement error (precision); c) identify the minimal 
clinically detectable change. 
Methods 
Sixteen patients with type 2 diabetes were measured twice within 8 days. After a clinical 
examination, patients walked, equipped with a Physilog®, on the 3 aforementioned 
surfaces. 
Results 
Intraclass correlation coefficients for each surface were excellent for within-visit analyses (> 
0.938). Inter-visit intraclass correlation coefficients were excellent (> 0.753) except for the 
knee range parameter (> 0.503). The coefficient of variation was lower than 5% for most of 
the parameters. Bland and Altman Plots, the standard error of the mean difference and the 
value of the smallest detectable change showed precise values, distributed around zero for 
all surfaces. 
Discussion and conclusion 
Gait parameters during complex locomotor activities (e.g. walking on uneven terrains, stair-
climbing, slopes) have not yet been extensively investigated. Good reliability, small 
measurement error, and values of minimal clinically detectable change recommend the 
utilisation of Physilog® for the evaluation of diabetic patients’ gait in conditions close to real 
life situations. 
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INTRODUCTION 
Human movement analysis is usually performed in specialised kinesiology laboratories. 
Cameras, force platforms, magnetic and ultrasound systems are commonly used 
technologies for gait analysis [1, 2]. However, time expenditure and financial constraints 
limit their use in clinical practice [3]. Moreover, gait analyses are traditionally performed 
indoors, on a predefined, clean and flat specific pathway. Such conditions enable precise 
recording but are not representative of the real life context. Activities of daily life require us 
to move about in challenging environments and to walk on varied surfaces. Irregular terrain 
has been shown to influence gait parameters such as speed, especially in a population at 
risk for falling [4]. Its influence on gait parameters and the fact that falls mainly occur in a 
complex environment [5] emphasise clinicians’ need for objective gait data recorded in a 
real life context [6]. 
The recent use of body-fixed sensors suggests that they could serve as a tool for analysing 
patients’ gait in their own environment [2, 7]. Body-fixed sensors (for example Physilog® [2], 
DynaPort® [8, 9], Xsens® [10]) have already been shown to be valuable for the analysis of 
human movement [1, 11, 12]. In comparison with other motion measurement devices, 
body-fixed sensors have the advantage of being lightweight and portable, which enables 
subjects to move relatively freely. They permit data collection in a challenging 
environment; they are easy to use, cost-effective and can capture data from many gait 
cycles. Thus, they seem ideal for analysing gait parameters in specific populations, such as 
diabetic patients. 
Diabetic individuals have been shown to suffer from increased risk of injurious falls [13]. 
Moreover, diabetes can seriously damage many of the body’s systems, especially nerves 
and blood vessels. However, the cause for diabetics’ increased fall risk is still under debate 
[14]. An objective evaluation in real life conditions might help to understand the causes of 
their gait problems and ultimately facilitate the choice or the development of appropriate 
physical treatment. For these reasons sensors’ potential should be investigated so as to 
ensure the precision and the reliability of data recorded during gait analysis on changing 
types of surfaces. 
With this in mind, we conducted this study to a) investigate the reliability of gait 
parameters measured with Physilog® in diabetic patients walking on different surfaces 
(tarred pathway, grass and cobblestones), b) identify the measurement error (precision) 
and c) identify the minimal clinically detectable change. 
METHODS 
The study was approved by the ethics committee in Geneva. All participants received 
written and oral information and were requested to sign an informed consent statement. 
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Subjects 
A convenience sample of 16 patients (mean age: 55 ± 8 years; Body Mass Index: 30.28 ± 5) 
with type 2 diabetes (with and without neuropathy) was recruited from the patients 
consulting the Service of Therapeutic Education for Chronic Diseases or the Service of 
Endocrinology at the University Hospital in Geneva. Patients were included if they were 
medically diagnosed with type 2 diabetes (blood sugar > 7.0 mmoll-1 in fasting state). 
Patients were excluded if they had concomitant foot ulcer, orthopaedic or surgical 
problems influencing gait parameters, a non-diabetic neuropathy (due to Charcot-Marie-
Tooth disease, alcohol or thyroid dysfunction), neurological pathology influencing gait 
parameters or incapacity to walk without a walking aid. 
Apparatus 
Gait analysis was performed using 4 miniature gyroscopes (ADXRS 250, Analog device) 
attached to each shin and thigh. Each sensor measured the velocity of the angular rotation 
per segment around the coronal axis (flexion-extension). Signals were digitised (16 bit) at a 
sampling rate of 200 Hz by a light portable data logger (Physilog®, BioAGM, CH) and stored 
for off-line analysis on a memory card (Figure 3.1a and 3.1b). Temporal parameters 
(including speed, cadence, gait cycle time, stance phase and double support relative to the 
gait cycle) and spatial parameters (including stride length, sagittal shin, thigh and knee 
range, and the maximal sagittal shin angle velocity during swing phase (degs-1)) were 
computed [15]. 
Procedure 
After signing informed consent patients received 2 appointments within 8 days. As diabetes 
type 2 is defined as a chronic disease with complications that increase progressively over 
time, we assumed that diabetic patients with stable blood sugar values would not change 
their physical status and gait within one week. 
At each appointment a clinical examination was performed. We checked that patients did 
not have foot ulcers and we controlled blood sugar values. The type of shoes patients wore 
during the first appointment was noted and patients were requested to use identical shoes 
during the second session. 
Patients were then equipped with the Physilog® system and requested to walk with a 
preferred walking speed (e.g. posting a letter) outside in the backyard of the hospital. The 
walkway consisted of two 50 m long tarred pathways, two 50 m grass pathways and two 20 
m cobblestone pathways. Three different combinations of the order of surfaces were 
possible. The order of the surfaces was randomly assigned but remained the same for both 
appointments. Between each surface the patients paused for 8 to 10 s. This interval was 
necessary for the Physiolog® system to identify the change from one surface to another 
(grass, tarred pathway or cobblestones). The identical procedure was repeated after 8 days. 
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Statistical analysis 
Descriptive statistics were used to define the study population and to calculate gait 
characteristics. We used the intra-class correlation coefficient (ICC1.1) to calculate within-
visit reliability (during visit 1) by having patients walk along the same surface twice [16]. We 
further evaluated inter-visit reliability between visit 1 and visit 2. The descriptive statistics 
and the ICC were computed with SPSS (SPSS for Windows rel. 15. Chicago: SPSS Inc.). To 
interpret ICC values we used benchmarks suggested by Shrout and Fleiss [16] (> 0.75 
excellent reliability, 0.4-0.75 fair to good reliability and < 0.4 poor reliability). 
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Figure 3.1. (a) Equipment with the Physiolog® system. Gait analysis was performed using 4 
miniature gyroscopes (ADXRS 250, Analog device) attached to each shin and thigh. 
Each sensor measured the velocity of the angular rotation per segment around the 
coronal axis (flexion-extension). (b) Raw data recorded with the Physilog® and its 
interpretation. Angular velocity recorded from shin segments during successive gait 
cycles. The detection of heel-strikes (o) and toe-offs (□) enables the estimation of 
stance phase (black zone) and double support periods (grey zone). 
(b) 
Signals were digitised at a sampling 
rate of 200 Hz by the portable data 
logger (Physilog®, BioAGM, CH) and 
stored for off-line analysis on a 
memory card. 
Thigh 
Shin 
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To evaluate precision the 95% limits of agreement statistics (Bland and Altman) was used. It 
expresses the degree of error proportional to the mean and was calculated as     ± 2 SDdiff. 
[17, 18], where d  is the mean of the difference and SDdiff the standard deviation of the 
difference. We further calculated the relative precision by the coefficient of variation (CV) 
as a ratio of the standard deviation to the mean. 
The measurement error (standard error of the mean difference (SEM)) [19] was reported 
and the smallest detectable change for each parameter was calculated as described by de 
Vet et al. [20]. SEM was derived by                       in which σ represents the total variance. 
The smallest detectable change (SDC) was calculated with the formula                        . Limits 
of agreement, SEM and SDC were calculated with Excel. 
To identify differences between surfaces we used an analysis of variance (ANOVA). All data 
were explored for normality and we checked with a skewness kurtosis test whether the 
distribution was Gaussian or not. Data were considered normally distributed if they were 
not significantly different (p > 0.05) from a normal distribution. Where necessary we 
applied an automatic algorithm which detects the best way of normalisation for each 
variable [21] to normalise data. 
RESULTS 
Gait Parameters 
The mean values and standard deviations of the gait parameters of 16 evaluated patients 
are reported in Table 3.1. Since the intra-visit reliability was based on the first visit, the 
results of laps 1 and 2 on each surface as well as the mean of both laps of this visit are 
summarised. For the second visit only the mean values of both laps are reported. 
The ICC for each surface within visit 1 was excellent (> 0.938). The inter-visit ICCs were 
excellent for all variables except for the sagittal knee range, for which it was good. The 
values ranged from 0.503 for sagittal knee range to 0.946 for the gait cycle time on a tarred 
pathway, from 0.639 for sagittal knee range to 0.958 for cadence and the gait cycle time on 
grass and from 0.728 for sagittal knee range to 0.955 for the maximal sagittal shin angle 
velocity in swing phase on cobblestones. All ICC values and their lower and upper 
boundaries are reported together with the CV (%), the mean difference between two 
recordings and the 95% limits of agreement in Table 3.2. 
The CV was lower than 5% for most of the parameters. Comparing the results within one 
visit the best CV was calculated for the stance phase on a tarred pathway (0.5%) and the 
worst was identified for the double support on cobblestones (4.8%). Comparing the inter-
visit values, the CV ranged from 1.26% for stance phase while walking on cobblestones to 
11.28% for double support while walking on a tarred pathway. Only 2 other parameters 
exceed a CV of 5% for the inter-visit comparison, namely speed and double support. The 
SEM and the SDC are illustrated along with the Bland Altman Plot in Figure 3.2. 
 
d
( )1 I C Cσ −
1.96 2SEM× ×
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Table 3.1.  Mean and SD of gait parameters on different surfaces (tarred pathway, grass and cobblestones) 
evaluated during visit 1 and visit 2 
Parameter Surface Visit 1 Visit 2 
  
 Mean (SD) 
First lap 
Mean (SD) 
Second lap 
Mean (SD) 
Both laps 
 Mean (SD) 
Both laps 
Tarred pathway  55.63 (4.43)  56.42 (4.54)  56.03 (4.45)  56.34 (5.12) 
Grass  54.32 (4.91)  54.86 (4.33)  54.59 (4.58)  54.90 (4.90) 
Cadence 
(cyclemin-1) 
Cobblestones 
 
 52.03 (4.77)  52.55 (5.18)  52.29 (4.93) 
 
 52.98 (5.43) 
 
Tarred pathway   1.23 (0.20)   1.27 (0.20)   1.25 (0.20)   1.27 (0.21) 
Grass   1.20 (0.22)   1.22 (0.20)   1.21 (0.21)   1.24 (0.21) 
Speed  
(ms-1) 
Cobblestones 
 
  1.11 (0.23)   1.13 (0.24)   1.12 (0.23) 
 
   1.17 (0.25) 
 
       
Tarred pathway   1.09 (0.08)   1.07 (0.09)   1.08 (0.08)   1.07 (0.09) 
Grass   1.11 (0.10)   1.1 (0.09)   1.11 (0.09)   1.10 (0.10) 
Gait cycle time 
(s) 
Cobblestones 
 
  1.16 (0.11)   1.15 (0.12)   1.16 (0.12) 
 
   1.15 (0.12) 
 
       
Tarred pathway  59.90 (2.19)  59.71 (2.18)  59.80 (2.17)  59.81 (2.16) 
Grass  59.62 (2.18)  59.62 (2.07)  59.62 (2.11)  59.67 (1.88) 
Stance phase  
(%) 
Cobblestones 
 
 60.07 (1.81)  59.99 (2.13)  60.03 (1.95) 
 
  59.79 (2.06) 
 
       
Tarred pathway  19.80 (4.37)  19.41 (4.36)  19.61 (4.34)  19.62 (4.32) 
Grass  19.23 (4.35)  19.23 (4.13)  19.23 (4.21)  19.34 (3.76) 
Double support  
(%) 
Cobblestones 
 
 20.14 (3.61)  19.97 (4.26)  20.05 (3.89) 
 
  19.58 (4.11) 
 
       
Tarred pathway   1.33 (0.18)   1.35 (0.19)   1.34 (0.19)   1.34 (0.18) 
Grass   1.33 (0.19)   1.34 (0.19)   1.33 (0.19)   1.35 (0.18) 
Stride  
(m) 
Cobblestones 
 
  1.28 (0.21)   1.29 (0.22)   1.29 (0.22) 
 
   1.32 (0.21) 
 
       
Tarred pathway  77.00 (5.78)  77.99 (6.11)  77.50 (5.93)  76.46 (5.71) 
Grass  77.25 (6.41)  77.78 (6.31)  77.51 (6.34)  77.20 (5.69) 
Shin range  
(deg) 
Cobblestones 
 
 74.50 (8.18)  74.83 (8.00)  74.67 (8.04) 
 
  74.78 (7.33) 
 
       
Tarred pathway  40.48 (6.64)  41.41 (6.72)  40.95 (6.66)  41.26 (6.47) 
Grass  41.85 (6.80)  42.28 (6.69)  42.06 (6.72)  43.35 (6.06) 
Thigh range  
(deg) 
Cobblestones 
 
 40.97 (7.34)  41.32 (7.36)  41.14 (7.33) 
 
  42.72 (7.40) 
 
       
Tarred pathway  61.60 (3.78)  62.03 (4.25)  61.82 (4.00)  60.24 (4.26) 
Grass  62.04 (3.49)  62.30 (3.79)  62.17 (3.59)  61.37 (4.18) 
Knee range  
(deg) 
Cobblestones 
 
 60.66 (5.06)  60.90 (4.63)  60.78 (4.79) 
 
  59.97 (5.54) 
 
       
Tarred pathway 371.39 (33.43) 379.16 (37.55) 375.27 (35.37) 371.17 (36.78) 
Grass 366.90 (41.58) 372.08 (39.97) 369.49 (40.52) 369.11 (38.41) 
Max shin angle 
velocity (degs-1) 
Cobblestones 
 
339.64 (50.28) 344.39 (51.15) 342.01 (50.47) 
 
 
344.58 (50.66) 
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The SEM revealed similar values for all surfaces within one visit. Comparing visit 1 with visit 
2, most of the parameters (cadence, stride length, speed, sagittal shin range, sagittal thigh 
range and maximal sagittal shin angle velocity in swing phase) showed a higher SEM and 
SDC while walking on cobblestones than while walking on grass or on a tarred pathway. 
However, stance phase, double support and sagittal knee range presented the highest SEM 
and SDC values while walking on a tarred pathway. 
Difference on surfaces 
Our findings show that patients tend to walk slower on cobblestones than on grass and 
slower on grass than on a tarred pathway. In line with these results, cadence decreases, 
gait cycle time increases and the degree of the shin and knee mobility decreases. 
Furthermore, we observed a decrease in the maximal sagittal shin angle velocity during the 
swing phase. The ANOVA showed that surfaces had an effect on these gait parameters. 
Compared to a tarred pathway, walking on cobblestones was significantly different (p < 
0.05) regarding cadence, speed, gait cycle time and maximal sagittal shin angle velocity in 
swing phase. The maximal sagittal shin angle velocity in swing phase was also significantly 
different when comparing grass and cobblestones. 
DISCUSSION 
This study aimed to investigate the reliability of gait parameters measured with body-fixed 
sensors in diabetic patients and to evaluate this tool’s clinical potential for gait analysis on 
varied surfaces (tarred pathway, grass and cobblestones). 
Overall Bland and Altman Plots showed similar results for all surfaces with values well 
distributed around zero. The ICC, SEM and SDC evaluated in this paper showed that the 
Physilog® enables precise recordings and detection of small changes in gait parameters. It 
could therefore be considered an appropriate tool for gait analysis in diabetic patients 
under real life conditions. 
All ICC values are higher than 0.8 except for the sagittal knee range. As the knee range 
calculation is based on the hip and shin values the low sagittal knee range ICC could be 
explained by interactions between these measurements. 
However, the SEM and SDC (inter-visit) for stance phase and double support showed higher 
values when recorded on a tarred pathway than on grass or cobblestones. Since we 
expected opposite results we checked our dataset for possible explanations. We found that 
the outlier, which was well identified on the Bland and Altman Plots, presented a short 
stance phase and a short double stance although with a speed corresponding to those of 
the other diabetic patients. This phenomenon could be due to a problem of gait cycle 
detection for this specific patient and might explain the higher observed values on the 
tarred pathway. 
Comparison with other study results: as far as we know this article is the first to evaluate 
reliability of gait parameters on different types of surfaces. For this reason we can only 
compare our results with studies performed on a level surface. Nevertheless, our ICCs and 
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CVs of spatiotemporal parameters showed similar values to those of other gait 
measurement systems [22, 23]. 
We found comparable between-visit ICCs for speed, cadence and step length (ICCs between 
0.89 and 0.93) to those calculated with the GaitRite® walkway [23] (within visit ICCs 
between 0.82 and 0.92). Our intra-visit CVs for these parameters (between 1.78% and 
5.55%) were slightly higher but still comparable to those recorded with the GaitRite® 
(between 1.4% and 3.5%). 
However, our intra-visit CVs were lower (between 1.34% and 2.79%). We further compared 
our ICC and CVs of spatiotemporal parameters (speed, cadence and stride length) with 
those recorded with an IDEEA® (body-fixed sensor composed of 5 accelerometers) and 
those recorded with a Kistler® force platform (FP) [22]. The latter found similar ICCs 
(between 0.988 and 0.994 on force platforms and between 0.965 and 0.987 with the 
IDEEA) to ours. Their CVs, recorded with a FP (between 1.6% and 2.6%), were similar to our 
intra-visit results. However, CVs recorded with the IDEEA® (between 2.7% and 5.7%) were 
significantly higher, in particular for stride length. In short, our ICCs and CVs show as good 
results as those of other measurement instruments, which recorded gait parameters on a 
level surface. All in all we may say that the reliability of the Physilog® reached similar results 
for gait analysis of diabetic patients on different surfaces to those obtained with other 
measurement instruments recording gait parameters of healthy persons while walking on a 
level surface. As irregular surfaces were shown to influence gait parameters such as speed, 
especially in a population at risk for falling [24], our results are of high clinical relevance. 
We may now start to investigate the possible causes for diabetics’ increased fall risk. Future 
studies should compare diabetics’ gait parameters with those of a healthy control group 
while walking on different surfaces. 
Another interesting clinical parameter to be evaluated is gait variability. Hausdorff et al. 
[25] showed that using gait variability measures could potentially enhance the prospective 
evaluation of fall risk. It is therefore necessary to extend gait analysis to gait variability 
features. Nevertheless, one should be careful with the interpretation of the said variability 
measures. As it was shown that this parameter is speed dependent [26], when studying gait 
variability, speed needs to be taken into account. 
The choice of body-fixed sensors and their location should be in line with the objective of 
the assessment. If the main interest is to detect spatiotemporal gait parameters, it has 
been shown that one accelerometer on the trunk is sufficient [27]. For clinical decision 
making however, the evaluation of spatiotemporal gait parameters are often not conclusive 
enough. In the clinic, assessment of other parameters such as joint kinematics would be 
useful and could be provided, as shown in our study, by accelerometers and gyroscopes on 
trunk, thighs and shins. However, in order to adequately evaluate varied surfaces’ influence 
on these patients’ gait, it was still necessary to supervise and standardise the acquisition of 
data. For this reason we restricted the extent of our study to a standardised pathway, even 
if real life conditions require an individualised assessment in the patient’s environment. 
Such an evaluation obviously incorporates situations such as stair climbing, walking 
up/down a slope, crossing a street and multiple-task situations. Devices enabling 3-D 
reconstruction have already been developed and evaluated during the execution of 3 
different locomotion tasks [28], but many complex locomotor activities have not yet been 
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fully investigated. Therefore gait evaluation and its interpretation under real life conditions 
can still be improved. 
CONCLUSION 
Body-fixed sensors provide reliable assessment of gait parameters outdoors on different 
surfaces. The small measurement error and the values of the minimal clinically detectable 
change recommend their utilisation for the evaluation of gait parameters in diabetic 
patients. The influence of different surfaces on gait parameters reveals further interesting 
findings and shows the importance of analysing gait in a challenging environment. Further 
studies are needed to investigate the surface and group effect on gait parameters in a 
challenging environment. 
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SUMMARY 
Background 
Patients with diabetes have been shown to suffer from increased fall risk. However, 
authors disagree as to whether only diabetic patients with neuropathy, or also those 
without neuropathy, present gait alterations. Existing studies evaluate gait indoors, i.e. in 
specialised gait laboratories. 
Aims 
This study aims to evaluate gait parameters in diabetic patients under various real life 
conditions and compares them to those recorded for healthy controls. 
Methods 
We conducted a clinical observation study. Forty-five subjects’ gait was assessed on 3 
different surfaces (tarred pathway, grass and cobblestones) with a Physilog® system 
(BioAGM, CH), consisting of accelerometers and gyroscopes. Temporal and spatial gait 
parameters as well as stride-to-stride variability of 30 patients with type 2 diabetes, 15 with 
and 15 without neuropathy were compared to 15 healthy controls. The 3 groups were 
comparable for age, height and body weight (p > 0.05). 
Results 
Diabetic patients’ gait parameters differed significantly from those of healthy controls. Post 
hoc analysis revealed a significant difference between healthy individuals and patients with 
neuropathy and between healthy individuals and patients without neuropathy. No 
significant difference was observed between patients with or without neuropathy. The 
highest surface effect was found in patients with diabetic neuropathy, followed by patients 
without neuropathy and healthy controls. 
Discussion and conclusion 
Walking under real life conditions revealed gait difficulties in patients with type 2 diabetes 
before neuropathy was clinically detectable. Clinicians should be aware that diabetic 
individuals’ gait capacity decreases and fall risk increases at an early stage of the disease. 
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INTRODUCTION 
Diabetic patients have been shown to suffer from increased risk of injuries from falls [1]. 
Since peripheral neuropathy (PN) affects both sensory and motor functions [2], the 
consecutive neuromuscular damage may result in altered lower extremity biomechanics. 
This could lead to gait abnormalities with the aforementioned increased fall risk. However, 
to date, the cause of increased fall risk in diabetic patients is still a subject of debate [3]. A 
systematic review [3] revealed that significant questions remain about the main causes of 
gait abnormalities in diabetic patients. Various authors [4-7] have found an association 
between neuropathy and gait abnormalities and/or falls. Cavanagh et al. [4] for example 
demonstrated that PN affects gait and posture. They described 15 times more falls in the 
diabetic neuropathy group than in the diabetic control group. Ducic et al. [5] further 
examined the intuitive relationship between increasing loss of foot sensibility (defined as 2 
and 1-point discrimination loss) and increasing loss of balance in diabetic patients. They 
stated that PN, rather than ocular changes, is responsible for gait problems and concluded 
that neuropathy could well represent the mechanism for gait abnormalities and increased 
risk of falls. Katoulis et al. [7], evaluating patients with and without diabetic PN found no 
gait alterations in diabetic patients without neuropathy but did in subjects with peripheral 
neuropathy. However, Petrofsky et al. [8] found gait impairments in diabetic patients with 
no sensory loss. These authors emphasised that whatever the mechanism, diabetic patients 
develop gait alterations well before objective loss of sensation in the feet. This apparent 
contradiction between authors underscores the need for further research in order to 
understand diabetic patients’ gait abnormalities and their increased risk of falls. In most 
existing studies authors assessed gait indoors, i.e. in specialised gait laboratories or on a flat 
indoor surface. Few authors have attempted to evaluate gait under various conditions such 
as irregular surfaces [9], a poorly lit pathway or an obstacle course [10]. Gait analysis 
performed indoors, on a predefined, clean and essentially flat, specific pathway is not 
representative of a real life situation. Activities of daily life require moving in challenging 
environments and walking on varied surfaces. Freiberger et al. [11], evaluating fall risk in 
the elderly, showed that falls often occur in a complex context. Falls are related to both 
intrinsic and extrinsic factors, such as physiological changes or environmental hazards [12]. 
We therefore consider that gait analysis should be performed in a real life environment to 
correctly understand what makes individuals fall [13, 14]. 
Nowadays, gait parameters can be reliably measured in real life situations with body-fixed 
measurement devices [15]. We were therefore able to assess diabetic patients’ gait 
parameters on 3 different surfaces, namely a tarred pathway (T), grass (G) and 
cobblestones (S). We then compared them to those recorded for healthy controls. Our 
overall hypothesis was that diabetic neuropathy influences the neuromuscular control 
system’s ability to respond to a challenging environment and therefore that: a) gait 
parameters deteriorate with the progression of diabetes (diabetic patients with neuropathy 
> diabetic patients without neuropathy > healthy controls), b) diabetic patients show more 
gait abnormalities on irregular surfaces than on a flat pathway (cobblestones > grass > 
tarred pathway) and c) that the influence of surfaces on gait parameters increases with the 
severity of the neuropathy. 
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METHODS 
The study was approved by the local ethics committee in Geneva. All participants received 
written and oral information and were requested to sign an informed consent statement. 
Subjects 
Forty-five subjects were included in the study. A convenience sample of 30 type 2 diabetes 
patients, 15 with (mean age: 61.3 ± 6.5 year; height: 1.67 ± 0.1 m, weight: 86.94 ± 9.1 kg) 
and 15 without neuropathy (mean age: 55.83 ± 8.2 year; height: 1.72 ± 0.1 m, weight: 90.3 
± 22.2 kg) was recruited from the patients consulting the Service of Therapeutic Education 
for Chronic Diseases or the Service of Endocrinology at the University Hospital in Geneva. A 
healthy control group of 15 individuals (matched for age, height and body weight) were 
recruited and compared to this diabetic population (Table 4.1). 
PN was evaluated by the vibration perception threshold (VPT) using a 128 Hz Rydel-Seiffer® 
tuning fork at the big toe and medial malleolus of both feet [16]. The patient was requested 
to indicate when he could no longer feel the vibration. At this point the investigator rated 
the vibration on a 9-point scale (0 to 8). The patient was considered to have peripheral 
neuropathy (PN group) if the VPT was equal to, or lower than 4/8. He was assigned to the 
non-neuropathic group (DM group) if the VPT was superior to 4, as 4 is the lower 
confidence limit for normal foot sensibility [16, 17]. Retinopathy was evaluated by a trained 
ophthalmologist and by a routine fundal examination (fundoscopy). 
Patients were excluded if they had concomitant foot ulcer, orthopaedic or surgical 
problems influencing gait parameters, Charcot foot, non-diabetes related neuropathy 
and/or a neurological pathology influencing gait parameters or incapacity to walk without a 
walking aid. 
Material 
Patients’ gait was recorded with a Physilog® system (BioAGM, CH), consisting of 
accelerometers and gyroscopes. The analysis of gait parameters was performed using 4 
miniature gyroscopes (ADXRS 250, Analog device) attached to each shin and thigh. Each 
sensor measured the velocity of the angular rotation per segment around the coronal axis 
(flexion-extension). Signals were digitised (16 bit) at a sampling rate of 200 Hz by a portable 
data logger and stored for analysis on a memory card. Temporal parameters (including 
cadence, gait cycle time, stance phase and double support relative to the gait cycle) and 
spatial parameters (including gait speed, stride length, sagittal shin, thigh and knee range) 
were computed [18]. We further evaluated the stride-to-stride variability (coefficient of 
variation (CV) of stride length and gait cycle time). 
Procedure 
After signing the informed consent form, patients underwent a clinical examination, during 
which a trained physiotherapist checked that patients did not have foot ulcers, controlled 
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blood sugar values and VPT. Each participant was then equipped with the Physilog® system 
and was asked to walk with a preferred walking speed outdoors, in the backyard of the 
hospital. The walkway consisted of two 50 m long relatively smooth tarred pathways, two 
50 m grass (lawn) and two 20 m cobblestone pathways (flat stones, 20 to 30 cm in 
diameter). 
For clinical interpretation one should be aware that the tarred pathway in this study is not 
analogous to the level walkways used in previous indoor studies, but it can be compared to 
level, outdoor surfaces. Outdoor studies report higher speeds and stride length than indoor 
studies [19]. 
The reliability of diabetic patients’ gait parameters on these surfaces has already been 
tested in a previous study [15]. Three different combinations of the order of surfaces were 
possible and were randomly assigned to each patient. Between each surface the patients 
paused for 8 to 10 s. This time period was necessary to identify the change from one 
surface to another (grass, tarred pathway or cobblestones) for the Physilog® system. 
Statistical analysis 
Statistical analyses were performed by using SPSS (SPSS for Windows rel. 15. Chicago: SPSS 
Inc.). The binary variable “retinopathy” was analysed using the Mann-Whitney test. The 
effect of diabetes and that of surfaces, as well as their interaction, were calculated with an 
analysis of variance (ANOVA) for repeated measures and a Bonferroni post hoc analysis. 
Results are expressed as means ± standard deviations (SD). A p value ≤ 0.05 was considered 
as statistically significant. All data were explored for normality and we checked with a 
skewness kurtosis test whether the distribution was Gaussian or not. For the non-normally 
distributed variables, namely the CV for stride length and the CV for gait cycle time, it was 
necessary to perform an inverse square root transformation. The variable “gait cycle time” 
was normalised using an inverse square transformation. 
RESULTS 
Group comparison 
The 3 groups were comparable for age, height and body weight (p > 0.05) (Table 4.1). 
Diabetic patients’ gait parameters differed significantly (p < 0.05) from those of healthy 
controls. Post hoc analysis revealed a significant difference between healthy persons and 
patients without neuropathy for speed (p = 0.002), cadence (p = 0.003) and gait cycle time 
(p = 0.002). Diabetic patients with neuropathy showed significant differences in all 
evaluated gait parameters except for the shin angle and knee angle when compared with 
healthy persons. Regarding the stride-to-stride variability, we recorded a significantly 
higher coefficient of variation of the gait cycle time in the PN group than in the healthy 
control group (p = 0.014). No difference between groups was found for the CV of stride 
length. Between the 2 diabetic populations, i.e. with and without neuropathy, no significant 
difference in their gait parameter was detected (Table 4.2). 
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Table 4.1.  Description of the population 
Participants’  
characteristics 
 
Healthy 
Persons 
(n = 15) 
Without 
Neuropathy
(n = 15) 
With 
Neuropathy
(n = 15) 
P 
 Mean (SD) Mean (SD) 
 
Mean (SD) 
 
H vs 
DM 
H vs 
PN 
DM vs 
PN 
Age (years) 57.42 (4.31) 55.83 (8.20) 61.29 (6.5) 1  0.336  0.082 
Height (m)  1.73 (0.10)  1.72 (0.12)  1.67 (0.0) 1  0.500  0.640 
Weight (kg) 79.93 (11.53) 90.30 (22.15) 86.94 (9.1) 0.214  0.655  1.000 
Vibration perception threshold  6.80 (0.86)  5.65 (1.14)  2.63 (1.5) 0.042 <0.001 <0.001 
Diabetes duration (year) a   9.87 (7.78)  8.83 (4.6)    0.688 
Number of cases with diabetic 
non-proliferative retinopathy a,b 
 
 
 3 
 
 5 
 
   
a We registered 3 missing values for these variables. 
b All of the 8 patients presented the background (non-proliferative) and unilateral retinopathy. 
Surface comparison 
Diabetic patients with, and those without, neuropathy adjusted to the variety of different 
surfaces using identical strategies. These strategies were similar to those used by healthy 
controls. In general the surface altered significantly all gait parameters (Figure 4.1). To 
change from a level surface (tarred pathway) to an irregular surface (cobblestones), 
patients with diabetes and healthy persons decreased their gait speed by reducing their 
cadence and increasing their gait cycle time. While changing from grass to cobblestones, 
again both patients and healthy subjects further decreased their speed and cadence and 
continued to increase their gait cycle time. Regarding stride length, all 3 groups shortened 
only slightly their stride length while changing from a tarred pathway to grass. When 
changing from grass to cobblestones, however, we observed a shortened stride length. This 
adaptation was more important in patients with neuropathy than in the other 2 
populations. Figure 4.1 further illustrates how all 3 groups increased their thigh and knee 
range while changing from a tarred surface to grass and decreased it while changing from 
grass to cobblestones. 
In contrast stance and double support time decreased while changing from the tarred 
surface to grass but increased again while changing from grass to cobblestones for all 
observed groups. Interestingly the gap between healthy controls and patients with 
neuropathy increased for the variables shin, knee and thigh range as well as for stance and 
double support time on the stony surface. Although similar strategies were used while 
changing from one to another surface, their effect was less marked in healthy controls than 
in diabetic patients. The highest surface effect was found in diabetic patients with 
neuropathy followed by diabetic patients without neuropathy and healthy controls. For 
example the alteration in the CV of the gait cycle time when changing from a tarred 
pathway to a cobblestone surface was significantly greater in the PN group (p < 0.05) than 
in the healthy control group. 
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Table 4.2.  Gait characteristics of the 3 different populations 
Variable Mean (SD)  P for group effect  P for surface effect 
 
Tarred 
surface 
Grass 
 
Cobble-
stones 
 
H vs 
DM 
H vs 
PN 
DM vs
PN 
 T vs G T vs S G vs S 
Speed (ms-1)   
Healthy 1.53 (0.12) 1.49 (0.12) 1.42 (0.19) 
Without PN 1.30 (0.17) 1.27 (0.17) 1.19 (0.2 ) 
With PN 1.22 (0.15) 1.19 (0.17) 1.06 (0.21) 
0.002 <0.001 0.333 <0.001 <0.001 <0.001 
Cadence (stridemin-1)   
Healthy 62.1 (4.2) 60.6 (4.3) 59.2 (4.9) 
Without PN 55.9 (3.4) 54.7 (3.1) 53.2 (3.2) 
With PN 55.9 (6.2) 54.6 (6.5) 52.0 (6.5) 
0.003  0.002 1 <0.001 <0.001 <0.001 
Stance (% of GCT)   
Healthy 58 (1) 58 (1) 58 (1) 
Without PN 60 (1) 59 (1) 60 (1) 
With PN 61 (2) 61 (2) 62 (3) 
0.073 <0.001 0.112  0.043  0.136  0.012 
Double support (% of GCT)*   
Healthy 17 (2) 16 (2) 17 (2) 
Without PN 19 (2) 19 (2) 20 (2) 
With PN 21 (4) 21 (4) 23 (7) 
0.073 <0.001 0.112  0.043  0.136  0.012 
Gait cycle time (s)   
Healthy 0.97 (0.06) 0.99 (0.07) 1.02 (0.08) 
Without PN 1.08 (0.06) 1.1  (0.06) 1.13 (0.07) 
With PN 1.09 (0.13) 1.12 (0.15) 1.18 (0.18) 
0.002  0.001 1  1 <0.001 <0.001 
Stride (m)   
Healthy 1.49 (0.14) 1.49 (0.15) 1.44 (0.18) 
Without PN 1.40 (0.18) 1.40 (0.18) 1.34 (0.22) 
With PN 1.31 (0.14) 1.31 (0.15) 1.21 (0.18) 
0.413  0.009 0.325  1 <0.001 <0.001 
Shin range (deg)   
Healthy 81 (5) 81 (6) 79 (7) 
Without PN 80 (6) 80 (6) 77 (8) 
With PN 77 (5) 77 (6) 72 (7) 
1  0.062 0.262  0.489 <0.001 <0.001 
Knee range (deg)   
Healthy 62 (5) 64 (4) 63 (5) 
Without PN 63 (3) 64 (3) 62 (5) 
With PN 63 (4) 64 (5) 61 (5) 
 
1  1 1 
 
<0.001  1  0.001 
Thigh range (deg)   
Healthy 48 (6) 50 (6) 48 (7) 
Without PN 43 (6) 45 (6) 43 (6) 
With PN 42 (5) 44 (5) 42 (5) 
0.067  0.018 1 <0.001  1 <0.001 
CV Stride length (%)       
Healthy 1.6 (0.5) 1.9 (0.8) 3.0 (1.4) 
Without PN 2.2 (0.8) 2.2 (0.8) 3.9 (2.2) 
With PN 2.0 (0.6) 2.1 (0.8) 4.5 (2.8) 
0.176  0.250 1  0.670 <0.001 <0.001 
CVGCT (%)       
Healthy 1.8 (0.5) 2.1 (0.6) 2.9 (0.9) 
Without PN 2.3 (0.9) 2.2 (0.72) 3.8 (1.3) 
With PN 2.6 (0.9) 2.7 (1.1) 5.9 (4.2) 
 
0.554  0.014 0.327  0.952 <0.001 <0.001 
H = healthy; DM = diabetes without neuropathy; PN = peripheral neuropathy; T = tarred surface; G = grass;  
S = cobblestones; GCT = gait cycle time; CV = coefficient of variation. 
* Double support and stance are reported in percentage of the gait cycle. 
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Figure 4.1. Boxplot representation of the recorded differences in gait parameters when changing from one to 
another surface (T = tarred surface; G = grass; S = cobblestones, e.g. T - G = difference between tarred 
surface and Grass) for the 3 groups: healthy (black), diabetic patients without PN (dark grey) and
diabetic patients with PN (clear grey). All differences are expressed in % of the reference surface value 
(a negative value indicates a decrease for the variable compared to the reference surface; a positive
value an increase). 
Interaction Group - Surface 
The interaction term was statistically significant (p = 0.0028) for only one parameter (CV 
stride length). Its values on the tarred surface (with PN = 2, without PN = 2.12) and grass 
(with PN = 2.1 without PN = 2.2) were similar in patients with and without PN. However, 
patients with PN showed a higher CV on cobblestones (mean CV = 4.5) than patients 
without PN (mean CV = 3.9). 
DISCUSSION 
The purpose of this study was to analyse gait parameters in diabetic patients and to 
investigate the surface effect on their walking pattern compared to healthy controls. We 
hypothesised that neuropathy would influence the neuromuscular control system’s ability 
to respond to a challenging environment. We therefore considered that gait parameters 
would deteriorate concomitantly with the severity of the patients’ diabetes and that the 
influence of surfaces on gait parameters would increase proportionally. Our results 
confirmed these hypotheses, which are in line with Ducic et al.’s [5], who described an 
association between loss of foot sensibility and balance in patients with peripheral 
neuropathy. However, our study showed that some of the diabetic patients’ gait 
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parameters are already significantly altered before neuropathy is clinically detected. The 
strategies used to change from a flat, tarred walkway to a more complex surface (grass or 
cobblestones) were the same, although less marked, in patients with type 2 diabetes 
without sensory loss. Patients’ adaptation was furthermore comparable to that used by 
healthy controls. The decrease in speed and cadence seems to be the first adaptation 
(tarred surface to grass), followed by shortening of stride length (grass to cobblestones). 
Our findings that some gait parameters are already altered in patients without sensory loss 
are in line with the conclusions of Petrofsky et al. [8], who were among the first authors to 
identify gait alterations in a diabetic population. Similarly to their recordings performed 
during a gait analysis on a linear path and, making turns, we observed a significantly slower 
walking speed in diabetic patients without neuropathy compared to healthy controls under 
real life conditions. Petrofsky et al. [8] evaluated only 2 groups, healthy persons and 
diabetic patients without sensory loss, so we were unable to compare our findings for 
patients with neuropathy with theirs. To demonstrate the relationship between disease 
severity and gait alterations it is necessary to carry out a 3-group-comparison, as was done 
in this study or in that of Katoulis et al. [7]. In contrast to our and Petrofsky’s et al. [8] 
results, Katoulis et al. [7] found no gait alterations in diabetic patients without sensory loss. 
Several points could explain these findings. Firstly, a flat 10 m surface inside a laboratory, 
used by Katoulis et al. [7], may not be challenging enough to reveal gait difficulties in non-
neuropathic patients. Our observations demonstrate that gait alterations are more 
sensitively detected on irregular, rather than on flat surfaces, which is in line with the 
observations of Richardson et al. [20] and Menz et al. [9]. Nevertheless, Petrofsky et al. [8] 
still found gait alterations in patients without sensory loss although evaluating them on a 
linear, flat path. Secondly, in Katoulis’ et al. [7] study, there was a significant difference in 
disease duration between patients with and without neuropathy. Their study population 
was also only matched for Body Mass Index, but not for height. Patients’ height or the short 
disease duration of the non-neuropathic group could have positively influenced gait speed 
in these patients. Another article [21], not actually evaluating spatiotemporal gait 
parameters but the distribution of plantar pressure during walking on a level gradient, 
revealed other significant alterations in type 2 diabetic patients without either peripheral 
neuropathy or peripheral vascular disease. The non-neuropathic population showed a 
significant increase in peak plantar pressure at the level of the big toe and 5th metatarsal 
head as well as significantly prolonged duration of plantar pressure compared to healthy 
controls. The authors concluded that these plantar pressure alterations could be premature 
signs of peripheral neuropathy. 
Our results show that a challenging environment could reveal gait alterations better than a 
level surface. We also demonstrated that gait is already altered in diabetic patients without 
sensory loss. The decreased gait speed in diabetic patients compared to healthy controls is 
not only statistically significant but also of great clinical relevance. A decrease of 0.36 ms-1 
represents a reduction of 25% compared to normal walking speed (1.53 ms-1). It is very 
likely that such a reduction in gait speed could influence individuals’ activities of daily living 
[22]. In addition to the decreased walking speed and the alteration of other gait 
abnormalities, both patients with and without neuropathy showed a tendency to increase 
stride-to-stride variability. This parameter is reported to be related to a heightened fall risk 
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[23]. For this reason, if gait analysis is included in the assessment of diabetic patients and if 
increased stride-to-stride variability is detected, clinicians should take it as a warning sign. 
The application of prevention strategies is thus shown to be imperative. Although we 
identified gait abnormalities in both patient groups (with and without neuropathy) the 
deterioration of gait parameters increases with disease severity (neuropathy). Patients with 
neuropathy have the most trouble adapting their gait to irregular surfaces when compared 
to those without neuropathy, or healthy controls. The possible causes of these gait 
alterations could include small fibre damage, which is undetected on clinical examination 
[24], impaired sight or simple retinopathy [25], leading to difficulty seeing details [26], 
vestibular disorders, or a combination of several of these factors. Longer disease duration 
may aggravate metabolic disorders, thus increasing fibre damage.  
Our subjects’ sight was regularly checked. We also compared the disease duration and the 
number of patients presenting retinopathy, but there was no significant difference 
between the group of patients with neuropathy and those without (Table 4.1 about 
population description). None of the patients reported vestibular problems. Further 
investigations should now evaluate the association between sensory loss, increased gait 
alterations and the risk of falls. With this intention in mind, Ducic et al. [5] evaluated the 
relationship between loss of foot sensitivity and balance in patients with PN with a 
pressure-specified sensory device (PSSD). They found a correlation coefficient between 
sway (degree to which the person moves while attempting to stand still) and foot 
sensitivity of 0.36. However, the VPT [16] we used to attribute patients to either the 
neuropathic or non-neuropathic group did not permit us to study such a relationship. For 
this reason a more sensitive sensory examination for example the PSSD or 
electroneuromyography [24] would have been necessary. Furthermore, other possible 
factors for heightened fall risk, such as muscle weakness or a decrease in joint mobility 
should be considered. 
CONCLUSIONS 
Walking in real life conditions revealed gait difficulties in patients with type 2 diabetes 
before neuropathy was clinically detectable. The strategies used by patients while changing 
from a flat, tarred walkway to a more challenging surface (grass or cobblestones) were 
similar between patients with and without sensory loss. Clinicians should therefore be 
aware that diabetic individuals’ gait capacity decreases and fall risk increases in an early 
stage of the disease. 
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SUMMARY 
Background 
Peripheral neuropathy is acknowledged to be the most symptomatic complication of 
diabetes. Moreover, it is also linked to postural instability. No study has yet evaluated the 
balance instability of diabetic patients using accelerometers. In addition, no balance study 
has explored the combination of accelerometers fixed at lumbar and ankle levels, which 
could bring additional insights into distal balance instability in diabetic patients. 
Aims 
The aim of the present study was to investigate the standing balance of type 2 diabetic 
patients with and without peripheral neuropathy using accelerometers. 
Methods 
Quiet standing balance was investigated using an accelerometric-based method in 24 
diabetic patients (12 with and 12 without peripheral neuropathy) compared with 12 control 
subjects. Accelerations were measured at lumbar and ankle levels using 3 accelerometers. 
Two standing conditions of 30 s were evaluated (i.e. eyes open, eyes closed). The range and 
root mean square values were calculated on the anterior posterior component of lumbar 
and ankle accelerations and for the medial lateral component of lumbar accelerations. 
Differences between parameters were compared between groups using analysis of 
variance and post hoc comparisons. 
Results 
Diabetic patients with peripheral neuropathy show higher range and root mean square 
values compared with those of control subjects and diabetic individuals without peripheral 
neuropathy. Significant differences between groups have been detected for anterior 
posterior range of lumbar acceleration, which was significantly higher for diabetic patients 
with peripheral neuropathy, compared with those of other groups. Significantly higher 
values for diabetic patients with peripheral neuropathy were also detected for anterior 
posterior range and root mean square of ankle accelerations compared with control 
subjects. Visual deprivation shows an increase in accelerometric parameters for each 
group. 
Discussion and conclusion 
This study is the first to investigate diabetic individuals’ balance instability using 
accelerometers. Results confirm that diabetic patients with peripheral neuropathy have 
greater postural instability with higher acceleration values than those of a control group 
and diabetic patients without peripheral neuropathy. 
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INTRODUCTION 
In 2002, 2.8% of the population was reported to suffer from diabetes. This proportion is 
estimated to increase to 4.4% in 2030 [1]. The main factors associated with the burden of 
this disease are obesity, increase in inactivity as well as the ageing of the population [1]. 
Amongst all patients diagnosed with diabetes and older than 60 years of age, 
approximately 50% is affected by peripheral neuropathy (PN), known to be the most 
symptomatic complication of this disease [2]. In the presence of diabetic PN plantar 
cutaneous and proprioception sensations are compromised [3], which together can result 
in postural instability and an increased risk of falling [4]. 
Postural control is a complex motor skill that involves mechanical and physiological aspects, 
linked together to maintain balance and prevent falls [5]. Recently, a framework has 
illustrated the numerous resources involved in the maintainance of postural stability and 
orientation [6]. Biomechanical constraints, movement and sensory strategies, orientation in 
space, control of dynamics, and cognitive processing were described as the main 
components. When one of these elements is impaired, postural stability is compromised. In 
diabetic PN, the possible loss of muscle spindle function, the decrease in plantar cutaneous 
sensation as well as the decline in the perception of movement may alter the sensory 
strategies required to maintain postural stability [3]. 
Although postural control during upright standing has been extensively studied in 
literature, the nature of its control mechanisms is still controversial [7]. The global 
approach of postural control supposes that in a quiet standing position, the entire body 
acts as an inverted pendulum around the centre of rotation of the ankles [8], which 
supposes a passive process. The other approach considers the nature of quiet stance as 
multi-segmental, which implies a constant and active reaction of the central nervous 
system (CNS) [7, 9]. The latter suggests that multiple strategies (i.e. various body 
configurations), which depend on multiple body segments, are used to maintain proper 
balance [9]. 
Postural stability is mostly investigated with force plates (FPs), using the measurement of 
the centre of pressure (COP) displacement [8]. The major measures extracted from the COP 
during standing are the COPnet and the total excursion of the COP in medial lateral (ML) 
and anterior posterior (AP) directions. Ankle and hip postural strategies using inverse 
dynamic calculations, sway area, as well as the scalar distance between the COP and the 
centre of mass (COM) are also reported (see review written by Bonnet et al. [10]). 
In diabetic patients with PN, the presence of postural instability has been well documented 
in biomechanical studies [11-18]. All the cited studies reported higher instability during 
standing in diabetic patients with PN compared with diabetic patients without PN and 
healthy control subjects. Larger COPnet [14], higher sway area [15, 17, 18], larger COP-COM 
distances in ML and AP directions [12] and higher instability during quiet standing with eyes 
closed [12, 16] have been reported. A reduction of the ankle strategy compensated by a 
greater use of hip strategy [14, 17] has also been described in patients with PN. More 
recently, Kanade et al. [13] evaluated balance in diabetic patients with PN at different 
stages of foot complications. Their results have shown a decrease in postural stability in 
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diabetic patients with PN alone compared with patients with a partial foot amputation, 
based on larger COP excursion in the AP direction. 
Although the conventional method is to use FPs to investigate postural control, miniature 
sensors such as accelerometers is becoming widely used and accepted for the evaluation of 
human motion in clinical settings [19]. The use of body-mounted accelerometers also 
allows the measurement of linear accelerations at different reference points over the body 
[20]. In recent years, the measurement of ML and AP trunk accelerometry data has been 
validated and compared with FPs [20] as well as recommended to investigate balance 
control (i.e. body sway) [21]. Accelerometry data could not be directly compared to COP 
parameters; however, they could be validated and used as an objective measure that can 
discriminate between different conditions challenging the balance control system [21]. 
Using an accelerometer fixed near the centre of mass (COM), trunk accelerometry data 
show good discriminative validity during standing. The root mean square (RMS) value of the 
accelerometric signal was used as the main parameter to discriminate young from elderly 
subjects during different standing conditions (i.e. quiet standing with eyes open, quiet 
standing with eyes closed and quiet standing on a compliant mat). Authors reported higher 
instability in elderly and in more perturbed conditions with larger RMS values [21]. More 
recently, the evaluation of body sway in participants with different athletic levels has been 
investigated [22] using a method similar to the one presented by Moe-Nilssen and 
Helbostad [21]. 
To the best of our knowledge, no study has yet evaluated the balance instability of diabetic 
patients using accelerometers [10]. In addition, no balance study has explored the 
combination of accelerometers fixed at lumbar and ankle levels, which could bring 
additional insights into distal balance instability in diabetic patients. 
The aim of the present study was therefore to investigate the standing balance of type 2 
diabetic patients with and without PN, using accelerometers fixed at both near the COM 
and at ankle levels. We also evaluated how sight affects each group during a quiet standing 
condition. Based on previous studies, we expected to find higher acceleration signals in 
diabetic patients compared with asymptomatic participants as well as higher accelerations 
in patients with PN compared with diabetic patients without PN. Higher values are also 
expected for the eyes closed condition. 
METHODS 
Subjects 
A total of 36 participants were included in this study (12 controls and 24 diabetic type 2 
patients). The diabetic patients were separated into 2 groups: diabetic patients without PN 
(DM; n = 12) and with PN (DPN; n = 12). The descriptive characteristics of the participants 
are presented in Table 5.1. Patients were included if they were diagnosed with diabetes 
type 2 with a blood sugar greater than 7.0 mmoll-1 in the fasting state. The presence of PN 
was diagnosed by a vibration perception threshold (VPT) of both big toes and medial 
malleoli using the Rydel-Seiffer 128-Hz tuning fork [23]. For each specific point, the patients 
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were asked to specify when they could no longer feel the vibration. The investigator rated 
the vibration on a 9-point grading scale (0–8). A patient was considered to have PN if the 
VPT was equal to, or lower than 4/8 [23, 24]. Patients were excluded if they had foot ulcer, 
a non-diabetic neuropathy (i.e. due to Charcot-Marie-Tooth disease, alcohol or thyroid 
dysfunction) or a past history of orthopaedic, surgical or neurological conditions, which 
could influence the evaluation. All control participants included in the study present no 
past history of orthopaedic, surgical or neurological conditions. The study protocol was 
approved by institutional ethics committees. All participants gave their written consent to 
participate in this study. 
Instrumentation 
The Physilog® system (BioAGM, CH) was used to measure linear accelerations at trunk and 
ankle levels. A tri-axial accelerometer (type ADXL202, range ± 2g; Analog Devices, 
Norwood, USA) was taped on a sacral belt at the level of lumbar segments L5-S1. Two bi-
axial accelerometers (type ADXL210, range ± 5 g; Analog Devices, Norwood, USA) were 
taped on the anterior face of the right and left shins just up to both malleoli and were 
oriented in AP and vertical (V) directions (Figure 5.1). All data were recorded 
simultaneously at a frequency of 200 Hz. 
Procedure 
The participant was first equipped with accelerometers. Then the Performance-Oriented 
Mobility Assessment scale for balance (POMA-B) [25] was performed. The POMA-B 
represents an evaluation of the balance skills based on 9 tasks (i.e. sitting balance, arises, 
attempts to arise, immediate standing balance, standing balance 1 min with eyes open, 
nudged, standing balance 1 min with eyes closed, turning 360 deg and sitting down). This 
test was developed and validated first to evaluate the risk of falling [26], but it is now 
largely used to evaluate balance disorders in the elderly [27]. The maximal score of the 
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Figure 5.1.  Experimental setup during the quiet standing tasks, showing the 
position and orientation of accelerometers at lumbar and ankle 
levels.  
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POMA-B test is 16, which means no balance deficit, whereas the minimum score (i.e. 0) 
means a complete instability. All participants wore flat-soled shoes during testing and no 
restriction for feet position was imposed. The chosen position remained the same between 
the eyes open and eyes closed conditions. 
Data analysis 
Acceleration signals were analysed for the eyes open (EO) and eyes closed (EC) standing 
conditions obtained during the POMA-B test. From the 1 min collected data at both 
conditions, 30 s were kept for data analysis (the first and last 15 s were removed). All signal 
processing was performed using MATLAB 7.4.0 (The MathWorks: USA, Inc.). The tilt of 
accelerometers, considered as an undesirable source of variability, has been corrected 
using the method described by Moe-Nilssen and Helbostad in 2002 [21]. Then, a third-order 
Savitzky–Golay filter was applied to smooth the accelerometer signals [28] without 
affecting the signal pattern and magnitude. Linear acceleration range (i.e. maximum minus 
minimum) and RMS have been calculated for the AP and ML components of the 
accelerometer fixed at the lumbar level (lumbaracc) and for the AP component of both 
accelerometers fixed at the ankle levels (ankleacc). Range and RMS parameters have 
demonstrated good discriminative capacity in previous balance accelerometric-based 
studies [21, 29-31]. Since no difference has been detected between right and left ankle 
accelerations, parameters have been averaged for further analysis. 
Statistical analysis 
Statistical analysis was performed using STATISTICA 8.0 (StatSoft 8.0: USA, Inc.). 
Comparisons between group characteristics in terms of age, height, weight and Body Mass 
Index (BMI) were performed using analysis of variance (ANOVA). Comparisons between 
conditions (i.e. eyes open and eyes closed) for each group on accelerometric parameters 
were performed using paired-t tests or Wilcoxon Matched Pairs test for parameters that 
had a non-normal distribution. Comparisons between groups on accelerometric parameters 
for each specific condition (i.e. eyes open or eyes closed) were then performed using 
ANOVA. For all accelerometric variables that had a non-normal distribution and the POMA-
B test, a Kruskal-Wallis ANOVA was performed. For significant main effects (i.e. p < 0.05), 
post hoc tests were performed to determine which groups were significantly different from 
others. The effect sizes (ES) using the partial Eta squared (hp
2) were also calculated to 
evaluate the strength of the effect. The ES represents the proportion of the effect (SSeffect) + 
error variance (SSerror) that is related to the effect [32]. 
 
hp
2 = SSeffect/(SSeffect + SSerror) 
 
 
THESIS_L_Allet_v15.pdf
B a l a n c e  p e r f o r m a n c e  o f  d i a b e t i c  p a t i e n t s  
 87 
RESULTS 
No difference has been detected between groups in terms of age, height and weight (Table 
5.1). The BMI was, however, significantly different between groups (p = 0.02). Coefficients 
of correlation between acceleration parameters and BMI were calculated to determine 
BMI’s effect on accelerometric parameters. Results show that the BMI has no influence on 
any parameters with correlation coefficients ranging from 0.01 to 0.31. In addition, since 
the number of male and female was not equivalent between groups, statistical analysis was 
performed including gender as covariate. Results show that gender has no effect on 
differences obtained between groups. The results presented in the next section were 
therefore obtained without using any covariate. 
Table 5.1.  Descriptive characteristics of each group presented by means and standard deviation values 
 
Gender 
(m / f) 
Age (years) 
Mean (SD) 
Height (m)
Mean (SD) 
Weight (kg)
Mean (SD) 
BMI (kgm-2) 
Mean (SD) 
POMA-B (x/16) 
Mean (SD) 
Control subjects  7 / 5 55.3 (7.0) 1.70 (0.11) 78.4 (15.3) 26.8 (3.2) 14.3 (1.4) 
Diabetic patients without PN 10 / 2 56.1 (8.3) 1.71 (0.11) 89.4 (15.6) 30.4 (3.8) 13.5 (2.0) 
Diabetic patients with PN  8 / 4 60.2 (5.2) 1.67 (0.09) 86.3 ( 9.7) 30.9 (4.0)a 12.0 (1.7) 
a Indicates a significant difference between the control and the DPN group (p < 0.05). 
Differences between conditions 
All groups show higher AP acceleration ranges during the quiet standing task with EC 
compared with the EO condition (Table 5.2). The control group (CG) increased lumbaracc of 
12.8% and ankleacc of 8.1% between both conditions whereas the DM and DPN groups 
increased lumbaracc of 11.4% and 27.6% and increased ankleacc of 36.1% and 22.6% 
respectively. The ML component of lumbaracc remained about the same between EO and EC 
conditions. Excepted for the AP range of the ankleacc in the DM group, all increases were 
non-significant. 
Differences between groups 
Quiet standing with eyes open 
Significant group effects have been detected for the AP range of the lumbaracc and for the 
AP range and AP RMS of the ankleacc parameters (Table 5.2). Post hoc tests revealed that AP 
range of the lumbaracc were significantly higher for the DPN group than that for the CG (p = 
0.001; ES = 0.40) and for the DM group (p = 0.017; ES = 0.23) (Figure 5.2a). Significant 
differences between control and DPN groups were also detected for AP range (p = 0.02; ES 
= 0.18) and AP RMS (p = 0.04; ES = 0.20) of the ankleacc parameters, noting larger values for 
the DPN group (Figure 5.2b). 
Quiet standing with eyes closed 
Significant group effects have been detected in 5 parameters: AP range of the lumbaracc, ML 
range and RMS values of the lumbaracc and AP range and RMS values of the ankleacc (Table 
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5.2). Post hoc tests showed significant higher AP range of the lumbaracc for the DPN group 
compared with that of the CG (p = 0.005; ES = 0.29) and the DM group (p = 0.022; ES = 0.22) 
(Figure 5.2a). For the ML range of the lumbaracc, significant difference was noticed between 
DM and DPN groups (p = 0.04; ES = 0.26), with higher-range values for the DPN group. For 
the ML RMS of the lumbaracc, significant higher value was found for the DPN group 
compared with that of the CG (p = 0.02; ES = 0.24) and the DM group (p = 0.01; ES = 0.27). 
As for the quiet standing with EO, significant differences between control and DPN groups 
were obtained for the AP range (p = 0.02; ES = 0.23) and AP RMS (p = 0.01; ES = 0.25) of the 
ankleacc parameters (Figure 5.2b). 
Table 5.2.  Results of lumar and ankle accelerations during quiet standing with eyes open and eyes closed 
 
 
 
Variable 
 
Control 
subjects 
Diabetic 
patients 
without PN
Diabetic 
patients 
with PN 
 
Differences between 
groups 
  Mean (SD) Mean (SD) Mean (SD)  P  Effect size 
 Lumbar acceleration (g×10−3)        
 AP RMS 7 (2) 8 (2)  9 (3)  0.080 0.14 
 ML RMS 4 (1) 4 (1)  6 (3)  0.079 0.21 
 Ankle acceleration (g×10−3)       
 AP RMS 6 (3) 6 (2)  9 (4)  0.041 a b 0.22 
   
 Lumbar acceleration (g×10−3)       
 AP RMS 7 (2) 8 (3) 12 (6)  0.055 0.24 
 Ankle acceleration (g×10−3)       
 ML RMS 4 (1) 3 (1)  5 (2)  0.006 a b c 0.26 
 AP RMS 6 (3) 7 (2) 10 (4)  0.015 a b 0.22 
p corresponds to the between-group effect. 
a Significant difference between groups with a p value < 0.05. 
b Significant difference between control and diabetic patients with PN with a p < 0.05. 
c Significant difference between diabetic patients without and with PN with a p < 0.05. 
 
 
Figure 5.2. Anterior posterior (AP) acceleration range at the lumbar (a) and ankle (b) levels for the eyes open 
(EO) and eyes closed (EC) quiet standing conditions. Significant differences (p < 0.05) between 
control group, diabetic group without peripheral neuropathy (DM) and with peripheral 
neuropathy (DPN) are indicated with an asterisk (*). 
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POMA-B test 
A significant group effect has been found for the POMA-B test (p = 0.007). The CG had the 
higher mean score with 14.3, DM had 13.5 and DPN had the lower score with 12. Post hoc 
test revealed a significant difference between control and DPN group (p = 0.006; ES = 0.39). 
DISCUSSION 
The objective of the present study was to evaluate the standing balance of diabetic patients 
with and without PN using accelerometers in 2 specific quiet standing conditions (i.e. EO 
and EC). We expected diabetic patients with PN to have greater balance instability than 
control subjects and diabetic patients without PN. The results obtained in the present study 
confirm our hypotheses with significant higher range and RMS acceleration values in the 
DPN group. Lower score for the POMA-B test was also found in the DPN group, which is 
related to a greater instability during the standing tasks compared with that of the other 
groups. The larger amplitude and variability in the accelerometric signal for the DPN group 
could be associated with higher balance deficit [21, 29] or different postural control 
strategies adopted to maintain proper balance [6]. In this study, all participants chose a 
comfortable position to perform quiet standing test with EO. This position remained the 
same after removing visual inputs (i.e. quiet standing with eyes closed). Thus, the 
differences obtained in the accelerometric signal between both conditions could be 
attributed to vision deprivation. As we hypothesised, higher accelerations for each group 
were detected during the EC condition compared with those during that of EO. Similar 
results were found in another accelerometric-based study comparing healthy young and 
older adults [21]. 
No significant difference has been detected between control subjects and diabetic patients 
without PN. However, a trend to increase lumbar acceleration compared with CG was 
observed (Figure 5.2a). As described by Centomo et al. [11] a more destabilising task may 
have been able to detect differences between groups; however, this was beyond the scope 
of this article. 
Several aspects are involved in postural control and thus in the capacity to maintain body 
equilibrium under static and dynamic conditions. It is well known that the most important 
aspect of balance control resides in the size and quality of base of support (i.e. feet). As 
reported [33] any modification in size, strength, range, pain or control of the feet will 
compromise balance. The onset of balance instability in diabetic patients is closely linked to 
the appearance of PN, which is characterised by somatosensory deficits. Complications 
induced by PN (i.e. decline in cutaneous sensation under feet and proprioception) will 
therefore lead to a reduction in the quality of information transmitted to the CNS, needed 
to maintain adequate balance [6]. Even though there is no important perturbation during 
quiet standing, the body equilibrium is still dependant of the vestibular, visual and sensory 
systems’ integrity. As previously reported, if the integrity of one system is compromised, as 
it is because of the complications induced by PN, the other systems will be more solicited. 
In fact, interesting results were found during the quiet standing condition without visual 
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inputs. The greatest difference was observed for the DM group with a significant increase 
of 36% for the AP range of the ankle acceleration compared with an increase of 22% and 
8% for the DPN and CG, respectively. We can assume that diabetic patients with PN may 
have compensated their cutaneous sensory loss by increasing dependence on visual inputs 
[34]. We can also speculate that if diabetic patients without PN presented early signs of PN, 
which are not yet detectable clinically, they will use more visual inputs compared with the 
control subjects. Thus, when visual inputs were removed, their stability was even more 
compromised. 
Besides the measurement of trunk accelerometry data, which has been previously 
recommended to evaluate body sway, this study also explored the measurement of 
accelerations at ankle level. Since postural control is described as a complex skill which 
integrates the interaction of dynamic sensorimotor processes [6], a multi-segmental 
approach seemed more appropriated for its investigation. For this reason, this study 
explored the measurement of accelerations at 2 specific levels to observe if it could bring 
new insights into the balance instability in diabetic patients. Our results show that control 
subjects as well as diabetic patients with and without PN use both ankle and lumbar sway 
to maintain balance. Moreover, all groups tend to increase range and RMS values at both 
levels during standing with EC compared with EO. However, our results clearly demonstrate 
higher acceleration values at both levels in the DPN group. An AP lumbar acceleration 
range greater than 49% and 32% in the DPN group was obtained compared with that in the 
control and the DM groups, respectively. An AP ankle acceleration range greater than 43% 
and 47% was also found in the DPN group compared with that in the control and the DM 
groups. It is recognised that diabetic patients with PN have distal muscle weakness, 
especially at ankle and knee [35]. During quiet standing, both proprioceptive dysfunctions 
as well as muscle weakness could have accounted for postural instability. The reduction of 
the muscle control next to the ankle joint could have lead to a greater solicitation of 
movements near the COM, increasing accelerations at both levels more than those in the 
other groups (i.e. control and DM). During quiet standing with EC, the DPN group had also 
demonstrated higher lumbar range accelerations compared with the one obtained at 
ankles. Further accelerometric-based balance studies are needed to evaluate the 
relationship of each accelerometry data level with clinical factors (e.g. muscle weakness, 
joint mobility) involved in PN during quiet standing and in more perturbed conditions. 
Several studies have shown that diabetic patients with PN have poor stability compared 
with control subjects and diabetic patients without PN using COP parameters [12-14, 17, 
18, 36, 37]. The results found in this study support these findings. Moreover, this study 
confirms the potential of accelerometers to be used in the investigation of balance 
instability as previously reported [21, 29-31]. Furthermore, accelerometers can be fixed at 
different levels of the human body, adding more information on the multi-segmental 
nature of quiet stance. 
This study had, however, some limitations that should be taken into consideration. First, 
neuropathy was clinically diagnosed by the VPT which could be influenced by the inter-
rater variability as well as the experience of the investigator. In the present study, we were 
careful that only one trained investigator did the VPT evaluation for all patients. In addition, 
the VPT has also been recently recommended for routine screening of diabetic neuropathy 
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[23]. Secondly, the ankle accelerations have been recorded only in the sagittal plane (i.e. AP 
component), since the most important movement of the ankle joint relies on the sagittal 
plane. However, ML ankle accelerations would have been of interest to compare their 
magnitudes with the one obtained at the lumbar level. Another limitation is due to the free 
feet position during testing. The fact that each subject chose his or her own feet position 
might have reduced or even eliminated differences between groups for some parameters. 
We can however speculate that if all subjects have selected their optimal feet position 
during the EO and EC balance testing (i.e. a position for optimal balance), differences 
between groups would have been even more important with an imposed feet placement. 
Further balance studies using accelerometers should also focus their analysis on more 
destabilising tasks, such as different perturbed standing conditions or walking on different 
surfaces, which have previously shown differences between diabetic patients with and 
without PN [38]. 
CONCLUSIONS 
This study is the first to have investigated the balance instability of diabetic patients with 
and without PN using accelerometers. The simple accelerometric-based method used in 
this study demonstrated an interesting potential to evaluate the balance skills of diabetic 
patients. With the burden of cost related to diabetic disease, the development of 
parameters that could be used in clinics to evaluate and follow diabetic patients is essential 
to detect early signs of instability and thus help in therapeutic planning managements. 
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SUMMARY 
Background 
Diabetic patients have an increased risk of injurious falls. Fifty percent of patients suffering 
from diabetes for more than 20 years develop peripheral neuropathy. The neuromuscular 
damage implied by peripheral neuropathy may result in altered lower extremity 
biomechanics, thereby leading to gait alterations with increased risk of falling. However, 
clinical factors which may be associated with these gait alterations in diabetic patients are 
still unclear and under debate. 
Aims 
To identify clinical factors associated with gait alterations in patients with type 2 diabetes. 
Methods 
A sample of 76 diabetic patients underwent clinical examination and an outdoor gait 
evaluation on tarred and cobblestone terrains. We calculated respective differences in gait 
speed (performance measure) and gait variability (fall risk index) on changing terrains. 
Associations with clinical factors were investigated using correlation coefficients and linear 
regression analysis. 
Results 
The mean walking speed on the tarred pathway was 4.52 ± 0.6 kmh-1 and 3.93 ± 0.8 kmh-1 
on the cobblestone pathway (p < 0.001). The coefficient of variation of gait cycle time 
increased from 2.58 ± 0.9% on the tarred pathway to 5.05 ± 2.8% on the cobblestone 
pathway (p < 0.001). Regression analysis showed that 36% of the decrease in gait speed 
was proportionally explained by the mean of maximal isometric lower limb strength 
(22.2%; p ≤ 0.01), fear of falls (7.4%; p ≤ 0.01) and participants’ perceived vibration 
perception threshold (6.4%; p ≤ 0.01). Moreover, mean maximal isometric strength 
explained 11.8% (p ≤ 0.01) of the increase of the coefficient of variation of the gait cycle 
time when participants changed from tarred terrain to cobblestones. 
Discussion and conclusion 
This study indicated that both physiological (strength and proprioception), and cognitive-
behavioural factors (fear of falls) should be considered when treating diabetic patients with 
gait alterations. Therapists should apply these findings when developing specific fall 
prevention and treatment programs. 
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INTRODUCTION 
Diabetic patients have an increased risk of injurious falls [1, 2]. Fifty percent of patients 
suffering from diabetes for more than 20 years develop peripheral neuropathy (PN). The 
neuromuscular damage implied by PN may result in altered lower extremity biomechanics 
[3], thereby leading to gait alterations (i.e. modified walking speed and gait pattern) with 
increased risk of falling. Clinical factors which may be associated with these gait alterations 
in diabetic patients are still unclear and under debate [4]. Allet et al. [5] showed that 
diabetic patients with PN present more gait alterations than patients without PN. 
Moreover, this same article demonstrated that gait alterations may appear well before 
peripheral neuropathy is detected clinically [5]. Petrofsky et al. [6] reported that patients 
with diabetes are at risk of falling before loss of foot sensation. Thus, clinical factors other 
than neuropathy [5] such as muscle strength [7], joint mobility [7], general de-conditioning 
or psychological traits (e.g. fear of falls) [8] may deteriorate diabetic patients’ gait. 
Diabetes’ high incidence, related gait alterations, increased fall risk and adjunct costs [9], 
require the identification of factors associated with gait alterations. The World Health 
Organisation (WHO) recommends that diabetics have 30 min daily physical activity, 6 times 
a week which implies adequate gait performance and safety. 
Performance can be measured by gait speed and/or walking distance. Reduced gait speed 
may indicate a security strategy used to avoid falls [10]. Gait safety requires among others 
adequate variability, stability, speed and reaction time and may be compromised by 
extrinsic and intrinsic factors [11]. Fall risk itself is currently assessed by variability between 
one gait stride to another [12, 13]. Gait cycle time variability (cycle time, stance time, swing 
time and percent stance), stride length variability or step width variability are widely used 
parameters. Hausdorff et al. [12] showed that the coefficient of variation of the gait cycle 
time (CVGCT) is a sensitive measure which provides important information about patients’ 
gait safety and fall risk. 
There is evidence that irregular terrain reveals clinically relevant impairments and 
accentuates differences in step time variability between groups of clinical interest (older 
women with and without peripheral neuropathy [14] and diabetic patients versus healthy 
controls [5]). Diabetic patients for example were shown to reduce their walking speed and 
to increase their step time variability while changing from smooth to irregular terrain, 
which indicates patients’ difficulties in adapting their gait pattern to a challenging 
environment [5]. 
As clinical factors may undermine individuals’ gait performance and safety, this study aims 
to examine the association of clinical factors (muscle strength, joint mobility, fear of falls, 
perception, sensitivity, age and Body Mass Index (BMI)) with gait speed and gait variability 
in diabetic patients with and without neuropathy, while walking in real life conditions. 
On the basis of existing knowledge [5] 2 questions were investigated: a) which clinical 
factors are associated with gait speed differences while changing from smooth to irregular 
terrain and b) which clinical factors are associated with differences in the CVGCT while 
changing from smooth to irregular terrain? 
We hypothesised that muscle weakness, limited joint mobility, fear of falling, severity of 
disease (neuropathy), increased BMI and age are associated with gait alterations. Gait 
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alterations will be assessed by gait speed differences (performance) and CVGCT differences 
(fall risk assessment) while changing from smooth to irregular terrain. 
METHODS 
The study was approved by the local ethics committee. All participants received written 
and oral information and were requested to sign an informed consent statement. 
Participants 
A convenience sample of 76 participants was recruited from the patients consulting the 
Service of Therapeutic Education for Chronic Diseases or the Service of Endocrinology at 
the University Hospital in Geneva. Patients were included if they were medically diagnosed 
with diabetes type 2 (Blood sugar > 7.0 mmoll-1 in fasting state). Patients were excluded if 
they had concomitant foot ulcers, orthopaedic or surgical problems influencing gait 
parameters, a non-diabetic neuropathy (due to Charcot-Marie-Tooth disease, excessive 
alcohol intake or thyroid dysfunction), neurological pathology influencing gait parameters 
or incapacity to walk without a walking aid a minimum of 500 m. 
Clinical examination 
The same experienced physiotherapist examined all participants. Participants were 
requested to report their fasting blood sugar level measured on the morning of the test. 
The physiotherapist confirmed the absence of foot ulcers. Maximum isometric strength of 
the hip, knee, ankle flexors and extensors was measured with a hand-held dynamometer 
(Microfet®, Hoggen health, USA) [15, 16]. Joint mobility of the hip, knee and ankle flexion 
and extension were measured with a manual goniometer. Vibration perception threshold 
(VPT) was evaluated with a Rydel-Seiffer tuning fork [17]. Plantar foot sensitivity was tested 
with a 5.07 Semmes Weinstein monofilament (10 g) [18]. Participants’ fear of falling was 
assessed with the Falls Efficacy Scale [19]. 
Gait evaluation 
Gait analysis was performed using 4 miniature gyroscopes (ADXRS 250, Analog device) 
attached to both shins and thighs with Velcro straps. The gyroscopes measured the angular 
velocity (rads-1) of each segment around the coronal axis (flexion-extension). Temporal 
parameters (speed, gait cycle time) were estimated from distinctive features of shin 
angular velocity signal recorded by Physilog® (BioAGM, CH) [20]. Signals were digitised (16 
bit) at a sampling rate of 200 Hz by a light portable data logger and stored for off-line 
analysis on a memory card. Equipped with the Physilog®, participants were asked to walk at 
their preferred walking speed (e.g. posting a letter). The walkway consisted of two 50 m 
tarred pathways, two 50 m grass pathways and two 20 m cobblestone pathways [5] in the 
garden of the hospital. Between each terrain the participants paused for 8 to 10 s to 
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identify the change from one terrain to another. Three different orders were possible 
(beginning with tarred surface, grass or cobblestones terrain) and were randomly assigned. 
For this study we were only interested in the tarred and cobblestone terrains. 
Analysis 
Definition of variables 
Mean gait speed and mean CVGCT on the tarred road and on the cobblestone terrain were 
calculated. Participants’ difficulty in changing from the smooth tarred terrain to the more 
irregular cobblestone terrain was estimated by 2 dependent variables. 
1.  The difference in walking speed 
Difference in walking speed = Speed on a tarred pathway – Speed on a cobblestone 
pathway. 
2.  The difference in the CVGCT 
Difference in CVGCT = CVGCT on a tarred pathway – CVGCT on a cobblestone pathway. 
Scatterplots and correlations between variables provided an overview of the distribution 
and range of measurements performed during the clinical examination. On the basis of 
these results as well as clinical experience, 7 independent variables were retained to be 
included in a linear regression model: 
-  Muscle strength: strength values of the different muscle groups were highly correlated 
and we therefore considered the mean value of all muscle groups. 
-  Vibration perception threshold: mean perception threshold of the medial malleoli and 
the big toes. 
-  Sensibility: the sum of all anatomical plantar foot points (toes 1, 3, 5, metatarsals 1, 3, 
5, heel, medial and lateral foot) on which a participant felt the 5.07 Semmes Weinstein 
monofilament (10 g) [18]. 
-  Joint mobility: as every participant showed joint mobility values within the range 
necessary for normal gait except for ankle dorsiflexion, we only retained this last value. 
-  Fear of falls: scores between 16 (best score) and 74 (worst score) established with the 
fear of falls questionnaire [19]. 
-  BMI (kgm-2): body mass divided by the square of height. 
-  Age: patients’ age in years. 
Statistical analysis 
All statistics were performed with SPSS (SPSS for Windows rel. 15. Chicago: SPSS Inc.). The 
level of significance was set for all parameters at p ≤ 0.05. Descriptive statistics were used 
to evaluate participants’ characteristics (Table 6.1). Statistical differences (p value) in gait 
speed and in CVGCT were calculated with a paired t-test. The association of each clinical 
parameter with each dependent gait parameter was analysed. Based on these results 
variables were added to a step forward regression model, respecting the importance of 
significance (p value) obtained with the previous independent analysis. All variables were 
checked for collinearity using the variance inflation factor (VIF). Three different models 
were analysed. 
Model A (for the decrease in gait speed): mean strength, fear of falls index, VPT, plantar 
foot sensitivity, ankle dorsiflexion mobility, age and BMI. 
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Model B1 (for the increase in CVGCT): mean strength, fear of fall index, age, ankle 
dorsiflexion mobility, plantar foot sensitivity, VPT and BMI. 
Model B2 (for the increase in CVGCT respecting speed difference): as gait speed is a 
frequently discussed factor, when investigating gait variability with the CVGCT [21], the 
change in walking speed was added to model B1. 
RESULTS 
All 76 volunteers (mean age: 63 ± 9.6 years; BMI: 31 ± 5.5) underwent the clinical 
examination and gait evaluation. The mean, standard deviation and range of all clinical 
variables are presented in Table 6.1. 
Table 6.1.  Description of results obtained in the clinical examination 
 Mean (SD) Minimum Maximum 
General information    
BMI  31 (5.5)  20  47 
Height (cm) 168 (9.4) 147 193 
Weight (kg)  88 (15.3)  54 138 
Age (years)  63 (9.6)  40  85 
Superficial sensitivity 
(Number of the 9 points which perceived the 10 g)   5 (2.8)    0   9 
Vibration perception threshold  
(Tuning fork: best score 8, worst score 0) 
   
   3.6 (1.6)   0   8 
Fear of fall  
(FES-I: best score 16, worst score 64 )  21 (5.9)  16  46 
Strength (N) 
- Mean of 6 lower limb muscle groups 199 (49.3)  90 311 
- Hip Flexors 243 (72.5) 111 426 
- Hip Extensorsa 142 (63.0)  30 322 
- Knee Flexors 124 (39.3)  50 235 
- Knee extensors 230 (65.7)  59 360 
- Ankle Plantar Flexors 243 (56.9)  96 356 
- Ankle Dorsal Flexors 211 (54.6)  99 336 
Mobility (mean value of right and left joint expressed in deg)    
- Hip Flexion 104 (9)  90 130 
- Knee Flexion 125 (6) 110 140 
- Knee Extension   0 (1)   -5   0 
- Ankle Plantarflexion  43 (8)  20  60 
- Ankle Dorsiflexion   6 (4)   -3  13 
a One person could not perform the hip extension in the required prone position. 
The mean walking speed on the tarred pathway was 4.52 ± 0.6 kmh-1 and 3.93 ± 0.8 kmh-1 
on the cobblestone pathway (p < 0.001). The CVGCT increased from 2.58 ± 0.9% on the 
tarred pathway to 5.05 ± 2.8% on the cobblestone pathway (p < 0.001) (Figure 6.1a and 
6.1b). 
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As all VIF values were lower than 1.3, we assumed no collinearity of the data. Step forward 
analysis showed that 3 clinical factors explained 36% of the decrease in diabetic patients’ 
gait speed when they changed from a tarred to a cobblestone terrain: mean lower limb 
isometric maximal strength (22.2%), fear of falls (explains an extra 7.4%) and VPT (explains 
an additional 6.4%) (Table 6.2). 
However, only mean lower limb isometric maximal strength explained the increase of 
CVGCT when participants changed from tarred terrain to cobblestones (11.8%). To take into 
consideration the decrease in walking speed due to change of terrain we added the speed 
differential to the step forward model. Gait speed difference alone explained 43% of the 
increase of the CVGCT, whereas strength no longer explained the increase of the CVGCT. 
Figure 6.2 resumes the associations of clinical factors identified as predictors for gait speed 
reduction and increase in gait instability while changing from a smooth to a more irregular 
terrain. 
Table 6.2. Regression model for the dependent variables: speed difference and CVGCT difference 
Model for speed difference
Model R R2 Dependent variable Unstandardised Coefficients T P 
.471 (a) 0.222 Strength   -0.07 (-0.09 to -0.04)  -4.59 <0.001 
Strength   -0.05 (-0.08 to -0.02)  -3.27 <0.001 .544 (b) 0.296 
Fear of falling   4.11 (1.15 to 7.07)  2.77  0.01 
Strength   -0.04  (-0.07  to  -0.01)   -2.54  0.01 
Fear of falling   4.22 (1.38 to 7.06)  2.96 <0.001 
A 
.600 (c) 0.360 
Vibration perception threshold  -13.52 (-23.53 to -3.51)  -2.69  0.01 
Model for CVGCT difference 
Model R R2 Dependent variable Unstandardised Coefficients T P 
B1 .344 (b) 0.118 Strength  0.15 (0.05 to 0.24)  3.15 <0.001 
B2 .656 (a) 0.431 Speed Difference  -2.00 (-2.53 to -1.47)  -7.48 <0.001 
CVGCT = coefficient of varation of gait cycle time. 
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Figure 6.1a and 6.1b.  Boxplot of (a) speed and (b) coefficient of variation of gait cycle time (CVGCT) recorded on a 
 tarred surface (tar) and cobblestones (stones).The third boxplot of each figure shows the 
 respective difference between the tarred surface and the cobblestones. 
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DISCUSSION 
This study aimed to determine clinical factors associated with gait speed differences and/or 
differences in the CVGCT while changing from smooth to irregular terrain. Factors 
influencing diabetic individuals’ gait pattern should be identified to understand the 
underlying mechanisms of gait alterations potentially related to a heightened fall risk. 
Three clinical factors explained 36% of the decrease in gait speed, namely mean lower limb 
isometric maximal strength, fear of falls and severity of neuropathy (vibration perception 
threshold). Mean lower limb isometric maximal strength alone explained 11.8% of the 
increase of the CVGCT when participants changed from smooth to irregular terrain. To date 
a majority of studies has investigated static balance, although falls mostly occur during 
walking [22]. Diabetic individuals’ difficulties are highlighted in challenging environments 
[5]. Diabetic patients also use more pronounced adaptation strategies than healthy 
controls when changing from level to irregular terrains [5]. Thus, irregular terrains may be a 
useful “tool” with which to analyse individuals’ gait and fall risk. Our study is one of the first 
to make use of this concept. 
We found gait speeds that are consistent with values recorded in previous studies on 
comparable surfaces, where walking speeds were between 3.4 kmh-1 [14] and 5.1 kmh-1 
[23]. The positive relationship between the decrease in gait speed and muscle strength is 
similar to that described, for example, by Chang et al. [24]. Perhaps lower limb weakness, 
especially of plantar flexors and hip extensors, influenced joint moments and muscle 
power, which play an important role in gait speed and balance recovery [25]. We believe 
that further evaluation of the latter kinematic parameters could provide extra information 
about the causes for gait alterations and increased fall risk. 
Recent results confirm that the degree of neuropathy influences walking speed when 
changing terrains. Neuropathy, together with muscle weakness, could influence the 
neuromuscular control process. Both may affect not only joint moments and power 
generation but also the timing of muscle activation and thus gait performance [26]. 
However, reduced gait speed could also be an adaptation strategy. Perhaps diabetic 
patients walk slower because of altered neuromuscular control processes leading to 
decreased balance and stability. The association between participants’ fear of falling and 
decreased speed could support this theory. Slowing down might be a security strategy to 
feel safer on irregular terrains. Nevertheless, reduced walking speed does not necessarily 
imply increased safety during walking according to Kang et al. [21]. Younger adults improve 
their dynamic stability by walking slower, whereas older adults fall yet more. 
When considering gait variability in our population we found muscle strength and the 
CVGCT to be related. Although our study design does not allow us to draw conclusions 
about causal mechanisms that explain associations between strength and fall risk (CVGCT) 
our data was consistent with previous findings where muscle weakness and reduced 
reaction time were associated with increased sway and increased fall risk [27]. As diabetic 
neuropathy leads to feedback delays, maybe increased ankle moment latency in response 
to perturbations (i.e. walking over cobblestones) contributes to the postural instability 
observed in neuropathic individuals. Feedback delays thus probably play also a part in 
increased gait variability and fall risk. This hypothesis should be further investigated. 
THESIS_L_Allet_v15.pdf
C h a p t e r  6  
 104 
After discussing gait speed’s influence on volunteers’ gait variability [28, 29], we added the 
variable “speed difference” to our regression model. In this model strength no longer 
influenced the increased CVGCT, which drew attention to the interpretation of the CVGCT. 
Nevertheless, our results indicated that diabetic patients’ gait performance and gait 
variability seem to be affected by both physiological factors (neurological and muscular 
function) and participants’ fear of falls. 
The data showed 1 extreme outlier (Participant 128 on Figure 6.1). We therefore checked 
our dataset for inconsistencies. We did, however, not find any technical flaw to explain the 
outlier. The patient had worse gait than the others and was used to walking longer 
distances with a walking stick. His steps were discontinuous and he stopped several times 
on the pathway during the test session, more so on cobblestones than on a tarred terrain, 
which increased the CVGCT difference. Nonetheless, he fulfilled our inclusion criteria. For 
these reasons it was decided to maintain this participant in the regression model. The 
research team further debated on whether to normalise participants’ lower limb strength 
for their body weight or height. Preliminary scatterplots showed no linear relationship 
between participants’ weight or height and isometric strength, therefore the investigators 
decided to integrate participants’ mean strength (N) and their BMI (kgm-2) separately in the 
regression model and not to normalise participants’ lower limb strength for their body 
weight or height. 
Speed showed a high association with the CVGCT. Further work should separate the effects 
of walking speed, which may help to clarify the picture concerning diabetic patients who 
fall or are ‘‘frail” [28]. A recent publication showed that the local and orbital dynamic 
instability are independent of walking speed and could be other subjects for fall risk studies 
[29]. 
We measured maximal lower extremity isometric strength with a hand-held dynamometer, 
which provides reliable [15] and objective [30] strength measures. These measurements 
are more precise than with manual muscle testing although they may be limited by the 
investigator’s ability to hold the dynamometer stationary and the fact that participants 
could overpower the testers. An additional point is the limited number of subjects. For 
power reasons we were not able to include each independent variable. Thus, the 
relationship between the strength of each muscle group and gait performance/stability 
could not be analysed. Over and above the clinical factors examined in the present study, 
further investigations should evaluate such specific relationships. Ideally, not only sagittal 
but also frontal plane muscle strength (i.e. hip adductors and abductors, which are involved 
in frontal plane stability during gait) should be considered. However, this was beyond the 
scope of this paper. 
Other variables such as ankle dorsiflexion may be associated with gait variability or gait 
performance, although they could not be identified in this study for presumably lack of 
statistical power. 
Correlations do not imply causality, but models examining potential contributors and how 
the R-square changes when potential contributors are added to the model, can help us to 
understand which factors determine the association between speed differences and/or 
CVGCT differences and how much of the association is explained. More studies are needed 
to verify causality between muscle strength and gait parameters in diabetic patients. 
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Despite these limitations our results document new factors to be addressed when 
developing specific physiotherapy programs to improve diabetic patients’ gait performance 
and safety. Programs should consider both physiological and cognitive-behavioural factors. 
They should include strength exercises, proprioceptive training and practice of 
progressively more complex activities of daily living, in order to improve the self-assurance 
of diabetic patients. Gait alterations are likely to influence patients’ physical activity level, 
thus triggering a vicious circle of functional limitation. Physical activity plays a central role 
in the management of metabolic diseases and is part of the lifestyle recommended to avoid 
complications. It enables individuals to forestall medical and functional complications. For 
national health care systems, physical activity is a cost-effective way of improving public 
health across the population. Diabetic patients need adequate gait performance and 
sufficient safety to feel confident in different environments. A fall prevention program 
based on this new knowledge may provide a complementary benefit to physicians’ 
provisions to avoid complications and help to manage fall risk [31] and thus further 
interdisciplinary care management. 
CONCLUSIONS 
This study shows an association between muscle strength, fear of falling, vibration 
perception threshold and gait alterations caused by surface transitions in diabetic 
participants. Both physiological and cognitive-behavioural factors should be considered 
when treating patients with gait alterations. Therapists are encouraged to develop fall 
prevention and/or treatment programs to improve gait performance and gait safety so that 
patients feel confident enough to reach the WHO’s recommended level of daily activity. 
Further studies should investigate the efficacy of such newly developed treatment 
approaches. 
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SUMMARY 
Background 
Gait characteristics and balance are altered in diabetic individuals. Little is known about 
possible treatment strategies. 
Aims 
This study aims to evaluate the effect of a specific training program on diabetic patients’ 
gait and balance. 
Methods 
A randomised controlled trial (n = 71) with an intervention (n = 35) and a control group (n = 
36). The intervention consisted of physiotherapeutic group training including gait and 
balance exercises with function-orientated strengthening (twice a week over 12 weeks). 
Controls received no treatment. Gait, balance, fear of falls, muscle strength and joint 
mobility were measured at baseline, post-intervention and at 6 month follow-up. 
Results 
After training, the intervention group increased habitual walking speed by 0.149 ms-1 (p < 
0.001) compared to the control group. Moreover patients in the intervention group 
significantly improved their balance (time to walk over a beam and balance index recorded 
on a Biodex balance system), their performance oriented mobility (POMA), their degree of 
concern about falling, their hip and ankle plantar flexor strength and hip flexion mobility, 
compared to the control group. After 6 months, all these variables remained significant 
except for the Biodex sway index and the ankle plantar flexor strength. 
Discussion and conclusion 
Specific training can improve diabetic patients’ gait speed, balance, muscle strength and 
joint mobility. Further studies are needed to explore these improvements’ influence on the 
number of reported falls, patients’ physical activity level and quality of life. 
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INTRODUCTION 
Type 2 diabetes and its common complication peripheral neuropathy (PN), affects a large 
population [1, 2]. PN leads to sensory and motor deficits which often result in mobility-
related dysfunction, alterations in gait characteristics [3, 4] and balance impairments [5, 6]. 
Diabetic patients with PN have lower gait velocity, decreased cadence, shorter stride 
length, increased stance time and higher step to step variability compared with healthy 
controls [3]. These gait alterations increase on irregular surfaces [3]. Moreover, these 
patients have less ankle moment and ankle power [7, 8], as well as a different onset and 
cessation time of muscle activity compared with healthy controls [7]. Patients present more 
co-contractions of agonist and antagonist muscles at the ankle and knee joints during 
stance phase. Kwon et al. [7] speculate that the co-contraction mechanism may enable 
these individuals to adopt a safer, more stable gait pattern to compensate for diminished 
sensory information. The same authors reported reduced ankle strength and mobility 
which they considered to be the primary factors contributing to gait alterations. Allet et al. 
[3] have also found lower limb strength, fear of falling and sensory problems to be related 
to spatiotemporal gait alterations. Additionally individuals with PN also show postural 
instability with a larger centre of pressure displacement [9], higher sway area [10] and 
greater instability [11] when standing still with eyes closed [9]. Postural instability was 
further found to be significantly associated with sensory neuropathy [12]. In addition to 
these gait and balance impairments, diabetic patients are known to suffer from increased 
risk of injurious falls [13]. Fall-related injuries are often assumed to trigger a vicious circle 
because of their potentially detrimental influence on patients’ physical activity level. Public 
Health guidelines for diabetes management recommend that patients perform at least 30 
min of physical activity a day, 6 times a week, requiring adequate gait security and balance. 
However, little is known about treatment strategies that could improve patients’ gait and 
balance, thereby also reducing fall risk [4]. Although there is evidence that an exercise 
regimen improves clinical measures of balance in patients with PN [14], clinical trials 
investigating diabetic individuals’ gait generally focus on increased foot pressure, another 
major problem in this population, related to patients’ high risk of ulcers [15]. Only few 
studies evaluate treatments that aim to improve gait and balance and decrease fall risk [16, 
17]. Petrofsky et al. [16] tested an insulin sensitiser, Rosiglitazone (RSG) which promises to 
reverse some of the circulatory impairments seen in diabetes, thereby improving patients’ 
gait. These authors report encouraging results after administering RSG (decreased step 
width, reduction in reaction time and less acceleration at the joints). However, RSG was 
recently associated with an increased risk for myocardial infarction and death from 
cardiovascular incidents [18]. Richardson et al. [17], evaluating patients with various form 
of PN (30 of 42 with diabetic PN) found that the use of a cane, ankle orthoses or touching a 
wall improved step-width range, step-time variability and speed while walking under 
challenging conditions. To our best knowledge, only Tsang et al. [19] and Orr et al. [20] 
investigated the effect of a specific physical training program not only on the activity level 
and quality of life of diabetic patients but also on their habitual and maximal walking speed. 
However, both studies seem to have evaluated the same group of subjects. In their studies 
the effect of a “Tai Chi for Diabetes” program (twice a week for 16 weeks) on gait, balance, 
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musculoskeletal and cardiovascular fitness, self-reported activity and quality of life was 
compared with that of sham exercises. Gait speed and balance improved, but no significant 
differences between groups were reported. Nevertheless, several studies [21-23] have 
shown positive training effects on gait speed, postural stability and mobility of elderly 
individuals. Additionally, a meta-analysis [24] evaluating fall prevention studies for the 
elderly showed a 4% decrease in the fall-rate for individuals who were in a treatment 
group. Since elderly people often show symptoms similar to those in diabetic patients (i.e. 
de-conditioning, muscle weakness, decreased joint mobility and decreased foot sensibility), 
we assumed that programs that have been developed for the elderly might also improve 
diabetic individuals’ gait and balance. Thus, this study aimed to evaluate the effect of a 
specific training program, based on previously elaborated core components for successful 
fall prevention programs for the elderly [25], on the gait and balance of diabetic patients. 
Gait speed and coefficient of variation of gait cycle time (CVGCT) were selected as primary 
outcomes because they have been shown to be related to increased risk of falls [22, 26] (a 
slow gait speed and high CVGCT indicate increased fall risk). Balance control, muscle 
strength and joint mobility are also important fall risk factors and are salient measures that 
may be influenced by exercise [27]. For these reasons, they were chosen as secondary 
outcomes. Fear of falls is a cognitive behavioural component that was recently shown to be 
related to the gait velocity of diabetic patients [28]. It therefore completed our outcome 
list. 
We hypothesised that diabetic patients participating in a training program would 
significantly improve their walking speed and gait variability (CVGCT). We further assumed 
that diabetic patients in the training program would significantly a) improve their balance, 
b) increase their lower limb strength (in particular hip extensors, knee extensors and ankle 
flexors) c) increase their ankle joint mobility and d) decrease their fear of falling. 
METHODS 
Study design 
This randomised controlled prospective trial with 2 arms (intervention group (IG) and 
control group (CG)) was conducted at the University Hospital of Geneva. The study was 
approved by the local ethics committee and registered at Clinical Trials.gov (NCT00637546). 
A sample of 71 diabetic patients was recruited from the patients consulting either the 
Service of Therapeutic Education for Chronic Diseases or the Service of Endocrinology at 
the University Hospital in Geneva. Thirty-five patients were allocated to the IG and 36 to 
the CG. Patients were included if they were medically diagnosed with type 2 diabetes 
(blood sugar > 7 mmoll-1 in fasting state). Only patients without medical contraindications 
for engaging in physical activity and with a clinically diagnosed neuropathy were enrolled. 
Clinically diagnosed neuropathy was evaluated by a vibration perception threshold (VPT) 
equal to, or lower than 4/8 with a Rydel-Seiffer tuning fork® [29]. Patients were requested 
to indicate when they could no longer feel the vibration. At this point the investigator rated 
the vibration on a 9-point scale (0 = severe neuropathy; 8 = no neuropathy). Patients with 
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concomitant foot ulcers, orthopaedic or surgical problems affecting gait parameters, those 
with non-diabetic neuropathy (due to Charcot-Marie-Tooth disease and alcohol), 
individuals presenting a neurological pathology other than PN that could influence gait 
parameters, or unable to walk a minimum of 500 m without a walking aid, were excluded. 
Training programs started as soon as there were enough patients (20 to 28): in September 
2007, January 2008 and April 2008. For each of these starting points a new randomisation 
list was electronically generated and was used by a person uninvolved in the recruitment, 
evaluation or treatment process. Each list ensured equal distribution over groups. 
All eligible patients identified by the medical staff were asked to participate. They were 
informed that if willing to participate, they would be randomly assigned to an IG or CG. 
Patients who orally agreed to join the study were contacted by the study coordinator for an 
individual appointment to sign the informed consent and undergo baseline evaluation. 
After this initial appointment during which patients underwent a clinical examination, a gait 
analysis, static and dynamic balance tests and answered a fear of falls questionnaire 
patients were randomly allocated to either the IG or to the CG. All outcome measures were 
realised at baseline, after 12 weeks and after 6 months and performed by the same 
experienced physiotherapist. 
Patients allocated to the IG received a timetable containing all planned sessions over 12 
weeks. The program started within 10 working days after the examination. Patients were 
kept unaware of the study hypothesis. However, the nature of the study made it impossible 
to blind patients and therapists. After the 12 week-program patients were encouraged to 
continue with the learned exercises during the next 6 months. No other advice or 
restrictions were provided. 
Test description and measures 
Prior to the clinical examination the physiotherapist checked the VPT with the tuning fork 
[29]. Maximum isometric strength of the hip, knee, ankle flexors and extensors was then 
measured with a hand-held dynamometer (MicroFET®, Hoggan Health Industries, Inc., USA) 
[30]. Joint mobility of the hip, knee and ankle flexion and extension was measured with a 
manual goniometer. Patients’ concern about falling when performing different activities 
was assessed with the Falls Efficacy Scale International (FES-I) [31]. Afterwards patients 
underwent the following functional tests: 
-  Performance-Oriented Mobility Assessement (POMA) [32], which scores 17 items (9 for 
the evaluation of balance and 7 items for the assessement of gait). 
-  Outdoor gait assessment [33] recorded with the Physilog® (BioAGM, CH). Participants 
were asked to walk wearing 4 miniature gyroscopes (ADXRS 250, Analog device) 
attached to both shanks and thighs with Velcro straps, on a specific walkway at their 
preferred walking speed. The walkway consisted of two 50 m tarred pathways, two 50 
m grass and two 20 m cobblestone pathways in the hospital’s backyard. For this study 
only the tarred terrain was evaluated. A detailed description of this gait assessment is 
published elsewhere [33]. 
-  Dynamic balance test in which participants had to walk as fast and as precisely as 
possible on the top of a 5 m beam (15 cm high and 15 cm wide). Time was measured 
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with a stopwatch. Patients had one practice trial before the test started. If a patient 
had to step off the beam he could redo the test. In case that they stepped-off again 
patients were asked to resume the exercise where they stepped off and from there 
continue to finalise the test. 
-  Static balance test which evaluated the patients’ postural control on a Biodex® Balance 
system (Biodex Medical Systems, New York, USA) [34]. The level of difficulty while 
standing on this platform can be manipulated by altering the resistance of the 
platform to deviations. The balance test is most difficult when the platform provides 
the least resistance to tilting and is therefore the least stable. Each subject stands 
barefoot on the platform and must perform 2 different tests (level 8 = easiest level and 
level 6 = a more difficult level). The foot position was standardised using a pre-formed 
triangle (heels together and feet forming an angle of 20 deg). Patients were instructed 
to keep their hands at their sides. For safety purposes they were permitted to touch 
handrails, but only to re-establish balance during extreme postural deviations. Once in 
this position, the stability platform was unlocked to allow motion. The subjects were 
then instructed to find a position at which they could maintain platform stability. Each 
recording lasted for 60 s with a rest for 60 s between each trial. We used a single 
recording per test condition and only one attempt per condition to reduce fatigue [34]. 
All tests were realised at baseline, after the 12 weeks intervention and 6 months after 
the intervention. A balance index is calculated by using the time and deviation (in deg) 
of the platform away from a level position [35]. 
Treatment description 
The training took place twice a week for 60 min over 12 weeks. This intensity was chosen 
based on previously developed successful interventions in pre-frail elderly [25, 36-38]. Each 
session was conducted in groups (5 to 8 participants) in order to promote long-term 
participation [39]. The program was directed by a physiotherapist and an assistant. Four 
different physiotherapists and 4 assistants were trained to direct the sessions in order to 
guarantee continuity. A session consisted of a warm up (5 min) followed by a circuit 
training (40 min) including gait and balance exercises. Each session was composed of a set 
of 10 tasks. Balance and walking tasks (stance on heel/toes, tandem stance, one leg stance, 
different kinds of walking) alternated with functional strength-endurance exercises (sit to 
stand, walking up and down a slope, stair climbing and mini hops). Each task was carried 
out twice during 1 min and the complexity of the task could progressively be increased (e.g. 
changing from stable to unstable surfaces (wobble board), increasing step height) [40]. 
Sessions were completed with interactive games (e.g. badminton, obstacle race in teams) 
to train agility (10 min) and a short feedback with suggestions for individual home exercises 
(5 min). As currently no specific gait and balance program is offered to diabetic patients, 
the CG received neither treatment nor specific advice. Both the IG and CG were allowed to 
continue their usual leisure activities. 
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Sample size calculation 
In prior studies the diabetic patients’ gait velocity was 1.25 ± 0.19 ms-1 compared to 1.45 ± 
0.14 ms-1 in a healthy CG [3]. Allowing that diabetic patients might improve their mean 
speed from 1.25 ms-1 to 1.35 ms-1, a total of 64 patients was needed to have an 80 percent 
probability that the study would detect a treatment difference at a two sided 5% 
significance level. We assumed a standard deviation of 0.14 of the response variable. A 10% 
drop out rate was hypothesised and therefore we aimed at including 71 patients in total. 
Data Analysis 
Statistical analyses were performed using SPSS Version 15 software package for Windows. 
The student t-test was used to compare baseline similarity. Each outcome was analysed by 
linear regression (i.e. analysis of covariance). The outcome at 12 weeks (i.e. post-
treatment) and 6 months were dependent variables. The intervention allocation was 
considered as a dichotomous independent variable in the analysis. The baseline values of 
the outcome measures were incorporated in the linear regression model as covariates.  
To reduce the risk of Type I error a Bonferroni corrected alpha level of p = 0.0026 (alpha 
divided by number of tests per follow up) was used to determine a significant difference 
between groups. However, to allow identification of areas of interest for future 
investigations and to reduce the risk of Type II errors, the results are presented with the 
corrected (p = 0.0026) and uncorrected (p = 0.05) significance level.  
An intention to treat analysis was performed and in case of missing values of variables, 
values were imputed by means of the last observation carried forward method. 
RESULTS 
The flow chart (Figure 7.1) provides a detailed description of drop outs and loss to follow-
up. 130 persons were contacted; 53 refused to participate, 6 did not meet inclusion criteria. 
One person developed a depression and 2 were concomitantly diagnosed with cancer and 
thus cancelled their participation. Finally, 71 patients with diabetes type 2 were randomly 
assigned, 36 to the CG and 35 to the IG. Five participants of the CG and 7 of the IG were lost 
to follow- up. Two patients developed pain in their Achilles tendon obliging us to slow 
down the progression for “toe walking” and “one leg stance” exercises. Exercise adherence 
ranged from 11 to 24 treatments with a median of 21. Groups were similar at baseline. 
Descriptive statistics show patients’ characteristics (Table 7.1) and illustrate the 
improvement of the IG in all variables post-intervention (PI) (Table 7.2; Figure 7.2).  
 
THESIS_L_Allet_v15.pdf
C h a p t e r  7  
 116 
Figure 7.1.  Flow chart with detailed description of recruitment, number of drop outs and reasons for abandon. 
The flow chart is based on the CONSORT statement recommendations [41]. 
IG participants partially lost their treatment benefit in the 6 month follow-up but their 
performance remained superior to that at baseline. CG patients’ parameters all 
progressively deteriorated compared to their baseline performance (Table 7.2).  
After intervention the IG increased their habitual walking speed by 0.149 ms-1 (0.54 kmh-1; 
p < 0.001) compared to the CG. In addition, a majority of secondary outcome variables 
showed significant between-group differences (at the Bonferroni corrected significance 
level of p < 0.0026) in favour of the IG: the dynamic balance test (time to walk over a 
beam), the POMA test (total score and sub-scores), the Biodex sway index recorded on the 
level 6, the FES-I score, the hip and ankle plantar flexor strength and the hip flexions 
mobility. After 6 months, all these variables remained significant (p < 0.0026) except for the 
Biodex sway index (p = 0.005) and the ankle plantar flexor strength (p = 0.217) (Table 7.2). 
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Table 7.1. Description of patients’ baseline characteristics 
Baseline evaluation Intervention group  
Mean(SD) 
Control group 
Mean (SD) 
Age (years)  63 (7.99)  64 (8.89) 
BMI (kgm-2)  30.46 (6.03)  31.46 (5.25) 
Number of falls in 12 months*   0.71 (1.07)   0.45 (0.89) 
Test with Tuning fork (score between 0 and 8)   3.23 (1.26)   3.32 (1.32) 
Height (cm) 166.14 (8.5) 168.56 (8.64) 
Weight (kg)  83.62 (16.56)  89.17 (12.33) 
The table shows the mean and standard deviation of evaluated patients’ characteristics per group.  
* A fall was defined as an unexpected event in which the participant comes to rest on the ground, floor or a 
 lower level. 
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Figure 7.2. Plots illustrating the baseline difference adjusted mean and the 95% CI of (a) gait speed, (b) CVGCT, (c) 
POMA score, (d) time to walk over a beam, (e) Biodex Sway Index (Level 6), (f) fear of falls for each 
group at baseline, after the intervention and at the 6 month follow-up. White squares and dotted line 
indicate the control group (CG), black circles and the continuous line represent the intervention group
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DISCUSSION 
This study aimed to evaluate the effect of a training program, based on core components 
for successful fall prevention in the elderly [25], on diabetic patients’ gait and balance. Our 
study results confirm that diabetic patients’ gait and balance can be concurrently improved 
by a targeted intervention. Patients in the IG increased gait velocity, balance, muscle 
strength and joint mobility and decreased their fear of falling. However, post-intervention 
evaluation showed no difference between groups for the CVGCT (Table 7.2). Possibly the 
tarred surface was not challenging enough to fully reveal diabetic patients’ gait problems. 
The CVGCT was relatively low at baseline (2.75% for CG and 2.6% for IG) and did 
consequently not improve (decrease) after treatment, probably due to a floor effect. Step 
time variability on smooth and irregular surfaces was recently shown to be most strongly 
associated with reduction in step length on the irregular surface as compared to the 
smooth surface [42]. Richardson et al. [42] showed that the greater the decrease in step 
length on the irregular surface, the greater the step time variability on both surfaces and 
the greater the increase in step time variability on the irregular surface. Thus, it may be 
that an analysis on a more challenging surface, e.g. cobblestone pathway, which was 
beyond this paper’s aim, would have revealed differences between groups. However, IG 
patients’ amount of improvement in gait velocity (0.54 kmh-1 or 11.6%) and dynamic 
balance – walking over a beam (3.39 s or 34%) - are not only significant but also clinically 
relevant. A decrease in gait speed of 0.1 ms-1 in the elderly has been associated with a 10% 
decrease in the ability to perform daily living activities [43]. Balance tests underscored 
patients’ progress. At baseline our population scored 23 to 24 points out of 28 possible on 
the POMA. These values were just within the critical range (19 to 24 points) that implies a 
moderate risk for falling [44]. IG patients passed this moderate risk for falling cut-off point 
after the training. In addition, their change of 2.0 points signifies a real improvement 
considering that effects greater than 0.8 (with a group size of n = 30), reputedly represent a 
significant improvement unrelated to chance fluctuations [44]. The more difficult Biodex 
balance test (level 6) also highlighted patients’ progress in postural control. The sway index’ 
decrease of 1.9 at level 6 represents a 31% progress. All gait and balance parameters 
(excepting the Biodex balance test) remained significant at 6 month follow-up although 
some treatment benefit was lost. Increased hip and ankle strength as well as ankle mobility 
may explain the progress in gait velocity and static and dynamic balance, although that the 
improvement of ankle dorsal flexor strength and of ankle dorsiflexion mobility just failed to 
be significant at the Bonferroni corrected significance level. These 2 values further 
decreased at 6 month which may explain the gait and balance measures’ regression. Knee 
flexion mobility showed normal baseline values, thereby explaining the absence of 
improvement after training. We decided not to calculate the post-treatment group effect 
on knee and hip extension mobility as none of the patients had a flexor contracture. 
Regarding the FES-I, patients showed a relatively small level of concern about falling. 
Perhaps this result reflects our study population’s relatively good gait function and 
functional capacity. Apparently, the degree of severity of participants’ diabetes was 
moderate, with on average only minimal neuropathy. This may have been influenced by the 
applied inclusion and exclusion criteria and must be considered for clinical decision making. 
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It may be hypothesised that patients with more severe diabetic PN or with worse functional 
capacity would benefit less from training, due to the fact that, from a functional point of 
view, the detrimental effects of the disease are impossible to reverse or compensate. 
However, the reverse may be considered. Patients that suffer from more severe PN may 
benefit even more from a structured exercise regimen, as their condition gives more scope 
for improvement. If balance and gait changes noticed in diabetic patients are probably 
primarily due to neuropathy, there are other potential contributors [5]. The fact that a 
recent article showed that gait impairments may be observed in diabetic patients without 
clinically detectable neuropathy [3], raises the question whether it could be worthwhile 
testing a similar program, only more intensive, on diabetic patients without neuropathy in 
order to prevent further gait and balance impairments. 
All exercises were taught by qualified physiotherapists and were function-orientated. To 
boost patients’ motivation and enable them to interact with other patients the program 
was carried out in small groups (5 to 8 patients) at the hospital’s gymnasium. For further 
discussion of the results, the effect of our primary outcome was compared with the results 
of a meta-analysis evaluating the effect of exercise on gait speed in the elderly [22]. This 
meta-analysis reported a success rate of 57% for exercise training on habitual gait speed. 
The overall gait speed change was 0.01 ms-1 compared to our 0.15 ms-1. However, the range 
of velocity change was large (-0.2 ms-1 to 0.34 ms-1) which could be due to the various 
studies included, evaluating populations with diverse comorbidities under varied conditions 
(e.g. 6 m distance compared to a 6 min walk). We further compared the baseline CVGCT 
with values reported for elderly patients. The values of our population (CG 2.6%; IG 2.75%) 
are between those reported for elderly non-fallers (2.1%; mean age of 76 years) and those 
for elderly fallers (3.8%; mean age of 82) [45], which was somewhat better than expected. 
However, this may be explained by the fact that our population was about 15 years 
younger than the participants in Hausdorff’s trial [45]. 
Despite the beneficial effect of our program on gait speed and balance, its influence on 
diabetic patients’ fall frequency still needs to be properly assessed. Although the CVGCT did 
not improve, our results provide encouraging data that justify further studies with larger 
sample sizes focusing on fall frequency itself, physical activity level and quality of life. 
Our baseline evaluation contains no information about patients’ cardiac status, severity of 
retinopathy, visual acuity, disease duration, orthostatic hypotension, medications or other 
possible factors related to gait and balance impairments and to treatment responsiveness. 
Nevertheless, we assume that randomisation balanced these potential confounders 
between groups. 
The fact that the CG was given no attention at all may have represented a confounder for 
this study’s results. The degree to which participants’ improvement depends on personal 
attention from the therapists, versus the effect of the actual exercise regimen, needs to be 
considered. However, the positive result on all different measured outcomes clearly points 
to a beneficial effect due to therapeutic exercise. 
Muscle strength was measured with a hand-held dynamometer, which gives a more precise 
measurement than manual muscle testing. However, the reliability and accuracy of the 
measurement may be limited by the investigator’s ability to hold the dynamometer 
stationary and by the fact that participants could overpower the testers. We tried to 
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minimize this problem by ensuring that the same person always carried out the tests. 
Nevertheless, the relatively low ratio between the ankle plantar flexor and the ankle dorsal 
flexor strength may indicate an underestimation of plantar flexor strength.  Further 
investigations should address this limitation. In addition, not only sagittal but also frontal 
plane muscle strength (i.e. hip abductors and adductors), which is involved in frontal plane 
stability during gait, should be evaluated. 
Although our study showed positive results we would like to caution clinicians about 
adverse events. Two patients developed pain in their Achilles tendon obliging us to slow 
down the progression for “toe walking” and “one leg stance” exercises. More moderate 
progression and a longer warm up could possibly avoid such incidents. 
To our best knowledge this is one of the first randomised controlled trials which describe 
an effective physiotherapy training program to improve concurrently diabetic patients’ 
balance and gait in “challenging” environments. Future studies should examine the effect 
of exercise regimens on patient groups differentiated by neuropathy status (patients 
without PN, with mild or with severe PN, identified by a more complex instrument for PN’ 
screening). In addition, outcomes such as patients’ functional capacity, the number of falls 
itself or patients’ physical activity level should be considered in order to draw final 
conclusions about exercise efficacy among patients with diabetes, thereby facilitating 
medical decision making. To appraise advantages, difficulties and feasibility of “treatment” 
and/or “prevention” of gait and balance problems and their related fall risk in diabetic 
patients may be another interesting issue for further quantitative and qualitative studies. 
CONCLUSION 
A specific gait and balance training program based on a circuit approach and including gait 
and balance exercises combined with function-orientated strengthening, can improve gait 
speed and balance, and increase muscle strength and joint mobility of diabetic patients 
with a VPT equal to, or lower than 4/8. Further studies with a larger sample size are needed 
to explore the influence of these improvements on the number of reported falls, patients’ 
physical activity level and quality of life. 
ADDITIONAL UNPUBLISHED DATA OF THE RANDOMISED CONTROLLED 
TRIAL 
In the recently submitted paper describing our randomised controlled trial we chose to 
present the results for only 2 gait parameters (gait speed and CVGCT measured on a tarred 
surface), together with the results concerning balance, strength, mobility and fear of falls. 
The aim was to make the paper of immediate relevance and interest to the clinician. 
However, several other gait parameters were explored during the study and these findings 
will also be submitted for publication. For the sake of completeness we summarise below 
the results of these other evaluated gait parameters.  
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Table 7.3 illustrates the gait characteristics of the included patients before and after 
treatment and at the 6 month follow-up. The IG showed improvement in all variables at 
post-intervention. IG participants partially lost their treatment benefits during follow-up, 
but their levels remained superior to that at baseline. All parameters in the CG 
progressively deteriorated. Table 7.4 provides the corresponding test statistics. After 
intervention a significant between group difference (p ≤ 0.05) was found for all measured 
variables except for the coefficient of variation of gait cycle time (CVGCT) (p = 0.99 for the 
tarred surface and 0.16 for cobblestones). These differences remained significant at 6 
month follow-up (Table7.4).  
Table 7.3.  Gait characteristics at baseline, post-intervention and after 6 month follow-up 
 
Variable 
Baseline 
Mean (SD) 
Post-intervention 
Mean (SD) 
After 6 months 
Mean (SD) 
 
Intervention 
Group 
Control 
Group  
 
Intervention 
Group 
Control 
Group  
 
Intervention 
Group 
Control 
Group  
Speed T (ms-1)  1.22 (0.17)  1.26 (0.18)   1.36 (0.19)  1.24 (0.19)   1.31 (0.18)  1.24 (0.15) 
Speed S (m-1)  1.05 (0.21)  1.10 (0.21)   1.22 (0.23)  1.08 (0.21)   1.19 (0.23)  1.09 (0.21) 
Cad T (stridemin-1) 55.03 (5.41) 56.34 (5.27)  60.31 (6.24) 55.57 (4.74)  58.55 (5.11) 56.10 (4.37) 
Cad S (stridemin-1) 50.92 (5.8) 52.59 (5.78)  56.82 (6.75) 51.79 (5.52)  55.80 (5.68) 52.57 (5.45) 
GCT T (%)  1.10 (0.12)  1.08 (0.1)   1.01 (0.11)  1.09 (0.1)   1.03 (0.1)  1.08 (0.08) 
GCT S (%)  1.20 (0.15)  1.16 (0.14)   1.07 (0.14)  1.18 (0.15)   1.09 (0.12)  1.16 (0.13) 
CVGCT T (%)  2.60 (0.73)  2.75 (0.96)   2.69 (0.99)  2.70 (1.12)   2.52 (0.95)  2.72 (0.88) 
CVGCT S (%)  4.93 (2.61)  5.11 (2.27)   4.29 (1.97)  5.12 (2.23)   4.69 (2.32)  5.12 (2.82) 
Stride T (m)  1.32 (0.13)  1.35 (0.15)   1.35 (0.14)  1.33 (0.17)   1.34 (0.14)  1.33 (0.16) 
Stride S (m)  1.24 (0.17)  1.25 (0.17)   1.29 (0.15)  1.24 (0.19)   1.27 (0.17)  1.24 (0.2) 
Stance T (%) 60.67 (1.87) 60.35 (1.78)  59.69 (2.47) 60.55 (1.96)  60.14 (2.28) 60.49 (2.03) 
Stance S (%) 61.38 (2.65) 60.68 (1.97)  59.89 (2.39) 60.91 (2.27)  60.36 (2.52) 60.69 (2.07) 
CV = coefficient of variation; GCT = gait cycle time; Cad = cadence; T = tarred surface and S = cobblestones.  
Table 7.4.  Effect of the treatment exercises on all gait parameters 
Variable Post-intervention  6 months follow-up 
 bi (95%CI) P  bi (95%CI) p 
Speed T (ms-1)  0.149 (0.090 to 0.207) <0.001   0.117 (0.063 to 0.172) <0.001 
Speed S (ms-1)  0.169 (0.111 to 0.226) <0.001   0.144 (0.081 to 0.206) <0.001 
Cad T (stridemin-1)  5.050 (3.663 to 6.437) <0.001   3.207 (1.953 to 4.461) <0.001 
Cad T (stridemin-1)  5.629 (4.145 to 7.114) <0.001   4.367 (2.829 to 5.906) <0.001 
GCT T (%)  -0.089 (-0.114 to -0.065) <0.001   -0.059 (-0.084 to -0.035) <0.001 
GCT S (%)  -0.119 (-0.151 to – 0.086) <0.001   -0.099 (-0.137 to -0.062) <0.001 
CVGCT T (%)  -0.003 (-0.406 to 0.400)  0.989   -0.235 (-0.659 to 0.188)  0.272 
CVGCT S (%)  -0.533 (-1.291 to 0.224)  0.164   -0.198 (-0.906 to 0.510)  0.579 
Stride T (m)  0.043 (0.002 to 0.084)  0.039   0.051 0.011 to 0.091)  0.012 
Stride S (m)  0.060 (0.016 to 0.106)  0.009   0.062 (0.014 to 0.110)  0.012 
Stance T (%)  -1.033 (-1.561 to -0.506) <0.001   -0.533 (-1.105 to 0.040)  0.068 
Stance S (%)  -1.473 (-2.027 to -0.919) <0.001   -0.957 (-1.570 to -0.344)  0.003 
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The goal of primary public health care is to increase individuals’ number of years of good 
health and to maintain their independence and quality of life for as long as possible [1]. 
Diabetes and diabetes-related complications may endanger mobility, physical performance 
and health [2-4]. Gait performance and gait safety are vital for ensuring mobility and 
independence [5-8]. Moreover, they are essential for carrying out the amount of daily 
physical activity recommended for preventing diabetes-related complications. Physical 
exercise in itself is one of the most important intervention strategies to improve physical 
performance. Exercise has also been shown to minimise or eliminate various fall risk factors 
such as impaired balance or gait, muscle weakness and limited range of motion [9-13]. Our 
studies focusing on gait characteristics in diabetic patients were performed with reference 
to known risk factors. The following chapter provides an overview and a discussion about 
our main findings and their limitations, as well as implications for practice and for future 
research. 
MAIN FINDINGS AND DISCUSSION 
Systematic Review 
In order to acquire an overview of gait characteristics in patients with type 2 diabetes, we 
first performed a systematic review of the literature (Chapter 2) [14]. Our review showed 
that authors investigating gait in a diabetic population are either interested in parameters 
associated with fall risk (gait speed, step length or step time variability) or with ulcers 
(pressure). The impact of abnormal gait parameters on falls in diabetic patients has been 
demonstrated and researchers agree that diabetic patients walk slower and with greater 
step variability. Nevertheless, results varied across different studies and questions 
remained about the main causes, especially about factors related to gait abnormalities. 
Although we know that most falls occur in a complex environment [15], only 2 authors [16, 
17] measured gait parameters in a challenging situation (a poorly lit walkway or with 
partially yielding, irregular surface). Moreover, only few interventions that aim to improve 
gait parameters were tested (auditory feedback, different shoes or soles, medication) [16, 
18-22]. 
Despite the known gait difficulties of diabetic patients and in spite of the recognition of the 
significance of gait safety and performance on an individual’s fall risk and independence, 
authors generally do not address these specific parameters in randomised controlled trials. 
To date, randomised controlled trials evaluating the effect of physical interventions or 
rehabilitation programs in diabetic patients focus on individuals’ mobility [23], 
musculoskeletal and cardiovascular fitness [23-25], patients’ physical activity level [23, 26, 
27], insulin resistance [24, 28] or quality of life [24]. Gait parameters seem to be 
overlooked. 
These findings prompted us to investigate gait characteristics in patients with type 2 
diabetes in greater detail and to assess the potential beneficial effects of a specific training 
program on spatiotemporal gait parameters, balance and clinical related factors. So far, no 
randomised controlled trial, other than the one that we conducted, has investigated the 
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effect of a specific physiotherapeutic training program on fall risk related gait parameters 
of diabetic patients since the aforementioned systematic review [14] was written. 
Assessments 
The prerequisite for an objective assessment of diabetic patients’ gait parameters in an 
outdoor setting was to have an appropriate, valid and reliable measurement instrument. In 
Chapter 3 the precision of an ambulatory gait measurement system (Physilog®; BioAGM, 
CH) with which to assess diabetic patients’ gait while walking on a tarred surface, grass and 
on cobblestones was investigated [29]. The Physilog® was shown to be a useful, reliable 
instrument for ambulatory gait assessment in a challenging environment for diabetic 
patients. 
Gait characteristics of diabetic patients while walking under real life conditions 
Based on the results of our systematic review, we were interested to know if gait 
parameters deteriorate proportionally to the severity of diabetes. We also wondered 
whether a more complex surface could reveal gait difficulties of patients better. We 
therefore conducted a study to evaluate the gait of 3 patient groups (healthy controls 
versus diabetic patients without peripheral neuropathy (PN), versus diabetic patients with 
PN) while participants walked on a tarred surface, grass and on cobblestones (Chapter 4) 
[30]. Results showed that gait parameters differ between healthy controls and diabetic 
patients with PN (for all measured parameters: speed, cadence, stance, double support, 
stride length, gait cycle time, knee range, thigh range, shin range and coefficient of 
variation of stride length and gait cycle time). We further demonstrated a difference 
between healthy controls and diabetic patients without PN for gait speed, cadence and gait 
cycle time. The gait parameters in diabetic patients with PN tend to be more altered than 
gait parameters in patients without PN. However, no significant difference was detected 
between patients with and without PN. These results indicate that gait parameters are 
already altered before PN is clinically detectable, a statement which is in line with the study 
results of Petrofsky et al. [31]. These authors investigated gait in a group of subjects with 
no impairment in feeling and no discernable loss of muscle strength. Slower reaction time 
and greater motor error at the joints (acceleration) were observed. The authors explained 
these findings by somatic motor and vestibular damage associated with diabetes. The 
mechanism of damage to the vestibular, somatic and autonomous nervous systems has 
been linked to compromised microcirculation associated with poor glycaemic control in 
type 2 diabetes. The vestibular apparatus in the inner ear and nerve synapses are richly 
vascularised: the diminished supply of oxygen and nutrients consecutive to microvascular 
lesions may be therefore expected to decrease autonomic and somatic reflexes [31, 32]. 
Petrofsky et al. [31] concluded that whatever the mechanism of endothelial cell damage in 
the peripheral circulation, there is indication of gait impairment independent of muscle 
strength and sensory loss in the foot. They further suggested that while part of the 
abruptness in gait could be linked to vestibular losses, another explanation might be the 
slowing of nerve conduction itself in the somatic nervous system, including the cerebellum 
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or motor cortex. A recent report [33] describes slowing of conduction in the peripheral 
nervous system (dorsal sural nerve) in diabetic patients (children with type 1 diabetes) 
before noticeable sensory and motor loss becomes apparent. A sluggish conduction would 
slow reflexes and motor control schemes and cause errors in movement, represented by 
increases in the acceleration at the joints during gait and an increased risk of falling. The 
overview of these findings confirmed the importance of further investigations regarding the 
factors associated with gait alterations in patients with diabetes. 
In addition to the observation of gait parameters in healthy controls and diabetic patients 
with and without PN, we were interested in the walking strategy of diabetic patients when 
they have to change from a regular to an irregular surface. Diabetic patients with and 
without PN adjust their walking technique to the varying of surfaces by using identical 
strategies. These strategies were similar to those used by healthy controls. To change from 
a level (tarred) to an irregular surface (cobblestones), patients with diabetes and controls 
decreased their gait speed by reducing their cadence and increasing their gait cycle time. 
They also shortened their stride length and increased their stride to stride variability. 
Nevertheless, the highest surface effect was found in patients with diabetic PN followed by 
patients without PN and lastly healthy controls. These observations illustrate how patients 
act in response to challenging environments, even if these conditions only approximate real 
life. Real life conditions require an unsupervised assessment in the patient’s usual 
environment. To adequately evaluate the influence of varying surfaces on these patients’ 
gait, one needs to know which gait strategy to associate with which surface and thus a 
supervised and standardised acquisition of data is necessary. Furthermore, real life 
conditions should incorporate a combination of stair climbing, walking up and down a 
slope, crossing a street and other multiple-task situations for which the measurement 
system used has yet to be validated. 
Standing balance in diabetic patients with and without neuropathy 
In the presence of diabetic PN, both plantar cutaneous and proprioceptive sensations are 
compromised, thus resulting in postural instability and increased risk of falling [34]. Falling 
is a complex phenomenon and poor balance is one of the major risk factors for falls among 
the elderly. We therefore also investigated standing balance with eyes open and eyes 
closed using accelerometers and the Performance-Oriented Mobility Assessment scale for 
balance (POMA-B) [35] in diabetic patients with and without PN (Chapter 5). Results 
confirmed that diabetic patients with PN have higher postural instability with higher 
acceleration values than those of the control group and diabetic patients without PN. 
Furthermore, postural instability increased with eyes closed. The greatest difference 
between eyes open and eyes closed was found in diabetic patients with PN. 
Taking into account our previous findings, we can conclude that gait and balance 
impairments seem to increase with the presence of neuropathy (screened by vibration 
perception threshold (VPT)). However, in the study which compared gait parameters of 
healthy controls with patients with and without PN (Chapter 4), significant gait alterations 
were already observable in patients without PN. With regard to balance, balance 
impairments tended to progressively increase from healthy controls to diabetic patients 
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without PN and patients with PN. However, the only significant difference was that 
observed between healthy controls and patients with PN. Nevertheless, these balance 
impairments seem likely to contribute to the gait alterations of diabetic patients. 
Structures, such as muscles, the vestibular system, or receptors involved in the perception 
of the position of a body-part (proprioception) affect both gait and balance. Consequently, 
the results of this study provided relevant and useful information for the development of a 
specific treatment approach. 
Clinical factors associated with gait difficulties of patients with type 2 diabetes 
In Chapter 6, clinical factors associated with gait difficulties of patients with type 2 diabetes 
are identified. It was decided to focus on 2 clinically relevant and commonly used fall 
related gait parameters, gait speed and the coefficient of variation of the gait cycle time 
(CVGCT). Regression analysis showed that the reduction of gait speed observed on 
cobblestones, compared with a tarred terrain, was partially associated with the mean of 
maximal isometric lower limb strength, fear of falls and participants’ perceived vibration 
threshold. Mean maximal isometric strength was associated with an increased CVGCT in 
the same conditions. Since gait speed was shown to influence volunteers’ gait variability 
[36] we also added the variable “speed difference” as an independent variable to our 
regression model. However, in this model, strength was no longer considered as a factor 
influencing the CVGCT. Therefore it may have been interesting to adjust for speed. 
However, as gait speed itself was one of the variables of interest, these adjustments could 
not be carried out. 
This study documents relevant factors to be addressed when developing specific 
physiotherapy programs to improve diabetic patients’ gait performance and safety. It was 
concluded that treatment programs for diabetic patients should consider both physiological 
(strength and proprioception) and cognitive-behavioural factors (fear of falls). They should 
include progressively more complex strength exercises, proprioceptive training and daily 
life activities in order to improve diabetic patients’ self-assurance. 
While the fact that patients with diabetic PN exhibit gait instability may appear trivial to the 
treating clinician, our results show the importance of considering the increased fall risk in a 
wider context. This result is in line with our previous findings (Chapter 4), where it was 
found that gait parameters are already altered before PN is clinically detectable and 
therefore factors, other than sensory loss, should be considered. 
When these results are compared to other studies some interesting points emerge. The 
association between fear of falls and gait speed difference, for example, is similar to the 
results of Chamberlin et al. [37] who found that fearful walkers demonstrated a slower 
walking speed, shorter stride length and longer double support time than walkers not 
identified as fearful. However, regarding cognitive-behavioural factors, we only 
investigated fear of falling. It may have been interesting to consider other factors such as 
patients’ motivation or awareness of the disease. 
Regarding the context of sensory loss and gait alterations, several studies deserve to be 
mentioned. Deshpande et al. [38] evaluated the association of vibrotactile and 
monofilament sensitivity with self-selected usual gait speed and gait speed over a 
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challenging narrow (20 cm wide) course in an elderly population. Both vibrotactile and 
monofilament sensitivity were significantly worse in elderly people who demonstrated 
reduced gait speed. However, after having adjusted for covariates (knee extensor torque, 
standing balance, visual acuity and contrast sensitivity, knee pain, depressive symptoms, 
high fasting glucose levels and peripheral arterial disease), vibrotactile, but not 
monofilament sensitivity, was independently associated with self-selected normal gait 
speed. Deshpande et al. [38] further stated that neither sensory function was associated 
with narrow-base gait speed, which was not studied in our population (see Chapter 6). 
Another study published in 2009 by Wrobel et al. [39] investigated, similarly to our study, 
clinical factors associated with a conservative gait pattern in older male veterans with 
diabetes. Conservative gait pattern was defined using visual gait analysis as failure to 
demonstrate a heel-to-toe gait during the propulsive phase. As could be expected, patients 
with a conservative gait pattern had a lower walking speed and decreased stride length 
compared to normal gait. In multivariate analysis, walking speed, age, ankle dorsiflexion 
and the presence of a forefoot weight-bearing callus were retained in the final model and 
explained 36% of the variance. The authors underscored the fact that with the inclusion of 
ankle dorsiflexion in the multivariate model, monofilament insensitivity was no longer an 
independent predictor for a conservative gait pattern. Walking speed, advanced age, 
limited ankle dorsiflexion and forefoot weight-bearing callus therefore characterise 
conservative gait better than clinical measures of neuropathy. In spite of their similarities, 
however, a one-to-one comparison between our findings and the findings of Wrobel et al. 
[39] cannot be performed, since we used gait speed as the dependent variable, whereas 
Wrobel et al. [39] used gait speed as an independent variable for explaining the 
conservative gait pattern. Nonetheless, these authors’ results are of interest, because 
monofilament insensitivity did not explain the patients’ conservative gait pattern. 
Similar to the results of Deshpande et al. [38] and Wrobel et al. [39], monofilament 
sensitivity was also not associated with diabetic patients’ gait alterations (reduced speed or 
increased CVGCT) in our study (Chapter 6). However, the gait speed reduction in our study 
was associated with the individuals’ perceived vibration threshold, which is another 
commonly used clinical diagnostic test for PN [40]. 
The test with monofilaments detects deteriorating sensory perception and absence of 
protective sensation [41]. It is thus a clinical tool for the detection of diabetic peripheral 
sensory neuropathy. The tuning fork is another commonly used screening tool for 
peripheral nerve dysfunction and symptomatic neuropathy [40]. It was shown to reliably 
detect peripheral neuropathy in comparison with the neurothesiometer [40]. More in-
depth investigations examining the association and interaction between gait parameters, 
monofilament insensitivity and abnormal perception of vibration are necessary and may 
reveal interesting findings for a better understanding of diabetic patients gait alterations. 
Although both methods mentioned above (monofilament and VPT) are commonly used 
clinical tools for evaluating diabetic PN, neither of them represents the gold standard tool 
for evaluating peripheral neuropathies. The diagnostic gold standard for PN is thought to 
be invasive electroneuromyography (ENMG), a test which may be complemented by nerve 
and muscle imaging [42]. Consequently the results of our study and those of Deshpande et 
al. [38] and Wrobel et al. [39] should be interpreted with care and it seems premature to 
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draw any final conclusions about the degree of neuropathy itself on diabetic patients’ gait 
alterations. 
We further wondered why Wrobel et al. [39] found an association between ankle 
dorsiflexion mobility and conservative gait when ankle dorsiflexion was not retained in our 
final model. One explanation could be that variables such as strength, VPT and fear of 
falling were not considered in their study [39]. 
Regarding the positive relationship between the decrease in gait speed and muscle 
strength in our study, similar results were previously described, for example, by Chang et al. 
[43]. They noted that quadriceps strength and hip flexion strength are associated with 
walking speed in an elderly population. Manor et al. [44], who investigated functional gait 
characteristics among individuals with and without PN, demonstrated that the PN group 
presented reduced functional gait, indicated by decreased “6 min walking distance” and 
increased “timed up and go time”. The PN group further presented a greater area of the 
centre of pressure trajectory during quiet standing and a higher standard deviation of the 
mean gait cycle time during treadmill walking. No group differences were observed in the 
knee extensor peak torque or local instability during treadmill walking (rate of kinematic 
divergence caused by small-scale perturbations). Interestingly, in control subjects leg 
strength and gait kinematics, but not standing balance, correlated significantly with 
functional gait, whereas in the PN group, neither measures of leg strength nor locomotor 
kinematics were significantly correlated with functional gait. Instead, only standing balance 
was associated with shorter “6 min walking distance” and longer “timed up and go time”. 
The authors of this study concluded that leg strength is an important factor for functional 
gait, providing that standing balance is adequate. Good standing balance seems thus to be 
a pre-requisite to functional gait in the PN group, contrary to individuals without PN. For 
this reason authors of this study recommend to tailor functional gait-related rehabilitation 
programs specifically for PN patients. In our study a relationship between strength and gait 
of diabetic patients was identified. However, we have not evaluated the associated factors 
separately for patients with or without PN. In addition it should be noted that in the study 
of Manor et al. [44] leg strength refers to the knee extensor peak torque, whereas in our 
study leg strength refers to the mean of the isometric hip, knee and ankle strength. 
Another difference is the environment of the gait evaluation. We focused on gait 
parameters evaluated outdoors, instead of on tests conducted under artificial and indoor 
conditions. 
In our study, because of the rather small sample size, no association between individual 
muscle groups and dependent variables “walking speed difference” or the “stride to stride 
variability difference” could be evaluated. Perhaps lower limb weakness, especially of 
plantar flexors and hip extensors, influenced joint moments and muscle power, which play 
also an important role in gait speed and balance recovery. We believe that further 
evaluation of three-dimensional kinematics, kinetics and muscle activity parameters could 
provide extra information about the causes for gait alterations and increased fall risk. 
Neuropathy, together with muscle weakness, could influence the neuromuscular control 
process. Both may affect not only joint moments and power generation but also the timing 
of muscle activation and thus gait performance [45]. Muscle weakness and reduced 
reaction time were previously associated with increased sway and increased fall risk [46]. 
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As diabetic PN leads to feedback delays, perhaps increased ankle moment latency in 
response to perturbations (i.e. walking over cobblestones) causes patients with PN to be 
unstable, which results in a slow gait and an increased gait variability. However, again no 
definitive conclusion may be drawn. Reduced gait speed could also be a simple adaptation 
strategy as discussed earlier with reference to Chamberlin et al. [37]. Perhaps diabetic 
patients walk slower because of the altered neuromuscular control processes leading to 
decreased balance and consequently fear of falling. The association between participants’ 
fear of falling and decreased speed could support this theory. Slowing down might be a 
security strategy to feel safer on irregular terrains. 
Efficiency of a physiotherapeutic approach to improve diabetic patients gait and gait-
related clinical factors 
The main part of this thesis consists of the development of a physiotherapeutic approach to 
improve diabetic patients’ gait and gait-related clinical factors. The effectiveness of this 
treatment had then to be assessed (Chapter 7). The intervention investigated was 
performed twice a week for 12 weeks. Patients in the intervention group significantly 
improved their gait speed, their balance (time to walk over a beam and balance index 
recorded on a Biodex balance system), their performance oriented mobility (POMA), their 
degree of concern about falling, their hip and ankle plantar flexor strength and their hip 
flexion mobility, compared to the control group. The positive effect mostly remained 
significant at 6 month follow-up although some treatment benefits were lost. This indicates 
the need for a periodically renewed participation in such a program. It can be concluded 
that the specific training program, which was based on a circuit approach including gait and 
balance exercises combined with function-oriented strengthening, improved diabetic 
patients’ gait speed and balance and increased muscle strength and joint mobility. The 
improvements in gait speed and balance were also shown to be clinically relevant. 
In order to understand the absence of improvement of the CVGCT, we compared the 
baseline values of the CVGCT of our study population with values reported for elderly 
patients. The values of our population (control group 2.6; intervention group 2.75) are 
between those reported for elderly non-fallers (2.1; mean age of 76) and those for elderly 
fallers (3.8; mean age of 82) [47], which was somewhat better than expected. This may be 
explained by the fact that our population was about 15 years younger than participants in 
Hausdorff et al.’s trial [47]. Thus, maybe the relatively low (good) CVGCT of our population 
at baseline explained the lack of improvement. For this reason, we expected the treatment 
effect to be greater on the CVGCT measured on the more challenging cobblestone surface. 
This however, was shown not to be the case (see additional data chapter 7). Another 
possible explanation is that the intervention period of 12 weeks was not long enough to 
produce a significant improvement in the CVGCT. In addition, as gait parameters of diabetic 
patients were shown to decline with the severity of disease, maintaining a baseline value 
could be considered a positive result. 
Concerning the Falls Efficacy Scale we were surprised at patients’ relatively small level of 
concern about falling. Given the results of the previous study [48], which showed an 
association between the decrease in gait speed and fear of falls, we expected our patients 
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to be more afraid of falling. The clinical importance of this issue warrants further discussion 
and evaluation. Future qualitative studies may also usefully investigate this topic. 
Furthermore, other cognitive-behavioural factors, such as motivation, awareness of 
difficulties, general beliefs and self-efficacy should be taken into account. Finally, it must be 
specified that our results are applicable to patients with a VPT equal to, or lower than 4/8. 
A training program such as ours may not have any significantly beneficial impact on 
patients with more severe diabetic PN, due to the extent and potentially irreversible 
character of the physiological damages in these patients. Conversely, more severe PN may 
offer greater scope for improvement with carefully tailored rehabilitation. A further study is 
needed to clarify these hypotheses. 
LIMITATIONS: 
METHODOLOGICAL AND INTERVENTION RELATED CONSIDERATIONS 
Group attribution 
Diabetic patients with PN or patients without PN were divided in groups based on a clinical 
test. This test measures the VPT with a 128 Hz Rydel-Seiffer tuning fork at the big toe and 
medial malleolus of both feet. The vibration is evaluated on a 9-point scale (0-8) and the 
patient is considered to have PN if the VPT is equal to, or lower than 4/8. Although this tool 
is recommended as a screening test for diabetic PN [40], it cannot precisely evaluate the 
degree of severity of peripheral neuropathy. To do so, more complex methods like ENG or 
ENMG [42, 49] are needed. For this reason, in the study identifying factors associated with 
gait abnormalities, we could only conclude that PN was associated with gait abnormalities, 
without making any distinction between the degrees of severity of neuropathy. 
Surface effect 
A recent study [50] showed that individuals probably choose a higher gait speed strategy 
over long walking distances (20 m) than on short walking distances (10 m). To evaluate the 
effect of 3 surfaces, gait parameters on a tarred pathway, grass and cobblestones were 
compared. The walking distances for all surfaces were equal to, or greater than 20 m. 
However, the walking distance on cobblestones was only 20 m while the distance on the 
tarred surface and grass was 50 m. Najafi et al. [50] brought 2 potential biases to our 
attention in the interpretation of the results concerning the influence of surfaces on gait 
parameters. Firstly, we did not evaluate fatigue during the 50 m walk on the tarred surface 
or grass. Secondly, regarding the change from slow to fast when comparing a short (10 m) 
to a long (20 m) distance in the study of Najafi [50], we cannot exclude that the change 
from a long distance (20 m) to an even longer distance (50 meter) would provoke another 
speed switch. However, only the comparisons between the different surfaces may have 
been potentially biased by this distance change during testing. As the protocol is the same 
for all the subjects, the differences between groups (healthy versus patients with PN versus 
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patients without PN) and the comparisons between pre- and post-treatment could not 
have been affected. Further research is required to investigate the trigger distances when 
the walking strategy switches from slow to fast. 
Standing balance 
The article evaluating standing balance [51] confirms the instability of diabetic patients 
with PN and highlights the tendency that balance instability increases with the severity of 
disease. Patients had a self-selected preferred standing position during the testing because 
of the fact that the recording of the accelerations on trunk and shin were simultaneously 
done with the POMA-B test. The POMA-B test normally requires free foot position for the 
“eyes open” test, whereas feet are kept as close together as possible for the “eyes closed” 
position. The fact that each subject chose their own foot position might have reduced or 
even eliminated differences between groups with regards to the acceleration values. Thus, 
it is likely that the differences between groups would have been even more important had 
foot placement been imposed. 
In our study, in order to compare the condition “eyes open” with “eyes closed”, patients 
maintained the same chosen foot position during the whole POMA-B test, which may have 
influenced the test results. For this reason a slight overestimation of the POMA-B score can 
also not be excluded. However, as it was the same for every group, this methodological 
weakness will probably not have influenced the between-group difference as regards the 
POMA-B. 
Selected dependent variables in the study: clinical factors associated with gait alterations 
in diabetic patients 
Our study evaluating factors associated with gait alterations was not exhaustive. Firstly, 
only global muscle strength was added to the model because our sample size did not allow 
us to consider separate muscle groups. Occasionally patients had some difficulty recruiting 
muscles selectively or to understand the isometric leg strength tests, which may have 
negatively influenced their real performance. Secondly, variables other than the mainly 
physical ones, such as mental status, duration of disease or medication, may also be 
associated with gait difficulties although they were not evaluated here. 
Randomised controlled trial and subjects 
The intervention study included only patients with a VPT equal to, or lower than 4/8. 
Consequently, the positive results of our intervention study cannot be generalised to all 
diabetic patients. In addition patients’ responsiveness was an issue, in particular that of 
patients with more severe diabetes. The patients who took part in our project were 
basically willing to perform physical exercises. Thus, the final study population is probably 
not representative of the most severely affected diabetic patients, who also present the 
worst gait alterations. This observation was confirmed by the relatively high VPT score 
(mean = 3.3) and the limited mean number of falls per person during the last 12 months (< 
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1). In addition, at baseline the outcome parameters were generally rather higher than 
expected. This fact influences the external validity and must thus be considered for clinical 
decision making and when comparing our results with those of other studies. Future 
studies should include patients with and without PN. In order to have enough participants 
with severe diabetic PN, multicentre studies might be helpful. 
Randomised controlled trial and blinding 
The study’s quality would improve considerably with a double blinded study design. This is, 
however, one of the most problematical points for all non-drug clinical trials. Patients know 
if they receive a treatment or not and which kind of treatment protocol they have joined. 
Furthermore, the investigator (L.A.) was not blinded as she also had to conduct the 
physiotherapy program. 
Randomised controlled trial and main outcome 
A major challenge is to determine the best outcome measure to use. In this intervention 
study we focused on gait speed and CVGCT. These are 2 clinically relevant gait parameters 
which are also currently used as fall risk predictors. In our intervention study all gait 
parameters were measured outdoors on predefined walking distances. With this method 
we expected to assess subjects’ gait during daily life more adequately. Measuring gait 
outdoors also enabled us to evaluate several gait cycles over a long distance. This strategy 
was approved by the results of a recent study [50] where test–retest reliability for long 
walking distances was consistently better than for short walking distances. However, the 
same authors observed that test–retest reliability for gait variability was poor, irrespective 
of walking distance or instrument. When we studied the reliability of the Physilog®, we only 
assessed the “direct” outcomes and not the calculated stride to stride variability (SD/mean 
× 100). With respect to this recent result of Najafi et al. [50] and in view of the known 
speed dependence of the CVGCT [36], the value of the measured stride to stride variability 
as an independent fall risk predictor should be re-discussed. In addition, the CVGCT of our 
population was rather low. Thus, another question to be addressed is whether the CVGCT 
threshold previously elaborated in the elderly [52] can be applied to diabetic patients. 
Our data was recorded on challenging surfaces and therefore reflects real life conditions 
better than studies conducted in a gait laboratory. Nevertheless, such conditions remain an 
approximation to real life situations. The walkway had to be standardised in order to fulfil 
the methodological criteria for a research proposal. 
This intervention study was important to establish whether gait in diabetes patients could 
be improved with a specific training program. Gait parameters and clinical variables such as 
strength are of great clinical relevance. However, these outcomes are only considered as a 
proxy to fall events. We cannot make any conclusions about falls themselves at this point in 
time. The Prevention of Falls Network Europe (ProFaNE) [53], a collaborative project to 
reduce the burden of fall injuries in older people, clearly recommends focusing on falls as a 
primary outcome in trials that intend to reduce falls in older persons. Further studies with a 
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larger sample size and longer follow-up are therefore needed to focus on diabetic patients’ 
falls as a primary outcome. 
Randomised controlled trial and compliance 
The subjects in this randomised controlled trial are volunteers who agreed to participate 
and who signed the informed consent. It would therefore be reasonable to believe that 
they were motivated to perform the exercises. Nevertheless, some individuals needed to 
be re-motivated regularly by the physiotherapists. Considering this, it would have been 
interesting to evaluate patients’ compliance with the individual tailored advice for home 
exercise – an issue that was omitted in the elaboration of this study protocol. Patient 
motivation seems to be a serious challenge. A more qualitative study aiming to evaluate 
experience, beliefs, motivation and attitudes of patients concerning this specific program 
may be helpful in order to achieve and optimise compliance, adherence and self-
management. In a similar vein, it would also be interesting to evaluate the effect of 
patients’ education about their condition on their compliance with the treatment program. 
Randomised controlled trial and adverse events 
Two patients developed pain in their Achilles tendon obliging us to slow down the 
progression for “toe walking” and “one leg stance” exercises. More moderate progression 
and a longer warm up could probably avoid such incidents. 
IMPLICATION FOR PRACTICE 
Although further research is needed to provide a stronger evidence base for the clinical 
usefulness of our treatment approach, our initial results show that patients with type 2 
diabetes may benefit from a specific gait and balance training program. A major challenge, 
however, is managing patients’ compliance. Diabetic patients are known to show only 
moderate motivation as well as poor compliance concerning the completion of treatments. 
A recent study [54] showed that 71.9% of patients with type 2 diabetes were not achieving 
the recommended physical activity levels. Physiotherapists in our study constantly 
encouraged and motivated the participants. We think that this therapeutic attitude, 
together with a “group effect”, helped to ensure that patients took part in a maximum 
number of training sessions. Social interaction and enjoyment may promote long-term 
participation [55]. For this reason, we believe that this particular population needs 
supervised training. Training improved gait parameters, balance, strength and joint 
mobility. Moreover, patients were sure to perform their recommended physical activity 
twice a week. However, as it was shown that the training effect decreased after 6 months, 
it is recommended that diabetic patients should take part twice a year in such a specific 
training program. Unfortunately, no such training program is currently offered at the 
University Hospital of Geneva. It is now important not only to publish this data, but also to 
consider how to integrate these findings into everyday clinical practice. 
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Collaboration between hospitals, patient organisations and other interested parties may 
facilitate and enhance the organisation of specific training programs. Thus, first contacts 
with the Diabetes Association in Geneva have been established and collaboration strategies 
between the University Hospital of Geneva and the Diabetes Association have been 
discussed. It was agreed that each party, with its specific competencies, could usefully 
contribute to the project. The hospital is responsible for providing well trained therapists, 
guaranteeing the quality of treatment and allocating an adequate infrastructure. The 
associations would be in charge of propagating the program (e.g. placing leaflets at 
patients’ disposal via general practitioners), emphasising its importance and performing all 
administrative tasks (e.g. registration, physiotherapists’ remuneration, patient information 
etc.) An initial program should start in September 2009. At the same time, this newly 
developed program could offer further research possibilities such as the evaluation of 
participants’ beliefs and experience, which could be the basis for recommendations on the 
behavioural-cognitive aspects to be considered in a training program for type 2 diabetes 
subjects. An overview of behaviours influencing treatment adherence, the type of patients 
which participate in such training programs and information about the potential reasons 
why others refuse to join in could be used by health care professionals and managers for 
future organisation, to improve patients’ motivation and treatment adherence. 
DIRECTIONS FOR FUTURE RESEARCH 
Ideas for future research, with 2 main directions, have emerged from this work on diabetic 
patients gait alterations: understanding gait alterations and evaluating the effect of the 
physiotherapy program. 
Understanding gait alterations 
Gait as a screening tool in neuropathy 
It would be interesting to examine, by using ENMG and muscle imaging, the relationship 
between the severity of neuropathy and gait characteristics and that between the severity 
of neuropathy and balance. Gait alterations or balance impairments could signal the early 
onset of neuropathy, undetected by the more commonly used clinical tests. If so, gait 
analysis and balance assessments could become useful screening tools and thus improve 
clinical decision making. 
Evaluating gait characteristics under self-selected speed and imposed speed 
To compare diabetic patients’ gait characteristics under both conditions (e.g. self-selected 
speed and imposed speed) may enhance the understanding of the different speed 
dependent gait parameters. 
Post-perturbation feedback loop delay as cause of gait and balance alteration 
Understanding of the mechanisms underlying diabetic individuals’ gait and balance 
alterations could be further enhanced by studying the relationship between specific muscle 
groups and gait. Similarly, post-perturbation step characteristics (e.g. post-perturbation 
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step width) and post-perturbation feedback loop delay (FLD - e.g. ankle inversion moment 
latency and inversion force latency) may be of mechanistic but also of clinical interest: a 
research team at the University of Michigan (USA) has recently started investigating such 
post-perturbation stimuli characteristics. 
Effect of the physiotherapy program 
Impact of the treatment program on falls themselves 
A major concern is to evaluate the impact of this program on fall risk itself [53]. In view of 
this objective, a study with a larger sample size and a longer follow-up is needed. The same 
study could further assess the impact of the program on patients’ physical activity level and 
their quality of daily life. These subsequent intervention studies should evaluate patients 
with and without PN. Our intervention study only included patients with a VPT equal to, or 
lower than 4/8. A subgroup analysis for different degrees of diabetes severity may help to 
identify the target population for such training programs. For example, individuals with 
diabetes, but without clinically detectable neuropathy, may also benefit from such a 
program, since we showed that these subjects have impaired gait as well. In our trial, the 
content of the physiotherapeutic treatment was chosen with reference to successful 
training programs for the elderly. Gait and balance training for diabetic patients may, 
however, benefit from other approaches such as the providing of assistive technologies, 
practicing walking in different environments alone, or a simple muscle strengthening 
program. More research is needed to explore these issues. 
Impact of this program on compliance and patient satisfaction 
Rehabilitation requires individuals’ adherence and compliance, which is why the evaluation 
of objective functional components should be complemented with the assessment of the 
beliefs and perceptions of the participants. Similarly, a measure of the effect of patient 
education programs on compliance with treatment interventions could also serve to 
confirm or to question programs’ value in disease management. 
Cost-effectiveness of this program 
Lastly, an evaluation of the consequences of falls in diabetic patients and their related 
costs, as well as an assessment of the benefit and costs of the treatment could provide 
further information about the utility of such intervention programs. 
PERSONAL OPINION AND CONCLUSIONS 
Diabetes is an international problem and a growing public health burden across the world. 
The increasing prevalence of diabetes will inevitably result in a greater number of patients 
presenting complications (micro-and macrovascular disease, retinopathy, nephropathy and 
neuropathy). Thus, the International Diabetes Federation has suggested using a 
multidisciplinary care team with specific diabetes expertise maintained by continuing 
professional education [56]. My experience is that physiotherapists, at least in Switzerland, 
are poorly integrated in the management of diabetes. Although there is ample evidence 
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about gait difficulties and increased risk of falling in diabetic patients, health care 
professionals are often oblivious to the problem. Falls are mostly associated with the 
elderly and concern about diabetic individuals’ gait problems is limited to fear of high foot 
pressures and ulcers. In contrast, this thesis shows that it is important not to limit fall risk 
assessment and fall prevention to the aged, and to consider gait parameters as much as 
pressure values when assessing the gait of diabetic patients. I am convinced that 
physiotherapy can significantly contribute to an interdisciplinary diabetes care 
management approach. The role of the physiotherapist should not be limited to conducting 
physical activity programs. Physiotherapists should perform standardised clinical testing 
combined with gait and/or balance assessments, thereby contributing useful information 
for best practice. 
This thesis provides promising results. Several fall risk related parameters have been 
improved by a specific treatment program. However, additional intervention studies are 
needed before any recommendations as to best clinical practice can be provided. Attracting 
clinicians’ attention and stimulating their awareness of the problem is now a major 
challenge so as to avoid a gap between research and practice. To maximise patient 
motivation, programs should be adapted to individuals’ needs and abilities. The focus of 
intervention programs should not be limited to short-term benefits. Patients’ enjoyment, 
sense of satisfaction and the programs’ functional relevance may be keys for long-term 
success. 
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ENGLISH SUMMARY 
The World Health Organisation has described type 2 diabetes as an international epidemic. 
Recent estimates indicated 171 million people in the world with diabetes in the year 2000. 
The number is projected to increase to 366 million by the year 2030. Approximately 58% of 
patients with type 2 diabetes have one or more complications from the disease resulting in 
an increased demand for medical services. The most symptomatic complication of this 
disease is peripheral neuropathy which affects nerve function from the periphery to more 
proximal regions. Approximately 50% of patients who have diabetes for more than 20 years 
develop peripheral neuropathy. Two main care paradigms are suggested for diabetic 
patients. The first paradigm is lifestyle management (including behavioural advice on diet 
and physical activity) and the second is medication (oral hypoglycaemics and insulin) 
proposed when lifestyle changes fail to be effective. In order to avoid the complications of 
diabetes, patients are recommended to be physically active for at least 30 minutes a day, 6 
days a week. However, as diabetes is associated with an increased risk of injurious falls, this 
advice leads to a dilemma: how can individuals with an increased risk of falling carry out 
regular physical activity? Patients with inadequate gait stability, who experience a fall 
related injury, may not be able to meet these recommendations and may fall into a vicious 
circle of reduced physical activity levels leading to an increased risk of diabetic 
complications and decreased musculoskeletal function. 
Thus, the overall aim of this project was to develop and test the efficacy of a 
physiotherapeutic approach seeking to improve diabetic patients’ gait, balance and related 
clinical factors. To achieve this aim, several steps were necessary and each of these steps is 
described in separate chapters of this thesis. 
The project started with a systematic literature review about gait characteristics of diabetic 
patients (Chapter 2: Gait characteristics of diabetic patients: a systematic review). The 
systematic review showed that the quality of existing articles investigating gait 
characteristics in diabetic patients is moderate to high. Results varied over different studies 
and questions remained about the main causes for impaired gait in diabetic patients, 
especially about factors related to observed gait abnormalities. Although we know that 
most falls occur in a complex environment, gait parameters were only rarely studied in a 
challenging situation (a poorly lit walkway or with a partially yielding, irregular surface). In 
addition, only few interventions that aim to improve gait parameters were tested (auditory 
feedback, different shoes or soles, medication). These findings confirmed the necessity of 
investigating gait characteristics in diabetic patients outdoors under real life conditions. In 
view of this objective an ambulatory gait measurement system was needed, for which 
reliability under the different measurement conditions had first to be tested (Chapter 3: 
Reliability of diabetic patients’ gait parameters in a challenging environment). Bland and 
Altman plots provided with a qualitative estimate of our measurement instrument’s 
(Physilog®) precision. Overall it showed similar results for the 3 tested surfaces (tarred 
surface, grass and cobblestones). The mean differences of each variable measured on 2 
different days were small and all mean difference values were well distributed around zero. 
These results were confirmed by the high reliability (Intraclass correlation coefficient values 
> 0.8) for all evaluated parameters (except for knee range, for which we only achieved fair 
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reliability). Based on these good inter-visit reliability measurements, together with the 
small measurement errors obtained and values of minimal detectable change, we decided 
to use the Physilog® for our investigations. This instrument was shown to be a useful, 
reliable instrument for ambulatory gait assessment in a challenging environment for 
diabetic patients. Following this reliability study, the gait characteristics of diabetic 
patients, with and without peripheral neuropathy, were evaluated outdoors on the 3 
different surfaces aiming to acquire a more in-depth insight into diabetic patients’ gait. 
(Chapter 4: Gait alterations of diabetic patients while walking on different surfaces). It 
was shown that gait parameters differ between healthy controls and diabetic patients with 
peripheral neuropathy (for all measured parameters: speed, cadence, stance, double 
support, stride length and gait cycle time, knee range, thigh range, shin range and 
coefficient of variation of stride length and gait cycle time). In addition, a difference 
between healthy controls and diabetic patients without peripheral neuropathy could be 
identified for gait speed, cadence and gait cycle time. The gait parameters in diabetic 
patients with peripheral neuropathy tend to be more altered than gait parameters in 
patients without peripheral neuropathy. However, no significant difference was detected 
between patients with and without peripheral neuropathy. Another interesting element in 
this study was the walking strategy of diabetic patients when they changed from a regular 
to an irregular surface. Diabetic patients with and without peripheral neuropathy, adjusted 
their walking technique to the varying surfaces using identical strategies. These strategies 
were similar to those used by healthy controls. To change from a level (tarred) to irregular 
surface (cobblestones) patients with diabetes and controls decreased their gait speed by 
reducing their cadence and increasing their gait cycle time. They also shortened their stride 
length and increased their stride to stride variability. Nevertheless, the highest surface 
effect was found in diabetic patients with peripheral neuropathy followed by patients 
without peripheral neuropathy and then healthy controls. 
Given that falling is a complex phenomenon and that poor balance is one of the major risk 
factors for falls, the balance performance of diabetic patients with and without peripheral 
neuropathy was compared to a healthy control group (Chapter 5: Investigation of standing 
balance in diabetic patients with and without peripheral neuropathy using 
accelerometers). Quiet standing balance (eyes open, eyes closed) was investigated using an 
accelerometer-based method. Accelerations were measured at lumbar and ankle levels 
using 3 accelerometers. Results demonstrated that diabetic patients with peripheral 
neuropathy have higher postural instability with higher acceleration values than those of 
the control group and of the diabetic patients without peripheral neuropathy. Furthermore, 
postural instability increased with eyes closed and the most important difference between 
eyes open and eyes closed was found in diabetic patients with peripheral neuropathy. 
Before developing the specific treatment approach, another scientific work which identified 
clinical parameters associated with gait abnormalities of patients with type 2 diabetes was 
conducted (Chapter 6: Clinical factors associated with gait alterations in diabetic 
patients). A sample of 76 diabetic patients underwent clinical examination and an outdoor 
gait evaluation on tarred and cobblestone terrains. Differential in gait speed (performance 
measure) and in gait variability (coefficient of variation of the gait cycle time as a fall risk 
index) on different terrains were respectively calculated. Differentials’ associations with 
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clinical factors were investigated using correlation coefficients and linear regression 
analysis. This study reveals that a decrease in gait speed is partially associated with the 
mean of maximal isometric lower limb strength, fear of falls and participants’ perceived 
vibration threshold. Moreover, mean maximal isometric strength is associated with an 
increased coefficient of variation of the gait cycle time. These results indicate that both 
physiological (strength and proprioception) and cognitive-behavioural factors (fear of falls) 
are associated with diabetic patients’ gait difficulties and should therefore be considered 
when treating diabetic patients with gait alterations. Treatment programs should include 
progressively more complex strength exercises, proprioceptive training and activities of 
daily life to improve diabetic patients’ self-assurance. Based on these aforementioned 
investigations a physiotherapeutic approach was developed and tested by means of a 
randomised controlled trial (Chapter 7: Diabetic patients’ gait and balance can be 
improved with a specific training program. A randomised controlled trial). Seventy-one 
patients were randomly assigned to either an intervention (n = 35) or a control group (n = 
36). The intervention consisted of group training, which was performed twice a week for 12 
weeks. A session consisted of a warm up followed by circuit training with gait and balance 
exercises (i.e. stance on heel/ toes, tandem stance, one leg stance, walking). These 
exercises alternated with functional strength exercises (i.e. sit to stand, walking up and 
down a slope, steps, jumps) expected to make patients more confident with daily activities. 
The complexity of the task could progressively be increased. Sessions were completed with 
interactive games and a short feedback with suggestions for individual home exercises. The 
training was shown to have a positive effect on diabetic patients’ gait speed, balance, 
muscle strength and joint mobility. After the 12 week program patients were encouraged 
to continue performing the exercises learned for the following 6 months. No other advice 
or restrictions were provided. Participants partially lost their treatment benefit during the 6 
months of follow-up but their performance level remained superior to baseline. 
Despite several limitations, discussed in detail in Chapter 8 (Chapter 8: General Discussion), 
this study provides promising results for improving gait and balance in patients with type 2 
diabetes. However, further intervention studies are needed before any recommendations 
can be provided to serve as best practice examples. Other approaches such as providing 
assistive technologies, practicing walking alone in different environments, or a simple 
muscle strengthening program, may also be effective for improving diabetic patients’ gait 
and balance. In addition, a more qualitative study aiming to evaluate experience, self-
efficacy, motivations and attitudes of patients concerning this specific program may be 
helpful in order to achieve and optimise compliance, adherence and self-management. 
Attracting clinicians’ attention and stimulating their awareness of diabetic patients’ gait 
problems and related fall risk represents a major challenge for the future. Only by bridging 
the gap between researchers and clinicians can this objective be achieved. 
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De Wereldgezondheidsorganisatie omschrijft diabetes mellitus type 2 als een internationale 
epidemie. Het aantal patiënten met diabetes werd in 2000 op 171 miljoen geschat en zal in 
2030 366 miljoen bedragen. Ongeveer 58% van de patiënten met diabetes mellitus type 2 
zal één of meerdere complicaties van de ziekte ontwikkelen, waardoor zij meer behoefte 
aan medische zorg hebben. De meest voorkomende complicatie is perifere neuropathie. 
Ongeveer 50% van de patiënten die langer dan 20 jaar diabetes hebben, ontwikkelen 
perifere neuropathie. De behandeling van diabetes kent twee benaderingswijzen. De eerste 
benadering is gericht op leefstijl (waaronder adviezen gericht op gezonde voeding en 
beweging). De tweede benadering bestaat uit een medicamenteus beleid (orale 
bloedglucoseverlagende middelen en insuline) dat onder andere toegepast wordt wanneer 
leefstijlveranderingen onvoldoende effect hebben. Om complicaties van diabetes te 
voorkomen wordt patiënten geadviseerd 6 dagen per week minstens 30 minuten per dag te 
bewegen. Diabetes verhoogt echter de kans op vallen met letsel tot gevolg, en het 
bewegingsadvies leidt dus tot het volgende dilemma: hoe kunnen mensen met een 
verhoogd valrisico toch in voldoende mate veilig bewegen? Patiënten met onvoldoende 
stabiliteit gedurende het lopen, die traumatisch letsel na een val ervaren, kunnen de 
bewegingsadviezen mogelijk niet opvolgen, wat kan leiden tot een vicieuze cirkel, waarin 
verminderde beweging zorgt voor een verhoogde kans op diabetescomplicaties met weer 
een verminderde functie van het bewegingsapparaat tot gevolg. 
Het doel van deze studie was het ontwikkelen en testen van een fysiotherapeutische 
benadering om het looppatroon, de balans en daaraan gerelateerde klinische factoren van 
patiënten met diabetes te verbeteren. Om dit te bereiken waren verschillende onderzoeks- 
en ontwikkelingsstappen noodzakelijk, en elke stap wordt in een ander hoofdstuk van dit 
proefschrift beschreven. 
Het onderzoeksproject startte met een systematisch literatuuronderzoek over de gang en 
gangkenmerken (looppatronen) van patiënten met diabetes (Hoofdstuk 2: “Gait 
characteristics of diabetic patients: a systematic review”). Het literatuuronderzoek laat 
zien dat de methodologische kwaliteit van de bestaande artikelen over karakteristieken van 
het looppatroon bij patiënten met diabetes gemiddeld tot hoog is. De resultaten van de 
verschillende studies zijn divers, en er blijven vragen bestaan over de oorzaak van een 
afwijkend looppatroon bij patiënten met diabetes, met name over factoren betreffende 
waargenomen afwijkingen in de gang (waargenomen gangafwijkingen). Hoewel we weten 
dat vallen meestal plaatsvindt in een complexe omgeving, zijn looppatronen maar zelden 
onderzocht in een uitdagende omgeving (bijv. een voetpad met slechte verlichting of een 
onregelmatig oppervlak). Daarnaast zijn slechts enkele interventies onderzocht die als doel 
hadden looppatronen te verbeteren (bijv. auditieve feedback, andere schoenen of 
inlegzolen, medicatie). Deze beperkingen bevestigen de noodzaak van een onderzoek naar 
looppatronen bij patiënten met diabetes buitenshuis onder real life omstandigheden. Om 
dit te bereiken was er een mobiel ganganalyse systeem nodig, waarbij eerst de 
betrouwbaarheid onder verschillende omstandigheden getest moest worden (Hoofdstuk 3: 
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“Reliability of diabetic patients’ gait parameters in a challenging environment”). Bland en 
Altman plots gaven een kwalitatieve schatting van de precisie van ons meetinstrument 
(Physilog®). Over het algemeen werden vergelijkbare resultaten voor de drie bestudeerde 
ondergronden (asfalt, gras en keien) gevonden. Het gemiddelde verschil tussen de gemeten 
variabelen op twee verschillende dagen was klein, en alle gemiddelde verschilwaarden 
lagen rond de nul. Deze resultaten werden bevestigd door de hoge betrouwbaarheid (ICC 
waarden > 0.8) van alle onderzochte parameters (met uitzondering van de 
bewegingsomvang van de knie waarvoor we alleen een redelijke betrouwbaarheid konden 
bereiken). Gebaseerd op deze goede test-hertest betrouwbaarheidsmetingen, kleine 
meetfouten en waarden van kleinst waarneembare verandering besloten wij de Physilog® 
voor onze studie te gebruiken. De Physilog® bleek een bruikbaar en betrouwbaar 
instrument te zijn voor de mobiele ganganalyse in een uitdagende omgeving voor patiënten 
met diabetes. Na deze studie naar de betrouwbaarheid werden de gangkenmerken van 
patiënten met diabetes, met en zonder neuropathie onderzocht, buitenshuis en op de drie 
verschillende ondergronden met als doel meer inzicht te krijgen in het looppatroon van 
patiënten met diabetes (Hoofdstuk 4: “Gait alterations of diabetic patients while walking 
on different surfaces”). Looppatronen tussen gezonde controlepersonen en patiënten met 
diabetes met perifere neuropathie verschilden (voor alle onderzochte parameters: 
snelheid, cadans, standfase, ‘double support’, paslengte en pastijd, bewegingsomvang van 
de knie, heup en enkel en de variatiecoëfficiënt van paslengte en tijd). Daarnaast was er 
een verschil tussen gezonde controlepersonen en patiënten met diabetes zonder perifere 
neuropathie zichtbaar, met name voor loopsnelheid, cadans en duur van de loopcyclus. De 
looppatronen bij diabetespatiënten met perifere neuropathie leken meer afwijkend te zijn 
dan looppatronen bij patiënten zonder perifere neuropathie. Er was echter geen significant 
verschil meetbaar tussen patiënten met en zonder perifere neuropathie. Daarnaast waren 
wij geïnteresseerd in de loopstrategie van patiënten met diabetes wanneer zij moesten 
veranderen van een regelmatige naar een onregelmatige ondergrond. Hierbij pasten zowel 
diabetespatiënten met als zonder perifere neuropathie hun looptechniek op vergelijkbare 
wijze aan. Deze methoden waren vergelijkbaar met die van gezonde controlepersonen. Om 
van een gladde (geasfalteerd) naar een onregelmatige ondergrond (keien) te gaan 
verminderden zowel patiënten met diabetes als controlepersonen hun loopsnelheid door 
hun stapfrequentie te reduceren en hun pasduur te vergroten. Daarnaast verkortten zij ook 
hun paslengte en verhoogden zij de variatie in pasduur. Desondanks werd het grootste 
oppervlakte-effect gevonden bij diabetespatiënten met perifere neuropathie, gevolgd door 
patiënten zonder perifere neuropathie en gezonde controlepersonen. 
Bewust van het feit dat vallen een complex fenomeen is en dat een slechte balans één van 
de grootste risicofactoren is voor vallen, werd de balans van patiënten met en zonder 
perifere neuropathie vergeleken met een gezonde controlegroep (Hoofdstuk 5: 
“Investigation of standing balance in diabetic patients with and without peripheral 
neuropathy using accelerometers”). Balans in rust (ogen open, ogen gesloten) werd 
onderzocht met een op een accelerometer gebaseerde methode. Bewegingen werden 
lumbaal en ter hoogte van de enkel gemeten met drie bewegingsmeters. Ons onderzoek 
laat zien dat patiënten met diabetes en perifere neuropathie een grotere 
houdingsinstabiliteit met meer bewegingsuitslag hebben dan de gezonde controlegroep of 
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patiënten met diabetes zonder perifere neuropathie. Daarnaast werd de 
houdingsinstabiliteit groter bij gesloten ogen. Het grootste verschil tussen de condities 
gesloten en open ogen werd gevonden bij diabetespatiënten met perifere neuropathie. 
Voordat wij een specifieke therapeutische benadering ontwikkelden, verrichtten wij eerst 
een ander onderzoek naar klinische parameters die geassocieerd zijn met afwijkingen in het 
looppatroon bij patiënten met type 2 diabetes (Hoofdstuk 6: “Clinical factors associated 
with gait alterations in diabetic patients”). Een steekproef van 76 patiënten met diabetes 
onderging een klinisch onderzoek waarin het looppatroon buitenshuis op een geasfalteerde 
oppervlakte en op keien werd geëvalueerd. Respectievelijke verschillen in loopsnelheid 
(mate van prestatie) en loopcyclus variatie (variatiecoëfficiënt van de loopcyclus duur als 
indicatie van het valrisico) op verschillende ondergronden werden berekend. Associaties 
met klinische factoren werden onderzocht met behulp van correlatiecoëfficiënten en 
lineaire regressieanalyse. Deze studie laat zien dat een vermindering van de loopsnelheid 
gedeeltelijk geassocieerd is met de gemiddelde maximale isometrische beenkracht, angst 
om te vallen en mate van neuropathie. Bovendien is de maximale isometrische kracht 
geassocieerd met een toegenomen variatie coëfficiënt van de loopcyclus. Deze resultaten 
laten zien dat zowel fysiologische (kracht en proprioceptie) als cognitieve gedragsfactoren 
(angst om te vallen) geassocieerd zijn met moeilijkheden die patiënten met diabetes 
ondervinden gedurende het lopen. Het verdient dus aanbeveling hiermee rekening te 
houden in de behandeling van patiënten met diabetes en afwijkingen in het looppatroon. 
Behandelprogramma’s moeten gericht zijn op progressief in moeilijkheidsgraad 
toenemende krachtoefeningen, proprioceptieve training en dagelijkse activiteiten om de 
zelfverzekerdheid van patiënten met diabetes te vergroten. Een fysiotherapeutische 
benadering gericht op deze adviezen werd ontwikkeld en onderzocht in een randomised 
controlled trial (Hoofdstuk 7: “Diabetic patients’ gait and balance can be improved with a 
specific training program. A randomised controlled trial”). Eenenzeventig patiënten 
werden gerandomiseerd toegewezen aan een interventie (n = 35) of een controlegroep (n = 
36). De interventie bestond uit groepstraining, tweemaal per week gedurende 12 weken. 
Elke training bestond uit een warming-up gevolgd door een circuittraining met daarin loop- 
en balansoefeningen (hielen- en tenenstand, tweebenen stand, stand op één been, lopen). 
Deze loop- en balansoefeningen werden afgewisseld met functionele krachtoefeningen 
(van zit tot stand, een helling op en neer lopen, traptreden, sprongen), die naast opbouw 
van kracht, patiënten meer vertrouwd moeten maken met dagelijkse activiteiten. De 
complexiteit van de taken werd progressief verhoogd. De training werd afgesloten met 
interactieve spelletjes en met een korte feedback en suggesties voor individuele 
oefeningen thuis. De training had een positief effect op de loopsnelheid, balans, spierkracht 
en gewrichtsmobiliteit van patiënten. Na het 12 weken durende programma werden 
patiënten aangemoedigd thuis door te gaan met de aangeleerde oefeningen gedurende 
een half jaar. De deelnemers ontvingen verder geen advies en er werden hen geen 
beperkingen opgelegd. Het voordeel van de behandeling was na 6 maanden follow-up 
gedeeltelijk verdwenen, maar de prestaties bleven beter dan bij aanvang van de studie. 
Ondanks verschillende beperkingen, welke meer gedetailleerd worden besproken in het 
laatste hoofdstuk (Hoofdstuk 8: “General discussion”), geeft deze studie hoopvolle 
resultaten voor de verbetering van de gang en de balans bij patiënten met diabetes type 2. 
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Er is echter meer onderzoek nodig voordat er aanbevelingen kunnen worden gedaan over 
de beste behandelmethode. Andere benaderingen zoals het gebruik van een hulpmiddel, 
training in het lopen in verschillende (en uitdagende) omgevingen of een 
krachttrainingsprogramma kunnen ook effectief zijn in het verbeteren van looppatroon en 
balans bij patiënten met diabetes. Daarnaast kan een meer kwalitatieve studie, gericht op 
het evalueren van ervaringen, zelfredzaamheid, motivatie en attitude van patiënten nuttig 
zijn om een optimale compliance, adhesie and zelfmanagement te bereiken. 
Het onder de aandacht brengen van de bevindingen uit dit proefschrift, met name de 
diabetes gerelateerde loop- en valproblematiek, bij clinici vormt nog een uitdaging voor de 
toekomst. 
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RESUME EN FRANÇAIS 
Résumé en français 
Resumé en français 
L’Organisation Mondiale de la Santé considère le diabète de type 2 comme une épidémie 
internationale. En 2000, 171 millions d’individus souffraient de diabète dans le monde. Une 
estimation prévoit que ce nombre devrait atteindre 360 millions en 2030. Environ 58% des 
patients diabétiques présentent une ou plusieurs complications liées à leur maladie, ce qui 
engendre une augmentation de la demande de soins médicaux. La complication la plus 
fréquente est la neuropathie périphérique qui affecte les fonctions neurales et se 
développe des régions périphériques vers les régions plus proximales. Près de 50% des 
patients souffrant depuis plus de 20 ans d’un diabète présentent une neuropathie 
périphérique. 
Deux axes principaux de traitement sont proposés aux patients diabétiques. Le premier est 
basé sur l’hygiène de vie: conseils diététiques et recommandations concernant l’activité 
physique. Le deuxième, utilisé lorsque le premier s’avère insuffisant ou inefficace, fait appel 
aux médicaments (insuline et antidiabétiques oraux). 
Pour éviter les complications liées au diabète, une activité physique de 30 minutes par jour, 
6 jours par semaine est conseillée. Comme il est connu que les patients diabétiques sont 
sujets à un risque de chute important ces recommandations créent un dilemme. Des 
personnes qui présentent un risque de chute élevé, des déséquilibres à la marche ou qui 
ont subi un traumatisme suite à une chute peuvent-elles suivre ces recommandations et 
réaliser une activité physique régulière? Si elles ne le font pas, elles vont entrer dans un 
cercle vicieux où la réduction de l’activité physique augmente le risque de complications 
diabétiques qui, à leur tour, limiteront le fonctionnement musculo-squelettique. 
L’objectif de ce projet était de développer et de tester l’efficacité d’une approche 
physiothérapeutique visant à améliorer la marche des patients diabétiques, leur 
équilibration et certains les facteurs cliniques liés à ces fonctions. Cette démarche 
nécessitait plusieurs étapes ; chacune d’entre elles est décrite dans les chapitres de cette 
thèse. 
La première étape a consisté en une revue systématique de la littérature au sujet des 
caractéristiques de la marche des patients diabétiques (Chapitre 2: “Gait characteristics of 
diabetic patients: a systematic review”). Cette revue systématique a montré que la qualité 
des études existantes sur la marche des patients diabétiques est de modérée à très bonne. 
Les résultats obtenus étaient variables. Cependant, les questions concernant les principales 
causes et particulièrement les différents facteurs cliniques en lien avec des altérations de la 
marche des patients diabétiques restent actuellement sans réponse. Par ailleurs, bien que 
la plupart des chutes se produisent dans un environnent complexe, les paramètres de la 
marche ont rarement été évalués dans des situations réelles (à l’extérieur, passage peu 
éclairé, surface irrégulière). De plus, peu d’études ont investigué l’effet d’interventions 
visant à améliorer la qualité de la marche (feedback auditif, différentes chaussures ou 
semelles, médicaments). En conclusion, les résultats de cette revue montrent qu’il est 
nécessaire d’étudier les caractéristiques de la marche des patients diabétiques dans des 
conditions proches d’un environnement réel. Pour réaliser de telles études, il fallait 
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disposer d’un système de mesure dont la précision serait préalablement testée dans les 
différentes conditions concernées. (Chapitre 3: “Reliability of diabetic patients’ gait 
parameters in a challenging environment”). Les profils de Bland et Altman nous ont fourni 
une image qualitative de la précision de notre instrument de mesure. Globalement, les 
résultats sont similaires pour les trois surfaces sur lesquelles des tests ont été effectués: 
goudron, gazon et pierres. La différence moyenne au sein de chaque variable mesurée sur 2 
jours différents était faible et toutes les différences étaient distribuées autour de zéro. Ces 
résultats ont été confirmés par une bonne fiabilité (valeurs ICC > 0.8) pour tous les 
paramètres testés (excepté la mesure de la mobilité du genou qui n’a montré qu’une 
fiabilité moyenne). Au vu de cette bonne fiabilité inter-séance et des valeurs de 
changement minimal détectable ainsi que des faibles erreurs de mesures constatées, nous 
avons décidé d’utiliser le système Physilog® pour effectuer nos recherches. Ce système de 
mesure s’est relevé être un instrument utile, précis et fiable pour évaluer la marche des 
patients diabétiques à l’extérieur, sur les différents terrains testés. Après avoir mené cette 
étude de reproductibilité, nous avons testé la marche des patients diabétiques, avec et 
sans neuropathie périphérique, à l’extérieur, sur ces 3 surfaces différentes (goudron, gazon 
et pierres) afin de mieux comprendre la marche de ces patients. (Chapitre 4: “Gait 
alterations of diabetic patients while walking on different surfaces”). Cette étude a 
montré que les paramètres de marche diffèrent entre les sujets sains et les patients 
atteints de neuropathie périphérique pour toutes les variables mesurées: vitesse de 
marche, cadence, durée de la phase d’appui et de l’appui bipodal, longueur et durée du 
cycle, mobilité du genou, de la hanche et de la cheville, coefficient de variation de la 
longueur et de la durée du cycle. De plus, une différence a été mesurée entre les sujets 
sains et les patients diabétiques sans neuropathie périphérique pour la vitesse de marche, 
la cadence et la durée du cycle de marche. Les paramètres de marche semblaient être plus 
altérés chez les patients atteints de neuropathie périphérique que chez les patients sans 
neuropathie périphérique. Néanmoins, aucune différence significative n’a été détectée 
entre les patients diabétiques atteints ou non de neuropathie périphérique. Cette étude 
s’intéressait également à la stratégie de marche utilisée par les patients diabétiques 
lorsqu’ils devaient passer d’une surface régulière à une surface irrégulière. Les patients 
diabétiques, avec ou sans neuropathie périphérique, adaptaient leur façon de marcher aux 
différentes surfaces en utilisant des stratégies identiques. Ces stratégies étaient semblables 
à celles utilisées par le groupe contrôle des sujets sains. En passant d’un terrain plat 
(goudron) à un terrain irrégulier (pierres), les patients diabétiques et les sujets contrôles 
ont diminué leur vitesse de marche en réduisant la cadence et en augmentant la durée du 
cycle. Ils ont diminué la longueur de leur pas et ont augmenté la variabilité entre les pas. 
L’effet le plus important dû au type de surface de marche a néanmoins été constaté chez 
les patients diabétiques atteints de neuropathie périphérique, suivi par les patients sans 
neuropathie périphérique et les sujets sains. 
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Sachant que les chutes sont un phénomène complexe et que les lacunes de l’équilibration 
constituent un des risques majeurs de chute, nous avons comparé  l’équilibre des patients 
diabétiques  atteints  ou  non  de  neuropathie  périphérique,  avec  un  groupe  contrôle. 
(Chaptitre  5:  “Investigation  of  standing  balance  in  diabetic  patients with  and without 
peripheral neuropathy using accelerometers”). L’équilibre debout (yeux ouverts et fermés)
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a été analysé avec des accéléromètres. Les accélérations ont été mesurées au niveau 
lombaire et au niveau des chevilles en utilisant des accéléromètres. Les résultats ont 
montré que les patients diabétiques atteints de neuropathie périphérique présentaient une 
plus grande instabilité avec des accélérations plus élevées que les sujets sains et que les 
patients diabétiques sans neuropathie périphérique. L’instabilité posturale augmentait avec 
les yeux fermés. Les patients diabétiques atteints de neuropathie périphérique 
présentaient aussi une différence plus importante entre les tests «yeux ouverts» et «yeux 
fermés». Avant de développer un traitement spécifique, il était nécessaire de mener une 
autre étude pour identifier les paramètres cliniques associés aux altérations de la marche 
des patients diabétiques. (Chapitre 6: “Clinical factors associated with gait alterations in 
diabetic patients”). Soixante-seize patients diabétiques ont été testés. Un examen clinique 
précédait l’évaluation de la marche qui a été réalisée sur une surface goudronnée et sur 
une surface pierreuse. Les différences respectives de vitesse de marche (performance de la 
marche) et de variabilité des pas (coefficient de variabilité de la durée du cycle - qui 
constitue un index de risque de chute) ont été calculées en comparant la marche entre ces 
deux surfaces (goudron versus pierre). Les associations entre cette différence et les 
facteurs cliniques ont été analysées au moyen de coefficients de corrélation et d’une 
régression linéaire. L’étude a montré que la diminution de la vitesse de marche liée au 
changement de terrain était partiellement associée à la force isométrique maximale 
moyenne des membres inférieurs, à la peur de tomber et à la capacité de perception des 
vibrations (neuropathie périphérique). La force isométrique maximale moyenne des 
membres inférieurs était également associée au coefficient de variabilité de la durée du 
cycle. Ces résultats montrent que les facteurs physiologiques (force et proprioception) et 
cognitivo-comportementaux (peur de tomber) sont associés aux problèmes de marche des 
patients diabétiques et devraient donc être pris en considération dans les traitements 
proposés à ces patients. Les programmes d’entraînement devraient inclure des exercices de 
force d’intensité progressive, un entraînement de la proprioception et des activités 
quotidiennes dans le but d’améliorer la confiance des patients. Considérant les résultats 
mentionnés ci-dessus, un programme d’exercices de physiothérapie a été développé et 
testé au moyen d’une étude randomisée contrôlée (Chapitre 7: “Diabetic patients’ gait and 
balance can be improved with a specific training program. A randomised controlled 
trial”). Un échantillon de 71 patients a été attribué de façon aléatoire à un groupe de 
traitement (n = 35) ou de contrôle (n = 36). L’intervention était réalisée en groupe, 2 fois 
par semaine, pendant 12 semaines. La séance était composée d’un échauffement, suivi 
d’un entraînement comportant des exercices d’équilibration (talons et pointes des pieds, 
en fente avant ou sur une jambe) ainsi que différentes formes de marche. Ces exercices 
alternaient avec des exercices fonctionnels de renforcement (se lever, s’asseoir, monter, 
descendre une pente ou des escaliers, sauter) qui, en plus du renforcement, visaient à 
rendre les patients plus confiants face aux activités de la vie quotidienne. Les exercices 
devenaient progressivement plus complexes. Les séances se terminaient par des jeux 
interactifs, un feedback et des recommandations d’exercices à effectuer à domicile. 
L’entraînement a montré un effet positif sur la vitesse de marche, l’équilibre, la force 
musculaire et la mobilité articulaire des patients diabétiques. Après un programme de 12 
semaines, les patients étaient encouragés à poursuivre au cours des 6 mois à venir les 
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exercices appris pendant les séances. Ils ne recevaient ni autres conseils, ni autres 
restrictions. Le suivi à 6 mois a montré que les participants ont partiellement perdu l’effet 
de l’entraînement, mais leur niveau de performance est resté supérieur à celui qu’ils 
avaient avant l’entraînement. 
Malgré plusieurs limites discutées dans le dernier chapitre (Chapitre 8: General 
Discussion”), cette étude fournit des résultats prometteurs pour l’amélioration des 
problèmes de marche et d’équilibration des patients diabétiques de type 2. Cependant, 
d’autres études sont nécessaires avant de pouvoir énoncer des recommandations 
définitives pour la pratique. D’autres approches, telles que l’aménagement de 
l’environnement, l’utilisation d’aides techniques, l’entraînement à la marche dans des 
environnements variés ou un programme de renforcement musculaire séparé de toute 
autre intervention pourraient également être en mesure d’améliorer la marche et 
l’équilibration des patients diabétiques. D’autre part, une approche plus qualitative qui 
évaluerait l’expérience, l’autonomie, les motivations personnelles ainsi que les attitudes 
des patients envers ce programme pourrait les aider à optimiser leur participation et leur 
auto-gestion. 
Un des défis futurs consistera à attirer l’attention des cliniciens sur les problèmes de 
marche ainsi que sur les risques de chute que rencontrent les patients diabétiques afin de 
combler le fossé existant entre la recherche et la clinique. 
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I. GAIT CYCLE 
With reference to Perry [1] 8 phases can be distinguished within one gait cycle: initial 
contact, loading response, mid-stance, terminal stance, pre-swing, initial swing, mid-swing 
and terminal swing (Figure A I and A II). 
Definition of gait phases 
1. Initial contact: this phase comprises the moment when the foot just touches the floor. 
Its primary concern is the way the foot strikes the floor. 
2. Loading response: this is the initial double stance period. The phase begins with the 
initial floor contact and continues until the other foot is lifted. The goal is the 
acceptance of body weight in a manner that ensures limb stability and still permits 
progression. 
3. Mid-stance: this is the first half of the single limb support interval. It begins as the 
other foot is lifted and continues until body weight is aligned over the forefoot. The 
advancement of the body and limb over a stationary foot is the functional objective of 
this gait phase. 
4. Terminal stance: this phase completes the single limb support. It begins with heel rise 
and continues until the other foot strikes the ground. Here, the forward fall to 
generate a propulsive force is the primary objective. 
5.  Pre-swing: this final phase of stance is the second double stance interval in the gait 
cycle. It begins with initial contact of the opposite limb and ends with ipsilateral toe-
off. Preparation of the limb for swing is the purpose of the actions that occur during 
the pre-swing phase. 
6. Initial swing: this phase begins with lift of the foot from the ground and ends when the 
swinging foot is opposite the stance limb. Limb advancement and preparation for 
stance are the objectives of this phase. 
7. Mid-swing: this phase begins when the swinging limb is opposite the stance limb. The 
phase ends when the swinging limb is forward and the tibia vertical. 
8. Terminal swing: this phase begins with a vertical tibia and ends when the foot strikes 
the floor. Advancement is terminated and the limb is prepared for stance. 
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Figure A I.1. Divisions of the gait cycles defined by Perry [1]. 
 
 
 
 
Figure A I.2. Representations of a gait cycle (stride) following Perry [1]. 
1 2 3 4 5 6 7 8
1. Initial contact  ( 0 - 2%) 
2. Loading response   ( 0-10%) 
3. Mid-stance  (10-30%) 
4. Terminal stance  (30-50%) 
5. Pre-swing  (50-60%) 
6. Initial swing  (60-73%) 
7. Mid-swing  (73-87%) 
8. Terminal swing  (87-100%) 
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II. DEFINITION OF SPATIOTEMPORAL GAIT PARAMETERS 
1. Gait speed or velocity (metre per second): gait speed or velocity is the distance 
travelled per unit time. The units for speed are metres per second (ms-1). 
2. Cadence (steps per minute): cadence defines the rhythm of the gait. It is the number of 
steps per minute (stepsmin-1). 
3. Stride length or gait cycle length (metres): stride length is defined as the distance from 
initial contact of one foot to the following initial contact of the same foot. This term 
may also be referred to as gait cycle length. 
4. Step length (metre): the step length is the distance from initial contact of one foot to 
the following initial contact of the opposite foot (Figure A III). 
5. Stance Phase (percentage of gait cycle): the stance time is the period of time when the 
foot is in contact with the ground. The stance phase represents about 60% of the gait 
cycle. 
6. Swing Phase (percentage of gait cycle): this is the period of time when the foot is not in 
contact with the ground. The swing phase represents about 40% of the gait cycle. 
7. Double Support Phase (percentage of gait cycle): the double support time is the period 
of time when both feet are in contact with the ground. This occurs twice in the gait 
cycle, at the beginning and at the end of the stance phase. This term is also referred to 
as left and right double limb stance. The double support time represents 20% of the 
gait cycle (2 x 10%). 
8. Single Support Phase (percentage of gait cycle): the single support time is the period of 
time when only one foot is in contact with the ground. The single support time 
represents 40% of the gait cycle. 
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Additional important definition 
Coefficient of variation (percentage): the coefficient of variation (CV) expresses the gait 
(stride to stride) variability. It is calculated as: standard deviation/mean × 100. Several 
studies showed associations between increased gait variability and the fall risk [2-4].  
III. THE AMBULATORY GAIT MEASUREMENT SYSTEM 
The Physilog® (BioAGM, CH) [5] is an ambulatory acquisition system with 16 channels. All 
data are stored on a multimedia memory card. This system records analog signals of 5 
sensors which are placed on both shins, both thighs and on the trunk (Figure A IV). 
The sensor on the trunk contains tri-axial accelerometers (type ADXL202, range ± 2g; 
Analog Devices, 162 Norwood, USA) and a gyroscope (type ADXRS150, sensitivity ± 200 
degs-1; Analog Devices, 162 Norwood, USA). Each sensor on the limbs contains bi-axial 
accelerometers (type ADXL210, range ± 5g; Analog Devices, Norwood, USA) and a 
gyroscope (type ADXRS150, sensitivity ± 500 degs-1 for thighs and 400 for shins; Analog 
Devices, 162 Norwood, USA). 
For the interpretation of gait, only the gyroscopes of the lower limbs are used. Each 
gyroscope measures the velocity of the angular rotation per segment around the coronal 
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Figure A III. Presentation of the main material used in this project. 
Size: 95 x 60 x 22 mm  
Weight: 150 g  
Autonomy: approximately 15 h  
Frequency: 200 Hz 
Accelerometer: ± 2 g 
Gyroscope: 200 degs-1 
Accelerometer: ± 5 g 
Gyroscope: 400 degs-1 
Accelerometer: ± 5 g 
Gyroscope: 600 degs-1 
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axis (flexion-extension). Signals are digitised (16 bit) at a sampling rate of 200 Hz and stored 
for off-line analysis on a memory card. 
In order to compute the temporal parameters such as the duration of swing, single and 
double stances during a gait cycle, it is necessary and sufficient to determine for each leg 
the precise moments of heel strike (when the foot first touches the floor) and toe-off 
(when it takes off) during that cycle. These events have distinctive signal features of shin 
angular velocity appearing as rather sharp negative peaks involving some medium and 
relative high frequencies [5] (see Chapter 3 Figure 3.3). 
For spatial parameters estimation, a double segment gait model involving both shins and 
thighs was used. In this model, the swing phase is considered as a double pendulum model, 
while the stance phase is considered as an inverse double pendulum model. 
Environment of gait analysis 
The environment used for gait analysis in this project was a walking course outside in the 
backyard of the University hospital offering 3 possibilities for combining the sequence of 
surfaces. Between each change of surface, patients had to wait for 8-10 s. This time was 
necessary to allow the identification of each surface change on the raw data. The two first 
and last cycles were not considered in the analysis to avoid acceleration and deceleration. 
 
First combination:  50 m tarred pathway - 50 m grass - 50 m tarred pathway – go up 20 m 
slope at 10% – go down 20 m slope at 10% - 50 m grass – 20 m 
cobblestones – go up and down 6 steps – 20 m cobblestones - go up 
and down 6 steps. 
Second combination: 50 m grass - 50 m tarred pathway - 50 m grass - go up 20 m slope at 
10% – go down 20 m slope at 10% - 50 m tarred pathway – 20 m 
cobblestones – go up and down 6 steps – 20 m cobblestones - go up 
and down 6 steps. 
Third combination:  20 m cobblestones – go up and down 6 steps – 20 m cobblestones - 
go up and down 6 steps – 50 m tarred pathway -- 50 m grass - 50 m 
tarred pathway – go up 20 m slope at 10% – go down 20 m slope at 
10%- 50 m grass. 
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IV. TREATMENT 
A session consisted of a warm up (5 min) followed by a circuit training (40 min) including 
gait and balance exercises. The circuit training was composed of a set of 10 tasks. Static and 
dynamic balance tasks were alternated with functional strength exercises. Each task was 
carried out twice during 1 min and the complexity of the task could progressively be 
increased. Each session was completed with interactive games (10 min) and a short 
feedback with suggestions for individual home exercises (5 min). The circuit training 
consisted of 10 circuit stations: 5 static or dynamic posts (depending on the balance 
capacity of each patient) linked with 5 functional posts. Patients worked alternatively for 1 
min on a static/dynamic station and then 1 min on a linked functional station. Patients 
should repeat each combined station twice before starting a new post. 
One of the main circuit stations of each session was the Biodex® stability system or the 
wobble board (Figure A V). Each patient received specific training for 8 min (equivalent of 
one combined post (4 times 2 min)). One patient worked on the Biodex® system with a 
visual feedback and the other on the wobble board. In the next treatment session they 
exchanged the therapeutic instrument. The Biodex® differs from a static force platform. Any 
movement of the body’s centre of gravity away from a perfectly balanced position (directly 
over the central portion of the base of support) results in the creation of a force moment 
that must be counteracted by an appropriate muscle activation pattern and generation of 
sufficient muscular torque to prevent the support surface from tilting. The level of difficulty 
while standing on the platform can be manipulated by altering the resistance of the 
platform to deviations [6, 7]. 
The level of difficulty of the training was progressively increased: with hands → without 
hands → bipodal → tandem stance → unipodal (and by decreasing the platform stability 
®
These postural exercises improve individual’s ability to perceive and to align gravitational 
and ground reaction forces through enhanced kinaesthetic awareness and rapid activation 
of the appropriate muscle recruitment patterns. The level of difficulty was progressively 
increased. 
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DYNAMIC EXERCISES 
Circuit I: Unipodal (30 s for both legs) 
Standing without support while swinging the no supporting leg forward and 
backward or while playing with a ball. 
Circuit II: Heel stands and walk 
 Walking along a straight line on heels with support.  
 Walking along a straight line on heels without support.  
 Walking along a straight line holding a tray. 
Circuit III: Toe stands and walk 
 Walking along a straight line on toes with support. 
 Walking along a straight line on toes without support. 
 Walking along a straight line holding a tray. 
Circuit IV: Stepping 
Stepping up and down a step (15–20cm), with support (30 s steps up with both legs 
as the leading leg). 
Stepping onto the step with the leading leg, tipping with the non-leading leg on the 
step and stepping off the step, without placing the non-leading leg onto the step, 
without support (30 s steps up with the leading leg and 30 s with the non-leading 
leg). 
 Stepping over the step, without support (30 s steps up with both legs). 
 Step over step, while holding a cup or tray. 
Circuit V: Standing on an unstable surface 
STATIC EXERCISES 
Circuit I: Balance exercises 
 Rubbing firmly one’s legs and ankles with the hands or with different materials. 
Circuit II: Unipodal (for all variations: 3 series of 10 s for both legs) 
 Standing on one leg with support. 
 Standing on one leg without support. 
 Standing without support and holding a ball, cup or tray. 
Circuit III: Heel stands and walks  
Standing on heels with support. 
Standing on heels without support.  
Standing on heels and holding a ball, cup or tray. 
Circuit IV: Toe stands and walks  
Standing on toes with support. 
Standing on toes without support. 
Standing on toes without support and holding a ball, cup or tray. 
Circuit V: Standing on an unstable surface 
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FUNCTIONAL EXERCISES 
Circuit I: Sit to stand 
Seat height adjusted to the knee position. 
With the use of arms. 
Without the use of arms for push-off and with seat height adjusted (knee flexed < 
90deg). 
Without the use of arms for push-off and with seat height adjusted (knee flexed 
90deg). 
Without the use of arms for push-off and with seat height adjusted (knee flexed > 
90deg). 
Stand up from the floor, with and without support of a chair and in different ways. 
Circuit II: Walking along a straight line forward, backward and sideways 
Walking without support. 
Stepping over sticks (height, 3 cm) that are lined up over a distance of 8 m with a 
variable inter-stick distance that can be covered in one step without support. 
Walking while carrying a cup filled with water. 
Walking while carrying a tray so the feet cannot be seen. 
Circuit III: Steps (up, down) 
Circuit IV: Slope 
Circuit V: Jump (up and down on different surfaces) 
Circuit VI: Running 
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Figure A IV.  
(a) Biodex balance® system  
(b) wobble board. 
 
 
(a) (b)
Tilting surface
Visual control 
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